aidx;assay_category;assay_cell_type;assay_chembl_id;assay_classifications;assay_organism;assay_parameters;assay_strain;assay_subcellular_fraction;assay_tax_id;assay_test_type;assay_tissue;assay_type;assay_type_description;bao_format;bao_label;cell_chembl_id;confidence_description;confidence_score;description;document_chembl_id;relationship_description;relationship_type;src_assay_id;src_id;target_chembl_id;tissue_chembl_id;variant_sequence
CLD0;;A2780;CHEMBL619118;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Compound was evaluated for cytotoxicity against A2780 cell lines.;CHEMBL1129744;Non-molecular target assigned;N;;1;CHEMBL614004;;
CLD0;;A2780;CHEMBL619150;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780/DX(RI);CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL614004;;
CLD0;;RPMI-8226;CHEMBL619302;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;In vitro inhibition of tumor cell growth in the human myeloma 8226 system.;CHEMBL1125355;Non-molecular target assigned;N;;1;CHEMBL614882;;
CLD0;;A549;CHEMBL620128;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;In vitro cytotoxic activity against human lung A549 cell line ( standard deviation in parenthesis);CHEMBL1135469;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;RPMI-8226;CHEMBL620360;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;In vitro inhibition of tumor cell growth in the human myeloma 8226/ADR system.;CHEMBL1125355;Non-molecular target assigned;N;;1;CHEMBL614882;;
CLD0;;A549;CHEMBL621429;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Tested against A549 lung carcinoma in the sulforhodamine B assay.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL623386;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Activity against A549 cancer cell line.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A549;CHEMBL620339;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Inhibitory concentration of compound against proliferation of lung carcinoma A549 cell line;CHEMBL1135121;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;A-375;CHEMBL624584;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308077;Target assigned is non-molecular;1;Inhibitory activity against human tumor cell line A0375 melanoma.;CHEMBL1128703;Non-molecular target assigned;N;;1;CHEMBL613859;;
CLD0;;A2780;CHEMBL619465;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Concentration required to inhibit A2780-cell growth by 50%;CHEMBL1131065;Non-molecular target assigned;N;;1;CHEMBL614004;;
CLD0;;A2780;CHEMBL619469;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;Cytotoxic potency required to inhibit A2780 cell growth by 50% after cell drug contact for 96 hrs;CHEMBL1130313;Non-molecular target assigned;N;;1;CHEMBL614004;;
CLD0;;A2780;CHEMBL623407;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308421;Target assigned is non-molecular;1;In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL614004;;
CLD0;;;CHEMBL626616;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.;CHEMBL1129744;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL626617;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.;CHEMBL1129744;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL633166;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Estimated pKa value of the compound;CHEMBL1125436;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL635339;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;"DNA binding dissociation constant as KD; No data";CHEMBL1122633;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL857734;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Apparent equilibrium constant for DNA binding (C-T);CHEMBL1144932;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;UACC-375;CHEMBL636873;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307880;Target assigned is non-molecular;1;Inhibitory activity against AUC375 cell line;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL614127;;
CLD0;;B16;CHEMBL647080;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308454;Target assigned is non-molecular;1;Tested for activity against murine B-16 melanoma in mice and percent treated to the control values with the number of 60 day survivors;CHEMBL1123657;Non-molecular target assigned;N;;1;CHEMBL381;;
CLD0;;B16;CHEMBL647084;[{'assay_class_id': 91, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Melanoma Oncology Models', 'l3': 'Experimental Melanoma', 'source': 'phenotype'}, {'assay_class_id': 92, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Melanoma Oncology Models', 'l3': 'General Melanoma', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Compound was tested against sc B16 melanoma at % tumor growth inhibition(TGI) in mice at 3.2 mg/kg dosage.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL381;;
CLD0;;B16;CHEMBL648693;[{'assay_class_id': 91, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Melanoma Oncology Models', 'l3': 'Experimental Melanoma', 'source': 'phenotype'}, {'assay_class_id': 92, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Melanoma Oncology Models', 'l3': 'General Melanoma', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Optimal dose per injection in mg/kg required to inhibit growth of murine B-16 melanoma in vivo;CHEMBL1123657;Non-molecular target assigned;N;;1;CHEMBL381;;
CLD0;;CCRF-CEM;CHEMBL656072;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity in human leukemic CCRF-CEM cells.;CHEMBL1144914;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;;CHEMBL660045;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;"Survivors of CDF1 mice on day 4 after 1st injection of compound 12 at mg/kg in six mice; 6/6";CHEMBL1124546;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL656350;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.75', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.75'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;"Survivors of CDF1 mice on day 4 after 1st injection of compound at 0.75 mg/kg in six mice; 6/6";CHEMBL1124546;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL656352;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;"Survivors of CDF1 mice on day 4 after 1st injection of compound at 1.5 mg/kg in six mice; 6/6";CHEMBL1124546;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL656359;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;"Survivors of CDF1 mice on day 4 after 1st injection of compound at 3 mg/kg in six mice; 6/6";CHEMBL1124546;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL656364;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;"Survivors of CDF1 mice on day 4 after 1st injection of compound at 6 mg/kg in six mice; 6/6";CHEMBL1124546;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL654326;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Inhibitory concentration against ethidium:calf thymus DNA (1.26:1) binding at pH 5;CHEMBL1130313;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL654328;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Inhibitory concentration against ethidium:Calf thymus DNA (1.26:1) binding at pH 7;CHEMBL1130313;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL651390;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Inhibitory concentration against ethidium:Calf thymus DNA(0.1:1) binding at pH 5;CHEMBL1130313;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL659370;[];Bos taurus;[];;;9913.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Thermal denaturation of calf-thymus DNA was evaluated;CHEMBL1126952;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;CH1;CHEMBL657466;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307620;Target assigned is non-molecular;1;Cytotoxic potency required to inhibit CH1 cell growth by 50%;CHEMBL1130313;Non-molecular target assigned;N;;1;CHEMBL614455;;
CLD0;;CH1;CHEMBL652119;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307620;Target assigned is non-molecular;1;Concentration required to inhibit CH1-cell growth by 50%;CHEMBL1131065;Non-molecular target assigned;N;;1;CHEMBL614455;;
CLD0;;ovary;CHEMBL662306;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Tested for the cytotoxicity against the repair deficient xrs-6 chinese hamster ovary cell line;CHEMBL1127394;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL666638;[];Clostridium perfringens;[];;;1502.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Increase in Melting temperature (delta Tm) for Clostridium perfringens DNA on interaction against ligand (mole ratio of 10:1);CHEMBL1125436;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL664085;[];Micrococcus luteus;[];;;1270.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Increase in Melting temperature (delta Tm) for Micrococcus lysodeikticus DNA on interaction against ligand (mole ratio of 10:1);CHEMBL1125436;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL660973;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;In vitro inhibition of calf thymus DNA/ethidium bromide complex formation.;CHEMBL1135469;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL660976;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;In vitro calf thymus DNA binding affinity by ethidium bromide displacement;CHEMBL1135121;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL664588;[];Bos taurus;[];;;9913.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Apparent equilibrium constant for binding to calf thymus DNA by competitive displacement fluorometric assay;CHEMBL1134414;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL663879;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity towards calf thymus DNA;CHEMBL1132293;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL663630;[];Bos taurus;[];;;9913.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Compound was evaluated for the increase in melting temperature (delta Tm) for calf Thymus DNA on interaction with Ligand at DNAp to ligand ratio 10:1;CHEMBL1125436;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL663631;[];Bos taurus;[];;;9913.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Compound was evaluated for the increase in melting temperature (delta Tm) for calf Thymus DNA on interaction with Ligand at DNAp to ligand ratio 20:1;CHEMBL1125436;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL663635;[];Bos taurus;[];;;9913.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is molecular non-protein target;3;Increase in Melting temperature (delta Tm) for Calf thymus DNA on interaction against ligand (mole ratio of 10:1);CHEMBL1125436;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL665844;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;CT-DNA binding required to produce a 50% drop in fluorescence of DNA-bound ethidium.;CHEMBL1135709;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL663967;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Concentration required to give 50% fluorescence quenching of bound ethidium for [ethidium]: [(poly dG-dC)]2 DNA in ratio of 0.1:1 at pH 5;CHEMBL1130313;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL663968;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Concentration required to give 50% fluorescence quenching of bound ethidium for [ethidium]: [poly(dA-dT)]2 DNA in ratio of 0.1:1 at pH 5;CHEMBL1130313;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;DU-145;CHEMBL665014;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line DU145;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL613508;;
CLD0;;;CHEMBL669721;[];;[];;;;;;B;Binding;BAO_0000224;protein format;;Multiple homologous protein targets may be assigned;4;In vitro inhibition of partially purified human ovarian carcinoma topoisomerase II of kDNA decatenation;CHEMBL1128184;Homologous protein target assigned;H;;1;CHEMBL2094255;;
CLD0;;EBV-positive nasopharyngeal cell line;CHEMBL679826;[];epstein barr virus;[];;;10376.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307883;Target assigned is non-molecular;1;Percent colony reduction in cell growth in EBV-positive nasopharyngeal cell lines after administration of 0.1 ug/mL dose;CHEMBL1122406;Non-molecular target assigned;N;;1;CHEMBL614154;;
CLD0;;EBV-positive nasopharyngeal cell line;CHEMBL679274;[];epstein barr virus;[];;;10376.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307883;Target assigned is non-molecular;1;EBV-positive nasopharyngeal colony count obtained from the examination of uniform plate surface areas after a dose of 0.1 ug/mL;CHEMBL1122406;Non-molecular target assigned;N;;1;CHEMBL614154;;
CLD0;;G-361;CHEMBL679417;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307514;Target assigned is non-molecular;1;Cytotoxic potency required to inhibit G-361 cell growth by 50%;CHEMBL1130313;Non-molecular target assigned;N;;1;CHEMBL614036;;
CLD0;;HCT-116;CHEMBL688361;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;"Tested for the cytotoxicity to inhibit replication assay against the human colon tumor cell line HCT116; ND is Not Determined";CHEMBL1127394;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;HL-60;CHEMBL687154;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Compound was tested in vitro for cytotoxicity against HL60 human leukemia cell line (72 hr exposure to compound);CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL689461;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;"Relative cytotoxicity against Human promyelocytic Leukemia(HL-60) cells; Value is in range, activity expressed as IC50";CHEMBL1132240;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL687286;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;"Relative cytotoxicity against Human promyelocytic Leukemia(HL-60) cells; Value is in range, activity expressed as IC90";CHEMBL1132240;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL880739;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Compound was tested for tumor cell growth inhibition against HL 60 cell line;CHEMBL1150507;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HT-29;CHEMBL692393;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line HT-29;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL692407;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;In vitro cytotoxicity was tested against human colon adenocarcinoma HT-29 cell line;CHEMBL1132293;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL691903;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Inhibitory activity against human tumor cell line HT-29.;CHEMBL1128703;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL696138;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at G1 phase of cell cycle at a dose of 100n g/mL after 72 hours of induction in HT-29 cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL696139;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at G1 phase of cell cycle at a dose of 25 ng/mL after 72 hours of induction in HT-29 cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL696140;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at G2/M phase of cell cycle at a dose of 100n g/mL after 72 hours of induction in HT-29 cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL696141;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at G2/M phase of cell cycle at a dose of 25 ng/mL after 72 hours of induction in HT-29 cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL696142;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at S phase of cell cycle at a dose of 100n g/mL after 72 hours of induction in HT-29 cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL696143;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at S phase of cell cycle at a dose of 25 ng/mL after 72 hours of induction in HT-29 cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL692884;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Effect of compound as percent survival at dose of 100n g/mL on HT-29 cell line after 72 hours;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL880161;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Effect of compound as percent survival at dose of 25 ng/mL on HT-29 cell line after 72 hours;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695183;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line HT-29/Mx;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at G1 phase of cell cycle at a dose of 1000 ng/mL after 72 hours of induction in HT-29 cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695188;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at G1 phase of cell cycle at a dose of 250 ng/mL after 72 hours of induction in HT-29/Mx cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL879711;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at G2/M phase of cell cycle at a dose of 100n g/mL after 72 hours of induction in HT-29/Mx cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695191;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at S phase of cell cycle at a dose of 1000 ng/mL after 72 hours of induction in HT-29/Mx cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695195;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Percent inhibition at S phase of cell cycle at a dose of 250 ng/mL after 72 hours of induction in HT-29/Mx cell line;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695196;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Effect of compound as percent survival at dose of 1000 ng/mL on HT-29/Mx cell line after 72 hours;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695200;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Effect of compound as percent survival at dose of 250 ng/mL on HT-29/Mx cell line after 72 hours;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695201;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Effect of compound as percent survival at dose of 3000 ng/mL on HT-29/Mx cell line after 72 hours;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL687687;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;In vitro cytotoxic potency against HT-29 (human colon adenocarcinoma) cell line.;CHEMBL1135709;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL690460;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxic potency required to inhibit HT-29 cell growth by 50% after cell drug contact for 144 hrs;CHEMBL1130313;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL691909;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Inhibitory concentration of compound against proliferation of colon carcinoma HT-29 cell line;CHEMBL1135121;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-1080;CHEMBL872954;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308396;Target assigned is non-molecular;1;Inhibitory activity against human tumor cell line HT1080.;CHEMBL1128703;Non-molecular target assigned;N;;1;CHEMBL614580;;
CLD0;;HT-29;CHEMBL690299;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Concentration required to inhibit cell growth by 50% in vitro against Human colon adenocarcinoma cell line;CHEMBL1134414;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL695863;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;In vitro cytotoxic activity against human colon HT-29 cell line ( standard deviation in parenthesis);CHEMBL1135469;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HeLa;CHEMBL699261;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Effective concentration required to inhibit by 50% the growth of HeLa S3 cells;CHEMBL1123978;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HeLa;CHEMBL693253;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Compound was tested for tumor cell growth inhibition against HeLa cell line;CHEMBL1150507;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;MCF7;CHEMBL699350;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308403;Target assigned is non-molecular;1;In vitro inhibitory activity against MCF-7 mammary cell line;CHEMBL1126952;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL697469;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro cytotoxic activity against human colon adenocarcinoma (HT-29).;CHEMBL1144932;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL701719;[];Human immunodeficiency virus 1;[];;;11676.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing;CHEMBL1133723;Direct protein target assigned;D;;1;CHEMBL3471;;
CLD0;;;CHEMBL701720;[];Human immunodeficiency virus 1;[];;;11676.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer;CHEMBL1133723;Direct protein target assigned;D;;1;CHEMBL3471;;
CLD0;;K562;CHEMBL701570;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Compound was tested in vitro for cytotoxicity against MDR cell line K562R (72 hr exposure to compound);CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL701571;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Compound was tested in vitro for cytotoxicity against MDR cell line K562R (RI) (72 hr exposure to compound);CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;L1210;CHEMBL705836;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against L1210 lymphocytic cells in vitro;CHEMBL1122737;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL700736;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.75', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.75'}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Effect of dosing on L1210 leukemia in vivo measured as mean at 0.75 mg/kg;CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL700739;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Effect of dosing on L1210 leukemia in vivo measured as mean at 0.4 mg/kg (cumulative dose 6.8 mg/Kg) with ip day 1,5&9 (once daily);CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703364;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"In vivo effect of dosing on L1210 leukemia measured as range at 0.4 mg/kg (cumulative dose 6.8 mg/Kg) with ip day 1,5&9 (once daily); value range 15 to 20";CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL706036;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.6'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Compound was tested against L1210 leukemia at % increase in life span (ILS) in mice at 1.6 mg/kg dosage.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708810;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Effective concentration required to inhibit by 50% the growth of L1210 cells;CHEMBL1123978;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL701043;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against murine L1210 resistant cell line by using MTT assay;CHEMBL1128275;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL872507;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Anti-tumor activity against murine L1210 sensitive cell line by using MTT assay;CHEMBL1128275;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705265;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Dose level for 50% inhibition of L1210 cell growth was measured after 24 h.;CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705267;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Dose level for 50% inhibition of L1210 cell growth was measured after 48 hr.;CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707961;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory concentration of compound against proliferation of murine leukemia L1210 cell line;CHEMBL1135121;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708947;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against sensitive L1210 murine leukemia cell lines.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708949;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antitumor activity against murine leukemia L1210 cell line.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL706332;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested in vitro against murine L1210 leukemia.;CHEMBL1123657;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707142;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Compound was tested in vitro for cytotoxicity against L1210 murine cell line (48 hr exposure to compound);CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL708991;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxic potency required to inhibit L1210 cell growth by 50% after cell drug contact for 48 hrs;CHEMBL1130313;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704051;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Percentage increase in lifespan of mice in L1210 leukemia cells (in vivo) at 0.4 mg/kg (cumulative dose 6.8 mg/Kg) with ip day 1,5&9 (once daily);CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704057;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.75', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.75'}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Percentage increase in lifespan of mice was measured (in vivo) at 0.75 mg/kg dose;CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705717;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory activity against resistant murine leukemia L1210 cell lines.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704122;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Inhibitory activity against sensitive L1210 cell lines;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707837;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested in vitro for inhibitory activity against L1210 murine leukemia;CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL709285;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested for inhibitory activity against murine cell line L12110, a strain resistant to doxorubicin using MTT assay.;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL709286;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Tested for inhibitory activity against murine cell line L12110, a strain sensitive to doxorubicin using MTT assay.;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL707497;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Number of tumor free survivors of mice was measured (in vivo) at a 0.75 mg/kg dose (cumulative dose 225 mg/kg);CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705030;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Number of tumor free survivors of mice was measured in L1210 leukemia cells (in vivo) at 0.4 mg/kg (cumulative dose 6.8 mg/Kg) with ip day 1,5&9 (once daily);CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705031;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 88, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'L1210 Experimental Leukemia', 'source': 'Hock_2016'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Number of tumor free survivors of mice was measured in L1210 leukemia cells (in vivo) at 3 mg/kg (cumulative dose 9 mg/kg) with ip day 1-9 (twice daily); value give as 7/10";CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL705038;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.75', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.75'}];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Number of mice dead with 0.75 mg/kg dose (in vivo);CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL710180;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro extracellular concentration required to reduce cell population to 50% against L1210 leukemia cells;CHEMBL1125436;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;MCF7;CHEMBL705895;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Inhibitory activity against human tumor cell line MCF-7 breast adenocarcinoma.;CHEMBL1128703;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MDA-MB-231;CHEMBL707198;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;In vitro cytotoxic activity against human breast MDA-MB-231 cell line ( standard deviation in parenthesis);CHEMBL1135469;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;LoVo;CHEMBL711067;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;In vitro cytotoxic activity against human colon adenocarcinoma resistant to doxorubicin (LoVo Dx) cells.;CHEMBL1133386;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL712584;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line LoVo;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL711139;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;In vitro cytotoxicity was tested against human colon adenocarcinoma LoVo cell line;CHEMBL1132293;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL709038;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Inhibitory activity against human colon adenocarcinoma cell line LoVo.;CHEMBL1128703;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL709042;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Tested in vitro for cytotoxic activity against Human colon Adenocarcinoma sensitive cell line (LoVo);CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL709053;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;In vitro cytotoxic activity against human colon adenocarcinoma (LoVo) cells;CHEMBL1133386;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL704611;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;In vitro cytotoxicity on human colon adenocarcinoma (LoVo ) tumor cell line.;CHEMBL1131450;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL707243;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line LoVo/Dx(RI);CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL708499;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Inhibitory activity against human colon adenocarcinoma cell line LoVo/Dx.;CHEMBL1128703;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL708500;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Tested in vitro for cytotoxic activity against Doxorubicin resistant Human colon Adenocarcinoma sensitive cell line;CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL708502;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;In vitro cytotoxicity on human colon adenocarcinoma resistant to doxorubicin (LoVo/Dx ) tumor cell line.;CHEMBL1131450;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL708503;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;In vitro cytotoxicity was tested against human colon adenocarcinoma LoVo/Dx resistant cell line;CHEMBL1132293;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL708504;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Resistance index is IC50 ratio of LoVo/Dx to LoVo;CHEMBL1132293;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;MCF7;CHEMBL880194;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;In vitro inhibition of tumor cell growth in the human mammary tumor MCF-7 system;CHEMBL1125355;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL712023;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;In vitro inhibition of tumor cell growth in the human mammary carcinoma MCF-7/ADR system.;CHEMBL1125355;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL715093;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Tested for inhibitory activity against human tumor cell line D40, a strain resistant to doxorubicin of breast carcinoma using sulforhodamine B assay.;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL715094;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Tested for inhibitory activity against human tumor cell line MCF7, a strain resistant to mitoxantrone of breast carcinoma using sulforhodamine B assay.;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL715095;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Tested for inhibitory activity against human tumor cell line MCF7, a strain sensitive to doxorubicin of breast carcinoma using sulforhodamine B assay.;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MX1;CHEMBL713503;[{'assay_class_id': 82, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Carcinoma Oncology Models', 'l3': 'Carcinoma', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308046;Target assigned is non-molecular;1;In vivo antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Optimal dose at 3 mg/kg/day;CHEMBL1131450;Non-molecular target assigned;N;;1;CHEMBL613704;;
CLD0;;MCF7;CHEMBL709966;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Tested against MXF7 breast carcinoma (doxorubicin resistant) cell line in the sulforhodamine B assay.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL709967;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Tested against MXF7 breast carcinoma (mitoxantrone resistant)cell line in the sulforhodamine B assay.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL879742;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Tested against MXF7 breast carcinoma (sensitive) cell line in the sulforhodamine B assay.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL709969;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antitumor activity against human mammary carcinoma mitoxantrone-resistant MXF7 breast cell line.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL712919;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antitumor activity against human mammary carcinoma doxorubicin-resistant MXF7 breast cell line.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL712920;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Antitumor activity against human mammary carcinoma sensitive MXF7 breast cell line.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;UACC-375;CHEMBL715479;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307880;Target assigned is non-molecular;1;Tested for inhibitory activity against human tumor cell line UA375 of melanoma using sulforhodamine B assay.;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL614127;;
CLD0;;;CHEMBL717381;[];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Compound was evaluated in vivo for the antitumor activity at a dose of 1.25 mg/kg & 3.75 mg/kg against mammary adenocarcinoma 16C to assess tumor growth delay (T-C).;CHEMBL1122737;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL717382;[];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Compound was evaluated in vivo for the antitumor activity at a dose of 2.5 mg/kg & 7.5 mg/kg against mammary adenocarcinoma 16C to assess tumor growth delay (T-C);CHEMBL1122737;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL717385;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;In vivo antitumor activity at a single dose of 12.5 mg/kg & 37.5 mg/kg total against mammary adenocarcinoma 16C;CHEMBL1122737;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL717386;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;In vivo antitumor activity at a single dose of 6.5 mg/kg & 18.8 mg/kg total against mammary adenocarcinoma 16C;CHEMBL1122737;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL716675;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;Colon;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Number of mice(with Colon 38 tumors) cured after treatment of 3.9 mg/kg/day dose given as 3 times in a day for 4 days out of 5 mice;CHEMBL1136718;Non-molecular target assigned;N;;1;CHEMBL375;CHEMBL3638202;
CLD0;;;CHEMBL722418;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Subcutaneous', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Subcutaneous', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antitumor activity against subcutaneous Colon 38 tumors in mice determined as delay in growth after 3.9 mg/kg/day dose given as 3 times in a day for 4 days;CHEMBL1136718;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL721945;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.6'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;The percent increase in life span of compound was measured against P388 Leukemia cells in mice at at a dose of 1.6 mg/kg on days 1,5 and 9;CHEMBL1128275;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL879451;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent increase in life span when given at a dose in P388 leukemia cells of mice;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL730538;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.6'}];;;10090.0;;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Therapeutic effect against P388 leukemia in mice on days 1, 5 and 9 after administration of 1.6 mg/kg dose expressed as median survival time of treated and control mice (in vivo);CHEMBL1126952;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;P388;CHEMBL733217;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo for the optimal dose for activity against P388 leukemia per injection;CHEMBL1124226;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL733219;[{'assay_class_id': 91, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Melanoma Oncology Models', 'l3': 'Experimental Melanoma', 'source': 'phenotype'}, {'assay_class_id': 92, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Melanoma Oncology Models', 'l3': 'General Melanoma', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;The compound was evaluated in vivo for the optimal dose for activity against murine B-16 melanoma;CHEMBL1124226;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL732267;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileukemic activity towards P388 Murine Leukemia at a dose of 0.1 mg/kg, expressed as body weight change;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL880798;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.2'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileukemic activity towards P388 Murine Leukemia at a dose of 0.2 mg/kg, expressed as body weight change;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL732268;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.4', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.4'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileukemic activity towards P388 Murine Leukemia at a dose of 0.4 mg/kg, expressed as body weight change;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL732191;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.8', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.8'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileukemic activity towards P388 Murine Leukemia at a dose of 0.8 mg/kg, expressed as body weight change;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL737730;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro inhibitory activity against L1210 leukemia cell line;CHEMBL1126952;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL737126;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro for its inhibitory activity against murine L1210 leukemia;CHEMBL1124226;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;;CHEMBL737405;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;The compound was tested for antitumor activity against P388 murine leukemia by measuring maximum tolerated dose;CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL740325;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro cytotoxicity against L1210 leukemia cell line;CHEMBL1126952;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL740563;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antileukemic activity towards P388 Murine Leukemia at a dose of 0.1 mg/kg, expressed as long time survivors tested in 12 animals;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL740564;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.2'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antileukemic activity towards P388 Murine Leukemia at a dose of 0.2 mg/kg, expressed as long time survivors tested in 6 animals;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL740565;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.4', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.4'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antileukemic activity towards P388 Murine Leukemia at a dose of 0.4 mg/kg, expressed as long time survivors tested in 12 animals;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL740566;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.8', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.8'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vivo antileukemic activity towards P388 Murine Leukemia at a dose of 0.8 mg/kg, expressed as long time survivors tested in 6 animals;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;L1210;CHEMBL742708;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Net log value for P388 leukemia cell kill in mice was determined;CHEMBL1124226;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;P388;CHEMBL742839;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Tested for antitumor activity against P388 murine leukemia;CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL737936;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;The compound was tested for antitumor activity against P388 murine leukemia by measuring median survival time of treated mice/median survival time of control x 100;CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739484;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.1'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileukemic activity towards P388 Murine Leukemia at a dose of 0.1 mg/kg;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739485;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.2'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileukemic activity towards P388 Murine Leukemia at a dose of 0.2 mg/kg;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739486;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.4', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.4'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileukemic activity towards P388 Murine Leukemia at a dose of 0.4 mg/kg;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL739487;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.8', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.8'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antileukemic activity towards P388 Murine Leukemia at a dose of 0.8 mg/kg;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;P388;CHEMBL746226;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percentage ratio of treated animals to cured animals against P388 leukemia (day 30 surv);CHEMBL1124226;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL746227;[{'assay_class_id': 91, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Melanoma Oncology Models', 'l3': 'Experimental Melanoma', 'source': 'phenotype'}, {'assay_class_id': 92, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Melanoma Oncology Models', 'l3': 'General Melanoma', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Percentage ratio of treated animals to cured animals against murine B-16 melanoma (day 60 surv);CHEMBL1124226;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745099;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"The compound was tested for antitumor activity against P388 murine leukemia at 2 (mg/kg/day) dose; 0/82 -no. of toxic deaths/no. of mice";CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745101;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"The compound was tested for antitumor activity against P388 murine leukemia at 3 (mg/kg/day) dose; 12/132 -no. of toxic deaths/no. of mice";CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL745102;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"The compound was tested for antitumor activity against P388 murine leukemia at 4 (mg/kg/day) dose; 43/48 -no. of toxic deaths/no. of mice";CHEMBL1127837;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;OVCAR-3;CHEMBL872736;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Anti-tumor activity against human OVCAR-3 ovarian cancer cell lines by using MTT assay;CHEMBL1128275;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;OVCAR-3;CHEMBL748128;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Antitumor activity against human ovarian OVCAR-3 cell lines.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;OVCAR-3;CHEMBL748137;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Inhibitory activity against OVCAR-3 cell line;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;P388;CHEMBL755742;[];Mus musculus;[];;;10090.0;;Bone marrow;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Relative cytotoxicity against Human bone marrow samples; Value is in range, activity expressed as IC50";CHEMBL1132240;Non-molecular target assigned;N;;1;CHEMBL389;CHEMBL3638253;
CLD0;;P388;CHEMBL755674;[];Mus musculus;[];;;10090.0;;Bone marrow;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;"Relative cytotoxicity against Human bone marrow samples; Value is in range, activity expressed as IC90";CHEMBL1132240;Non-molecular target assigned;N;;1;CHEMBL389;CHEMBL3638253;
CLD0;;P388;CHEMBL762168;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Activity against P388 leukemia cells in mice, by intraperitoneal dosing and net log tumor cell kill was reported;CHEMBL1123657;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL755367;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antitumor activity was measured on systemic P388 murine leukemia cells. Optimal dose at 3 mg/kg/day;CHEMBL1131450;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL757012;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.6'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Compound was tested against P388 leukemia at % increase in life span (ILS) in mice at 1.6 mg/kg dosage.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL756321;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.06', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.06'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 0.06 mg/kg;CHEMBL1123842;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL753741;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.12'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 0.12 mg/kg;CHEMBL1123842;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL753742;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 0.25 mg/kg;CHEMBL1123842;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL753743;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 0.5 mg/kg;CHEMBL1123842;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL753744;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 1 mg/kg;CHEMBL1123842;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758009;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 2 mg/kg;CHEMBL1123842;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL757077;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antitumor activity against P388 leukemia cells at a dose of 0.75 mg/kg as a single injection and 1.5 mg/kg as a total;CHEMBL1122737;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL757078;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;In vivo antitumor activity against P388 leukemia cells at a dose of 1.5 mg/kg as a single injection and 3 mg/kg as a total;CHEMBL1122737;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL759554;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Inhibition of P388 leukemia cells in mice, measured as percent treated to the control values with the number of 30 day survivors;CHEMBL1123657;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL758597;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Optimal dose per injection in mg/kg required to inhibit growth of P388 leukemia cells in mice;CHEMBL1123657;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL760474;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.75', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.75'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 0.75 mg/kg;CHEMBL1124546;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL759438;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 1.5 mg/kg;CHEMBL1124546;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL765521;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '12.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '12.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 12 mg/kg;CHEMBL1124546;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL766194;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 3 mg/kg;CHEMBL1124546;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL766198;[{'assay_class_id': 87, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'General Leukemia', 'source': 'phenotype'}, {'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '6.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 6 mg/kg;CHEMBL1124546;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;PC-3;CHEMBL763715;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line PC3;CHEMBL1132370;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;;CHEMBL773034;[];Rattus norvegicus;[];;;10116.0;;Heart;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Cardiotoxicity by a neonatal rat heart myocyte assay;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638187;
CLD0;;;CHEMBL772067;[];Rattus norvegicus;[];;;10116.0;;Heart;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Cardiotoxicity measured by the ATP/protein ratio compared with untreated controls using neonatal rat heart myocyte assay.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL376;CHEMBL3638187;
CLD0;;;CHEMBL801011;[];Rattus norvegicus;[];;;10116.0;;Heart;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cardiotoxicity was measured by using Neonatal rat heart myocyte assay;CHEMBL1128275;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3638187;
CLD0;;N592;CHEMBL805683;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307825;Target assigned is non-molecular;1;Cytotoxicity against human small-cell lung cancer (SCLC);CHEMBL1127036;Non-molecular target assigned;N;;1;CHEMBL613969;;
CLD0;;SCLC;CHEMBL873001;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307967;Target assigned is non-molecular;1;Cytotoxicity against human SCLC cells resistant to cisplatin (SCLC/CDDP);CHEMBL1127036;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;SK-OV-3;CHEMBL800729;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Compound was evaluated for cytotoxicity against SCOV-3 cell lines.;CHEMBL1129744;Non-molecular target assigned;N;;1;CHEMBL614925;;
CLD0;;;CHEMBL802472;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];;;90371.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Bacterial mutagenicity was measured against Salmonella Typhimurium TA1538 at dose range of 0-5 ug/plate;CHEMBL1131105;Non-molecular target assigned;N;;1;CHEMBL351;;
CLD0;;;CHEMBL802473;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];;;90371.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Bacterial mutagenicity was measured against Salmonella Typhimurium TA97a at dose range of 0-400 ug/plate;CHEMBL1131105;Non-molecular target assigned;N;;1;CHEMBL351;;
CLD0;;;CHEMBL802474;[];Salmonella enterica subsp. enterica serovar Typhimurium;[];;;90371.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Bacterial mutagenicity was measured against Salmonella Typhimurium TA98 at dose range of 0-10 ug/plate;CHEMBL1131105;Non-molecular target assigned;N;;1;CHEMBL351;;
CLD0;;SK-BR-3;CHEMBL806577;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308062;Target assigned is non-molecular;1;The IC50 value was measured on human breast cancer cell line SK-BR-3.;CHEMBL1128261;Non-molecular target assigned;N;;1;CHEMBL613834;;
CLD0;;CCRF S-180;CHEMBL802953;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;"Mean percentage reduction in tumor weight at 0.75 mg/kg (cumulative dose 525 mg/Kg) introduced (in vivo) ip; Significant";CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL804675;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Mean percentage reduction in tumor weight on S180 tumor cell at 0.75 mg/kg (cumulative dose 16 mg/Kg) introduced ip (in vivo);CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;CCRF S-180;CHEMBL804455;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;"Percentage of tumor free survivors of mice at 0.75 mg/kg (cumulative dose 525 mg/Kg) introduced (in vivo) ip; value given as 0/10";CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;SK-OV-3;CHEMBL805529;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Concentration required to inhibit SKOV-3-cell growth by 50%;CHEMBL1131065;Non-molecular target assigned;N;;1;CHEMBL614925;;
CLD0;;CCRF S-180;CHEMBL806790;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307278;Target assigned is non-molecular;1;Number of mice dead with toxic dose was measured on S180 tumor cell at 0.75 mg/kg (cumulative dose 16 mg/kg) introduced (in vivo) ip;CHEMBL1124090;Non-molecular target assigned;N;;1;CHEMBL614027;;
CLD0;;SK-OV-3;CHEMBL801182;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Cytotoxic potency required to inhibit SKOV-3 cell growth 50%;CHEMBL1130313;Non-molecular target assigned;N;;1;CHEMBL614925;;
CLD0;;;CHEMBL813448;[];Crithidia fasciculata;[];;;5656.0;;;F;Functional;BAO_0000019;assay format;;Multiple homologous protein targets may be assigned;4;Effect of dose dependent inhibition of TOPO II-catalyzed kDNA decatenation in vitro;CHEMBL1127394;Homologous protein target assigned;H;;1;CHEMBL2094255;;
CLD0;;;CHEMBL811893;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of commercially obtained pure Drosophila Topoisomerase II in catalytic DNA unwinding.;CHEMBL1128184;Homologous protein target assigned;H;;1;CHEMBL2671;;
CLD0;;;CHEMBL816437;[];Thermus aquaticus;[];;;271.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of Taq polymerase at 10 uM (Slight inhibition);CHEMBL1131065;Direct protein target assigned;D;;1;CHEMBL3564;;
CLD0;;;CHEMBL814424;[];Thermus aquaticus;[];;;271.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of Taq polymerase at 50 uM (Total inhibition);CHEMBL1131065;Direct protein target assigned;D;;1;CHEMBL3564;;
CLD0;;UACC-375;CHEMBL873381;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307880;Target assigned is non-molecular;1;Anti-tumor activity against human UACC375 melanoma cell lines by using MTT assay;CHEMBL1128275;Non-molecular target assigned;N;;1;CHEMBL614127;;
CLD0;;UACC-375;CHEMBL818943;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307880;Target assigned is non-molecular;1;Antitumor activity against human melanoma UACC375 cell line.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL614127;;
CLD0;;Tumor cell line;CHEMBL815616;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308444;Target assigned is non-molecular;1;An average for IC50 values in the two solid tumor cell lines.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL614310;;
CLD0;;;CHEMBL819953;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;In vitro extracellular concentration required to reduce cell population to 50% against Walker 256 (WS) carcinoma cells;CHEMBL1125436;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;WiDr;CHEMBL817162;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Tested for inhibitory activity against a multi drug resistant (MDR) strain of human colon carcinoma WiDr using sulforhodamine B assay (it is MRP positive but non-P-glycoprotein).;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;WiDr;CHEMBL817163;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Tested for inhibitory activity against a sensitive strain of human colon carcinoma WiDr using sulforhodamine B assay (it is MRP positive but non-P-glycoprotein).;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;WiDr;CHEMBL817042;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Activity against resistant cell line of WiDr human colon tumor;CHEMBL1128275;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;WiDr;CHEMBL819653;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Activity against sensitive cell line of WiDr human colon tumor;CHEMBL1128275;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;WiDr;CHEMBL816180;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Tested against WiDr colon carcinoma (resistant) in the sulforhodamine B assay.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;WiDr;CHEMBL816182;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Tested against WiDr colon (sensitive) in the sulforhodamine B assay.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;WiDr;CHEMBL816201;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Activity against human colon carcinoma sensitive WiDr cell line.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;WiDr;CHEMBL816202;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307674;Target assigned is non-molecular;1;Activity against human colon carcinoma multi drug resistant (MDR)-WiDr cell line.;CHEMBL1129597;Non-molecular target assigned;N;;1;CHEMBL614647;;
CLD0;;XRS6;CHEMBL824192;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307295;Target assigned is non-molecular;1;Cytotoxicity against CHO cell line xrs6;CHEMBL1128184;Non-molecular target assigned;N;;1;CHEMBL614060;;
CLD0;;;CHEMBL823493;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity towards [poly(dA-dT)]2;CHEMBL1132293;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL823494;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity towards [poly(dG-dC)]2;CHEMBL1132293;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;A549;CHEMBL823133;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Default value - Target unknown or has yet to be assigned;0;Tested for inhibitory activity against human tumor cell line A549 (a non small, drug resistant cell line that does not produce P-glycoprotein) of lung carcinoma using sulforhodamine B assay.;CHEMBL1133612;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL822590;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of cellular growth was evaluated in vitro against human colon carcinoma LOVO.;CHEMBL1125604;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL822591;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of cellular growth was evaluated in vitro against human colon carcinoma subline resistant to DOXO (LOVO/DOXO).;CHEMBL1125604;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;OVCAR-3;CHEMBL872805;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Tested for inhibitory activity against human tumor cell line OVCAR-3, a resistant ovarian carcinoma using sulforhodamine B assay.;CHEMBL1133612;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;L1210;CHEMBL843990;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Default value - Target unknown or has yet to be assigned;0;An average for IC50 values in the two solid tumor cell lines and sensitive L1210 leukemia cell line.;CHEMBL1129062;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL846843;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;"Dose modifying factor expressed as the ratio of IC50 for the chemotherapy drug to IC50 for drug + GG918; Range = 1.2-1850";CHEMBL1146678;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL845602;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;"Concentration required to reduce ethidium bromide fluorescence to 50% of control in presence of calf thymus DNA; ND is Not Determined.";CHEMBL1127394;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;LoVo;CHEMBL845915;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Resistance index measured as the ratio of IC50 of LoVo/Dx cell line to that of LoVo cell line.;CHEMBL1131450;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL845975;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Default value - Target unknown or has yet to be assigned;0;Resistance index as the ratio of IC50 value against LoVo/Dx to that of LoVo cell lines.;CHEMBL1128703;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;LOVO/DOXO;CHEMBL848215;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;It is the ratio of IC50 for LOVO tumor cell line to that of LOVO/DOXO cell line.;CHEMBL1125604;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL845133;[];;[];;;;;Bone marrow;F;Functional;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Ratio of antilog(mean log IC50 in bone marrow sample) and antolog(mean log IC50) in HL-60);CHEMBL1132240;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3638253;
CLD0;;;CHEMBL845134;[];;[];;;;;Bone marrow;F;Functional;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Ratio of antilog(mean log IC50 in bone marrow sample) and antolog(mean log IC90) in HL-60);CHEMBL1132240;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3638253;
CLD0;;;CHEMBL844332;[];;[];;;;;Bone marrow;F;Functional;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Ratio of antilog(mean log IC90 in bone marrow sample) and antolog(mean log IC90) in HL-60);CHEMBL1132240;Non-molecular target assigned;N;;1;CHEMBL3879801;CHEMBL3638253;
CLD0;;;CHEMBL852135;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance index is the ratio of IC50 of resistant cell line/IC50 of sensitive cell line;CHEMBL1127837;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL848174;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Differential cytotoxicity was determined from the ratio between BR1(IC50) and xrs-6 (IC50);CHEMBL1127394;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL852519;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Ratio of BR1 IC50 to xrs-6 IC50;CHEMBL1128184;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;V79;CHEMBL851338;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307528;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 against V79 cells in the presence of air to that of nitrogen.;CHEMBL1128261;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL850358;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;The quotient of the IC50 in the myocytes divided by the mean IC50 in the three cell lines;CHEMBL1129597;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL826020;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Toxicity ratio determined by the quotient of IC50 values in the myocytes divided by the average value in the three tumor lines.;CHEMBL1129062;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL851288;[];;[];;;;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity ratio of quotient of the IC50 in myocytes divided by the average IC50 for three tumor cell lines;CHEMBL1128275;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL848847;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Resistance index was determined by ratio of cytotoxicities of human colon adenocarcinoma (LoVo) cells to human colon adenocarcinoma resistant to doxorubicin (LoVo Dx) cells.;CHEMBL1133386;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL840341;[];Homo sapiens;[];;;9606.0;;Intestine;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;"Fraction absorbed in human intestine after oral administration compound was measured; NA=Not available";CHEMBL1145178;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3638176;
CLD0;;2/4/A1;CHEMBL851907;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Permeability Coefficient in 2/4/A1 cell model;CHEMBL1145178;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL851908;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Permeability Coefficient in Caco-2 cell culture model;CHEMBL1145178;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL851909;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;Permeability Coefficient in hexadecane membranes model;CHEMBL1145178;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL826140;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;Percentage of mass balance in hexadecane membranes model;CHEMBL1145178;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL827154;[];;[];;;;;;A;ADME;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibitory concentration against cytochrome P450 2D6;CHEMBL1137221;Homologous protein target assigned;H;;1;CHEMBL289;;
CLD0;;;CHEMBL874570;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Concentration required to displace ethidium from CT-DNA was determined from fluorescence binding studies;CHEMBL1138784;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL835259;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Thermal denaturation of calf thymus DNA at 37 degree C;CHEMBL1137037;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;L1210;CHEMBL834298;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro cytotoxicity against mouse leukemia L1210 cell lines;CHEMBL1137037;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;PC-3;CHEMBL837533;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cancer cell line was determined after 144 hr;CHEMBL1138784;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;LoVo;CHEMBL837599;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Cytotoxicity against human LoVo cancer cell line was determined after 144 hr;CHEMBL1138784;Non-molecular target assigned;N;;1;CHEMBL614721;;
CLD0;;Cancer cell lines;CHEMBL824871;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307923;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human H460M cancer cell line was determined after 144 hr;CHEMBL1138784;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;MKN-45;CHEMBL824872;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307603;Target assigned is non-molecular;1;Cytotoxicity against human MKN45 cancer cell line was determined after 144 hr;CHEMBL1138784;Non-molecular target assigned;N;;1;CHEMBL614354;;
CLD0;;HCT-116;CHEMBL836336;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cancer cell line was determined after 144 hr;CHEMBL1138784;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;HT-29;CHEMBL874973;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity is determined as the concentration required to inhibit the growth of human colon adenocarcinoma (HT-29) cell line;CHEMBL1138784;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;Cancer cell lines;CHEMBL877298;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307923;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human PC3 cancer cell line was determined after 1 hr;CHEMBL1138784;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;LoVo;CHEMBL874878;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307691;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human LoVo cancer cell line was determined after 1 hr;CHEMBL1138784;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;Cancer cell lines;CHEMBL874880;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307923;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human H460M cancer cell line was determined after 1 hr;CHEMBL1138784;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;Cancer cell lines;CHEMBL874881;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307923;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human MKN45 cancer cell line was determined after 1 hr;CHEMBL1138784;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;HCT-116;CHEMBL874883;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308372;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human HCT116 cancer cell line was determined after 1 hr;CHEMBL1138784;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;MES-SA ;CHEMBL883178;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;Resistant factor as ability to overcome multidrug resistance of MES-SA/Dx5 cells compared to MES-SA cells;CHEMBL1143647;Non-molecular target assigned;N;;1;CHEMBL614343;;
CLD0;;MES-SA ;CHEMBL885013;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;In vitro cytotoxicity variant MES-SA/Dx5 multidrug resistant cells;CHEMBL1143647;Non-molecular target assigned;N;;1;CHEMBL614343;;
CLD0;;MES-SA ;CHEMBL885025;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;In vitro cytotoxicity against uterine sarcoma MES-SA cells;CHEMBL1143647;Non-molecular target assigned;N;;1;CHEMBL614343;;
CLD0;;L1210;CHEMBL884217;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;In vitro cytotoxicity against murine leukemia cell line L1210;CHEMBL1143647;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;HT-29;CHEMBL884328;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;In vitro cytotoxicity against colorectal adenocarcinoma HT-29 cells;CHEMBL1143647;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL907426;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against HT29 cells by MTT assay after 72 hrs;CHEMBL1149365;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;MES-SA ;CHEMBL907427;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;Antiproliferative activity against MES-SA cells by MTT assay after 72 hrs;CHEMBL1149365;Non-molecular target assigned;N;;1;CHEMBL614343;;
CLD0;;MES-SA/Dx5;CHEMBL907428;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;Antiproliferative activity against doxorubicin-resistant MES-SA/Dx5 cells by MTT assay after 72 hrs;CHEMBL1149365;Non-molecular target assigned;N;;1;CHEMBL613827;;
CLD0;;MES-SA/Dx5;CHEMBL907429;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;Resistant factor, IC50 for MES-SA/Dx5/ IC50 for MES-SA cells by MTT assay after 72 hrs;CHEMBL1149365;Non-molecular target assigned;N;;1;CHEMBL613827;;
CLD0;;MDA-MB-435;CHEMBL855605;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855609;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against MDA435/LCC6 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;P388/ADR;CHEMBL855610;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388;CHEMBL855617;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against P388 cells by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;MDA-MB-435;CHEMBL855045;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855046;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM verapamil by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;MDA-MB-435;CHEMBL855052;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant MDA435/LCC6 cells;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;P388/ADR;CHEMBL855054;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388/ADR;CHEMBL855055;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM verapamil by ELISA;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL614218;;
CLD0;;P388;CHEMBL855056;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant P388 cells;CHEMBL1137344;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;MDA-MB-231;CHEMBL918569;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Antiproliferative activity against human MDA-MB-231 cells by WST-1 method after 72 hrs;CHEMBL1142974;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;HL-60;CHEMBL886126;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Growth inhibition of human HL60 cells by Almar blue assay;CHEMBL1139925;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;MX2;CHEMBL886127;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Growth inhibition of topoisomerase 2 mutated mitoxantrone-resistant MX2 cells by Alamar blue assay;CHEMBL1139925;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL886129;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of GI50 for mitoxantrone-resistant human MX2 cells to GI50 for human HL60 cells;CHEMBL1139925;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;K562;CHEMBL927383;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 5 days by XTT assay;CHEMBL1141448;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;MDA-MB-231;CHEMBL937447;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Antiproliferative activity against human MDA-MB-231 cells;CHEMBL1142405;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;;CHEMBL929837;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as thermal denaturation temperature at 10 uM;CHEMBL1143145;Molecular target other than protein assigned;M;;1;CHEMBL3140325;;
CLD0;;MCF7;CHEMBL929838;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells at 4 ug/ml after 48 hrs by SRB assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI-H460;CHEMBL929839;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H460 cells at 4 ug/ml after 48 hrs by SRB assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;SF-268;CHEMBL929840;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Cytotoxicity against human SF268 cells at 4 ug/ml after 48 hrs by SRB assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL613977;;
CLD0;;PC-3;CHEMBL929841;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells after 48 hrs by SRB assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;HL-60;CHEMBL929842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs by MTT assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL60/MX2;CHEMBL929843;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Cytotoxicity against DNA topoisomerase-2 deficient human HL60/MX2 cells by MTT assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL929844;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of GI50 for human HL60/MX2 cells to GI50 for human HL60 cells;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;MCF7;CHEMBL929833;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;NCI-H460;CHEMBL929834;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;SF-268;CHEMBL929832;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Cytotoxicity against human SF268 cells after 48 hrs by SRB assay;CHEMBL1143145;Non-molecular target assigned;N;;1;CHEMBL613977;;
CLD0;;MCF7;CHEMBL939282;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308403;Direct single protein target assigned;9;Inhibition of human BCRP mediated mitoxantrone accumulation in wild type MCF7 cells at 5 uM by flow cytometry;CHEMBL1143908;Direct protein target assigned;D;;1;CHEMBL5393;;
CLD0;;MCF7;CHEMBL939283;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308403;Direct single protein target assigned;9;Inhibition of human BCRP mediated mitoxantrone accumulation in mitoxantrone resistant MCF7 cells at 5 uM by flow cytometry;CHEMBL1143908;Direct protein target assigned;D;;1;CHEMBL5393;;
CLD0;;K562;CHEMBL961862;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 48 hrs by MTT assay;CHEMBL1148132;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;C6;CHEMBL987562;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Cytotoxicity against rat C6 cells at 50 ug/mL to 2.5 mg/mL after 3 days treated 4 hrs before db-cAMP challenge by MTT assay;CHEMBL1158219;Non-molecular target assigned;N;;1;CHEMBL614657;;
CLD0;;C6;CHEMBL987566;[];Rattus norvegicus;[];;;10116.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308345;Default value - Target unknown or has yet to be assigned;0;Inhibition of tubulin polymerization in rat C6 cells at 50 ug/mL to 2.5 mg/mL after 4 hrs;CHEMBL1158219;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;C6;CHEMBL988383;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Cytotoxicity against rat C6 cells assessed as cell release at 50 ug/mL to 2.5 mg/mL after 5 hrs by MTT assay in absence of db-cAMP;CHEMBL1158219;Non-molecular target assigned;N;;1;CHEMBL614657;;
CLD0;;NCI60;CHEMBL996148;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antitumor activity against human NCI60 cells after 48 hrs by SRB assay;CHEMBL1140056;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HeLa;CHEMBL966979;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Cytotoxicity against human HeLa cells expressing telomerase after 96 hrs by MTT assay;CHEMBL1140074;Non-molecular target assigned;N;;1;CHEMBL399;;
CLD0;;HEK-293T;CHEMBL966980;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human 293T cells expressing telomerase after 96 hrs by MTT assay;CHEMBL1140074;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL995340;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Displacement of [3H]PSB0413 from human platelet P2Y12 receptor;CHEMBL1136967;Direct protein target assigned;D;;1;CHEMBL2001;;
CLD0;;;CHEMBL995341;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM;CHEMBL1136967;Direct protein target assigned;D;;1;CHEMBL2001;;
CLD0;;K562;CHEMBL979642;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 48 hrs by MTT assay;CHEMBL1154573;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;HL-60;CHEMBL979643;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs by MTT assay;CHEMBL1154573;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HCT;CHEMBL979644;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human HCT cells after 48 hrs by MTT assay;CHEMBL1154573;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;MKN-28;CHEMBL979645;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307602;Target assigned is non-molecular;1;Cytotoxicity against human MKN28 cells after 48 hrs by MTT assay;CHEMBL1154573;Non-molecular target assigned;N;;1;CHEMBL614353;;
CLD0;;;CHEMBL967537;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as change in thermal stability at 2 uM in tris-HCl buffer at pH 7.5 by thermal denaturation assay;CHEMBL1157147;Molecular target other than protein assigned;M;;1;CHEMBL3140325;;
CLD0;;K562;CHEMBL967538;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Growth inhibition of human K562 cells after 72 hrs by MTS method;CHEMBL1157147;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;;CHEMBL967539;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Growth inhibition of etoposide-resistant human K/VP.5 cells after 72 hrs by MTS method;CHEMBL1157147;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;K562;CHEMBL967540;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Resistance factor, ratio of IC50 for etoposide-resistant human K/VP.5 cells to IC50 for human K562 cells;CHEMBL1157147;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;;CHEMBL967541;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human topoisomerase 2alpha decantation activity;CHEMBL1157147;Direct protein target assigned;D;;1;CHEMBL1806;;
CLD0;;;CHEMBL1014323;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to poly(dA).poly(dT) DNA assessed as change in melting temperature;CHEMBL1152837;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;Sf9;CHEMBL1006005;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Direct single protein target assigned;9;Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control;CHEMBL1150338;Direct protein target assigned;D;;1;CHEMBL5748;;
CLD0;;HL-60;CHEMBL964486;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human mitoxantrone-sensitive HL60 cells after 72 hrs;CHEMBL1150431;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL60/MX2;CHEMBL964487;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Cytotoxicity against mitoxantrone-resistant human HL60/MX2 cells after 72 hrs;CHEMBL1150431;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL965236;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Resistant index, ratio of IC50 for mitoxantrone-resistant human HL60/MX2 cells to IC50 for mitoxantrone-sensitive human HL60 cells;CHEMBL1150431;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL965578;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOA;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3681;;
CLD0;;;CHEMBL1035433;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Total body clearance in human;CHEMBL1151930;Non-molecular target assigned;N;;1;CHEMBL372;;
CLD0;;;CHEMBL1035434;[];Homo sapiens;[];;;9606.0;In vivo;Kidney;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Renal clearance in human;CHEMBL1151930;Non-molecular target assigned;N;;1;CHEMBL372;CHEMBL3638241;
CLD0;;A549;CHEMBL1057281;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells by MTT assay;CHEMBL1153479;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;HL-60;CHEMBL1057282;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells by MTT assay;CHEMBL1153479;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HT-29;CHEMBL1057283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Cytotoxicity against human HT-29 cells by MTT assay;CHEMBL1153479;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;MCF7;CHEMBL1061623;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells by MTT assay;CHEMBL1153479;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;SK-OV-3;CHEMBL1061624;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Cytotoxicity against human SKOV3 cells by MTT assay;CHEMBL1153479;Non-molecular target assigned;N;;1;CHEMBL614925;;
CLD0;;U-937;CHEMBL1061625;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308006;Target assigned is non-molecular;1;Cytotoxicity against human U937 cells by MTT assay;CHEMBL1153479;Non-molecular target assigned;N;;1;CHEMBL612794;;
CLD0;;HL-60;CHEMBL1055754;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL60/MX2;CHEMBL1055755;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL1055756;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of GI50 for human HL60/MX2 cells to GI50 for human HL60 cells;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;;CHEMBL1041292;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of VIM2 using nitrocefin as substrate after 15 mins by microtiter plate assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041294;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of IMP1 using nitrocefin as substrate after 15 mins by microtiter plate assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041295;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of VIM2 using CCF2 as substrate after 15 mins by FRET assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041297;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of VIM2 using nitrocefin as substrate by rapid dilution method;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041298;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of VIM2 using nitrocefin as substrate at 44 uM after 15 mins by microtiter plate assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041302;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of IMP1 using nitrocefin as substrate at 56 uM after 15 mins by microtiter plate assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041304;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of TEM-1 using nitrocefin as substrate after 15 mins by microtiter plate assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041305;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of TEM-1 using nitrocefin as substrate at 25 uM after 15 mins by microtiter plate assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041306;[];Enterobacter cloacae;[];;;550.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Enterobacter cloacae AmpC using nitrocefin as substrate after 15 mins by microtiter plate assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041307;[];Enterobacter cloacae;[];;;550.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Enterobacter cloacae AmpC using nitrocefin as substrate at 25 uM after 15 mins by microtiter plate assay;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041308;[];Escherichia coli BL21(DE3);[];;;469008.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antibacterial activity against imipenem-non resistant Escherichia coli BL21(DE3) after 18 hrs by twofold serial broth dilution method;CHEMBL1154107;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1041309;[];Escherichia coli BL21(DE3);[];;;469008.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Antibacterial activity against imipenem-resistant Escherichia coli BL21(DE3) expressing VIM2 gene after 18 hrs by twofold serial broth dilution method;CHEMBL1154107;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1041311;[];Escherichia coli BL21(DE3);[];;;469008.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of VIM2 in imipenem-resistant Escherichia coli BL21(DE3) assessed as potentiation of imipenem-induced bactericidal activity at 50 uM after 18 hrs by twofold serial broth dilution method;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041313;[];Escherichia coli BL21(DE3);[];;;469008.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of VIM2 in imipenem-resistant Escherichia coli BL21(DE3) assessed as potentiation of imipenem-induced bactericidal activity at 2.1 ug/mL after 18 hrs by checkerboard microdilution method;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041314;[];Escherichia coli BL21(DE3);[];;;469008.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Bactericidal activity against imipenem-resistant Escherichia coli BL21(DE3) expressing VIM2 gene at 2.1 ug/mL after 24 hrs by broth microdilution method;CHEMBL1154107;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1041315;[];Escherichia coli BL21(DE3);[];;;469008.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Bactericidal activity against imipenem-non resistant Escherichia coli BL21(DE3) at 2.1 ug/mL after 24 hrs by broth microdilution method;CHEMBL1154107;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1041322;[];Escherichia coli BL21(DE3);[];;;469008.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Bacteriostatic activity against imipenem-resistant Escherichia coli BL21(DE3) expressing VIM2 gene at 2.1 ug/mL after 24 hrs by broth microdilution method;CHEMBL1154107;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1041323;[];Escherichia coli BL21(DE3);[];;;469008.0;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;Bacteriostatic activity against imipenem-non resistant Escherichia coli BL21(DE3) at 2.1 ug/mL after 24 hrs by broth microdilution method;CHEMBL1154107;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1041325;[];Escherichia coli BL21(DE3);[];;;469008.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of VIM2 in imipenem-resistant Escherichia coli BL21(DE3) assessed as potentiation of imipenem-induced bactericidal activity at 8.4 ug/mL after 18 hrs by checkerboard microdilution method;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1041326;[];Escherichia coli BL21(DE3);[];;;469008.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of VIM2 in imipenem-resistant Escherichia coli BL21(DE3) assessed as potentiation of imipenem-induced bactericidal activity at 4.2 ug/mL after 18 hrs by checkerboard microdilution method;CHEMBL1154107;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1056843;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Displacement of fluorescent pyrene-neomycin conjugate from tau stem-loop RNA;CHEMBL1154635;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL1056844;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to tau stem-loop RNA assessed as inhibition of RNA stem-loop unfolding;CHEMBL1154635;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;HL-60;CHEMBL1071874;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells by MTT assay;CHEMBL1153134;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL1101455;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Growth inhibition of human HL60 cells by MTT assay;CHEMBL1155373;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;SK-OV-3;CHEMBL1101456;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Growth inhibition of human SKOV3 cells by MTT assay;CHEMBL1155373;Non-molecular target assigned;N;;1;CHEMBL614925;;
CLD0;;A549;CHEMBL1101457;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Growth inhibition of human A549 cells by MTT assay;CHEMBL1155373;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;HT-29;CHEMBL1101458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Growth inhibition of human HT-29 cells by MTT assay;CHEMBL1155373;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;;CHEMBL1103695;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as temperature required to cause 50% of DNA denatured at 10 uM by thermal denaturation assay;CHEMBL1157022;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL1103696;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Displacement of ethidium bromide from calf thymus DNA assessed as decrease of fluorescence of bound ethidium bromide by fluorometric assay;CHEMBL1157022;Molecular target other than protein assigned;M;;1;CHEMBL345;;
CLD0;;;CHEMBL1108963;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Octanol-water partition coefficient, log P of the compound;CHEMBL1157036;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;;CHEMBL1167965;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as ratio of final absorbance area to the absorbance at 100 uM after 24 hrs by UV spectrophotometer analysis relative to control;CHEMBL1165945;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;;CHEMBL1266185;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay;CHEMBL1255231;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1267245;[];Plasmodium falciparum;[];3D7;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267246;[];Plasmodium falciparum 7G8;[];;;57266.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267247;[];Plasmodium falciparum D10;[];;;478861.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267248;[];Plasmodium falciparum;[];Dd2;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267249;[];Plasmodium falciparum;[];GB4;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267250;[];Plasmodium falciparum HB3;[];;;137071.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL1267251;[];Plasmodium falciparum;[];W2;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay;CHEMBL1255382;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;HL-60;CHEMBL1286016;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 72 hrs;CHEMBL1275381;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL1286017;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60/MX2 cells after 72 hrs;CHEMBL1275381;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL1286018;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells;CHEMBL1275381;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;;CHEMBL1285392;[];Candida albicans;[];;;5476.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u;CHEMBL1275276;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1285393;[];Saccharomyces cerevisiae;[];AD1-8u;;4932.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay;CHEMBL1275276;Non-molecular target assigned;N;;1;CHEMBL361;;
CLD0;;;CHEMBL1285394;[];Candida albicans;[];;;5476.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u;CHEMBL1275276;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL1285395;[];Saccharomyces cerevisiae;[];AD1-8u;;4932.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay;CHEMBL1275276;Non-molecular target assigned;N;;1;CHEMBL361;;
CLD0;;;CHEMBL1292792;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA assessed as ratio of final absorbance area to absorbance of compound at 100 uM after 24 hrs by UV spectrophotometer analysis;CHEMBL1287653;Molecular target other than protein assigned;M;;1;CHEMBL612514;;
CLD0;;HL-60;CHEMBL1293121;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells by MTT assay;CHEMBL1287676;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HCT-116;CHEMBL1293122;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells by MTT assay;CHEMBL1287676;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;confirmatory;;CHEMBL1614114;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1816;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614166;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2675;7;CHEMBL1293317;;
CLD0;confirmatory;;CHEMBL1614171;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1967;7;CHEMBL1293298;;
CLD0;confirmatory;;CHEMBL1614177;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle Pyruvate Kinase. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;954;7;CHEMBL1075189;;
CLD0;confirmatory;;CHEMBL1614234;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ];CHEMBL1201862;Direct protein target assigned;D;1457;7;CHEMBL1293238;;
CLD0;confirmatory;;CHEMBL1614236;[];Influenza A virus (A/WSN/1933(H1N1));[];;;382835.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2326;7;CHEMBL1293303;;
CLD0;confirmatory;;CHEMBL1614240;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;887;7;CHEMBL2903;;
CLD0;confirmatory;;CHEMBL1614249;[];Equus caballus;[];;;9796.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)];CHEMBL1201862;Direct protein target assigned;D;485281;7;CHEMBL1293254;;
CLD0;confirmatory;;CHEMBL1614250;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Direct protein target assigned;D;1468;7;CHEMBL1293224;;
CLD0;confirmatory;;CHEMBL1614310;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation of Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1459;7;CHEMBL1293235;;
CLD0;confirmatory;;CHEMBL1614456;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ];CHEMBL1201862;Direct protein target assigned;D;914;7;CHEMBL4261;;
CLD0;confirmatory;;CHEMBL1614458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))];CHEMBL1201862;Direct protein target assigned;D;1030;7;CHEMBL3577;;
CLD0;confirmatory;;CHEMBL1614521;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]";CHEMBL1201862;Direct protein target assigned;D;1454;7;CHEMBL4040;;
CLD0;confirmatory;;CHEMBL1614522;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)]";CHEMBL1201862;Direct protein target assigned;D;2364;7;CHEMBL1293237;;
CLD0;confirmatory;;CHEMBL1613791;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: A counter screen for small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 2252, 1985 ];CHEMBL1201862;Default value - Target has yet to be curated;U;2384;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613803;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 914 ];CHEMBL1201862;Direct protein target assigned;D;915;7;CHEMBL4261;;
CLD0;confirmatory;MEF;CHEMBL1613805;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307598;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2668;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL1613808;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;995;7;CHEMBL4040;;
CLD0;confirmatory;;CHEMBL1614198;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1815;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614207;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1877;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614257;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1768;7;CHEMBL2093861;;
CLD0;confirmatory;;CHEMBL1614263;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Quantitative High-Throughput Screen for Regulators of Epigenetic Control. (Class of assay: confirmatory) [Related pubchem assays: 1041, 1039, 890, 1036, 1653, 1035, 1043, 1038, 990, 597, 1042, 1037 ];CHEMBL1201862;Default value - Target has yet to be curated;U;1865;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614265;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;958;7;CHEMBL1075189;;
CLD0;confirmatory;;CHEMBL1614274;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;895;7;CHEMBL3251;;
CLD0;confirmatory;;CHEMBL1614275;[];Giardia intestinalis;[];;;5741.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ];CHEMBL1201862;Direct protein target assigned;D;2451;7;CHEMBL1293234;;
CLD0;confirmatory;;CHEMBL1614280;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)];CHEMBL1201862;Direct protein target assigned;D;485360;7;CHEMBL1287622;;
CLD0;confirmatory;;CHEMBL1614283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) [Related pubchem assays: 1707, 1708 ];CHEMBL1201862;Direct protein target assigned;D;1705;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1614328;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;"PUBCHEM_BIOASSAY: Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 2528 (qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2585 (qHTS Confirmation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";CHEMBL1201862;Default value - Target has yet to be curated;U;2712;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614330;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)];CHEMBL1201862;Direct protein target assigned;D;2353;7;CHEMBL1293236;;
CLD0;confirmatory;;CHEMBL1614331;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;927;7;CHEMBL1293227;;
CLD0;confirmatory;;CHEMBL1614342;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485313;7;CHEMBL1293277;;
CLD0;confirmatory;;CHEMBL1614410;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)];CHEMBL1201862;Direct protein target assigned;D;2662;7;CHEMBL1293299;;
CLD0;confirmatory;;CHEMBL1614466;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) [Related pubchem assays: 1705 (qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) ), 2324 (Probe Development Summary of Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1707 (Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay), 2517 (qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1708 (Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV)];CHEMBL1201862;Direct protein target assigned;D;2572;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1614531;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1766;7;CHEMBL2093861;;
CLD0;confirmatory;;CHEMBL1614537;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1882;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614544;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1487;7;CHEMBL1293235;;
CLD0;confirmatory;;CHEMBL1613823;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 895 ];CHEMBL1201862;Direct protein target assigned;D;928;7;CHEMBL3251;;
CLD0;confirmatory;;CHEMBL1613829;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))];CHEMBL1201862;Direct protein target assigned;D;2549;7;CHEMBL1293236;;
CLD0;confirmatory;;CHEMBL1613856;[];Leishmania mexicana mexicana;[];;;44270.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;959;7;CHEMBL5149;;
CLD0;confirmatory;;CHEMBL1613897;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))];CHEMBL1201862;Default value - Target has yet to be curated;U;2711;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613900;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1876;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1613913;[];Leishmania mexicana mexicana;[];;;44270.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;945;7;CHEMBL5149;;
CLD0;confirmatory;;CHEMBL1613914;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2147;7;CHEMBL1293226;;
CLD0;confirmatory;;CHEMBL1613918;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ];CHEMBL1201862;Direct protein target assigned;D;1688;7;CHEMBL5514;;
CLD0;confirmatory;;CHEMBL1613970;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay for Compounds that Induce Erasure of Genomic Imprints. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1948;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613991;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;944;7;CHEMBL276;;
CLD0;confirmatory;;CHEMBL1613992;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;902;7;CHEMBL4096;;
CLD0;confirmatory;;CHEMBL1613995;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ];CHEMBL1201862;Direct protein target assigned;D;924;7;CHEMBL4096;;
CLD0;confirmatory;;CHEMBL1613997;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;943;7;CHEMBL276;;
CLD0;confirmatory;;CHEMBL1614052;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1461;7;CHEMBL5162;;
CLD0;confirmatory;;CHEMBL1614067;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";CHEMBL1201862;Direct protein target assigned;D;2528;7;CHEMBL1293237;;
CLD0;confirmatory;;CHEMBL1614079;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485314;7;CHEMBL2392;;
CLD0;confirmatory;;CHEMBL1614086;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 918 ];CHEMBL1201862;Direct protein target assigned;D;917;7;CHEMBL1293256;;
CLD0;confirmatory;;CHEMBL1614087;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2551;7;CHEMBL1293231;;
CLD0;confirmatory;;CHEMBL1614100;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1864, 2252, 1985 ];CHEMBL1201862;Default value - Target has yet to be curated;U;1850;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614108;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ];CHEMBL1201862;Direct protein target assigned;D;885;7;CHEMBL340;;
CLD0;confirmatory;;CHEMBL1614110;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ];CHEMBL1201862;Direct protein target assigned;D;891;7;CHEMBL289;;
CLD0;confirmatory;;CHEMBL1614142;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1886;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1614211;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2517;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1614213;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;901;7;CHEMBL1293238;;
CLD0;confirmatory;;CHEMBL1614291;[];Equus caballus;[];;;9796.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Identification of Novel General Anesthetics. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2323;7;CHEMBL1293254;;
CLD0;confirmatory;;CHEMBL1614362;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Validation screen for inhibitors of Lassa infection. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;463096;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614364;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485290;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL1614421;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Direct protein target assigned;D;1460;7;CHEMBL1293224;;
CLD0;confirmatory;;CHEMBL1614433;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV. (Class of assay: confirmatory) [Related pubchem assays: 1705, 1707 ];CHEMBL1201862;Homologous protein target assigned;H;1708;7;CHEMBL1293285;;
CLD0;confirmatory;;CHEMBL1614441;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;2546;7;CHEMBL1293231;;
CLD0;confirmatory;;CHEMBL1614493;[];Photuris pennsylvanica;[];;;41716.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Counterscreen for Luciferase (Kinase-Glo TM) Inhibition. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1379;7;CHEMBL1293247;;
CLD0;confirmatory;;CHEMBL1614502;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ];CHEMBL1201862;Homologous protein target assigned;H;1463;7;CHEMBL1293224;;
CLD0;confirmatory;;CHEMBL1613767;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)];CHEMBL1201862;Non-molecular target assigned;N;1883;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1613838;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;485297;7;CHEMBL1293294;;
CLD0;confirmatory;;CHEMBL1613842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1458;7;CHEMBL1293232;;
CLD0;confirmatory;;CHEMBL1613886;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ];CHEMBL1201862;Direct protein target assigned;D;884;7;CHEMBL340;;
CLD0;confirmatory;;CHEMBL1613923;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: A cytotoxicity screen of small molecule inhibitors of the PhoP region in Salmonella typhi identified in the primary screen. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 1985 ];CHEMBL1201862;Default value - Target has yet to be curated;U;2252;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613927;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter. (Class of assay: confirmatory) [Related pubchem assays: 2281 (Summary of qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a)];CHEMBL1201862;Direct protein target assigned;D;463106;7;CHEMBL1293227;;
CLD0;confirmatory;;CHEMBL1613928;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))];CHEMBL1201862;Direct protein target assigned;D;2708;7;CHEMBL1293236;;
CLD0;confirmatory;;CHEMBL1613941;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;463097;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL1614019;[];Drosophila;[];;;7215.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1519;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614034;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 917 ];CHEMBL1201862;Direct protein target assigned;D;918;7;CHEMBL1293256;;
CLD0;;;CHEMBL1614670;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Volume of distribution at steady state in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614671;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Clearance in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614672;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction unbound in human after iv administration;CHEMBL1614632;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1614673;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Mean residence time in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1614674;[];Homo sapiens;[];;;9606.0;In vivo;;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Half life in human after iv administration;CHEMBL1614632;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
CLD0;;;CHEMBL1654778;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in Luria-Bertani broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654779;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in carbon-limited broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654780;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in nitrogen -limited broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654781;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in Luria-Bertani broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654782;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in carbon-limited broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1654783;[];Mycobacterium smegmatis;[];;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis grown in nitrogen -limited broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay;CHEMBL1649296;Non-molecular target assigned;N;;1;CHEMBL613088;;
CLD0;;;CHEMBL1663502;[];Homo sapiens;[];;;9606.0;;Intestine;A;ADME;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Drug absorption in human assessed as human intestinal absorption rate;CHEMBL1649380;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3638176;
CLD0;;;CHEMBL1697722;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset;CHEMBL1697692;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697730;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Human drug-induced liver injury (DILI) modelling dataset from Ekins et al;CHEMBL1697723;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697778;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697779;[];Rodentia;[];;;9989.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697780;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697797;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA HLAED, liver enzyme composite activity;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697798;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, alkaline phosphatase increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697799;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697800;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697801;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, lactate dehydrogenase (LDH) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697802;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, gamma-glutamyl transferase (GGT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;confirmatory;;CHEMBL1738023;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488970];CHEMBL1201862;Default value - Target has yet to be curated;U;488966;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738312;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391];CHEMBL1201862;Direct protein target assigned;D;504333;7;CHEMBL1741220;;
CLD0;confirmatory;Jurkat;CHEMBL1738369;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465];CHEMBL1201862;Default value - Target has yet to be curated;U;489035;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613800;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702];CHEMBL1201862;Direct protein target assigned;D;881;7;CHEMBL2457;;
CLD0;confirmatory;;CHEMBL1614221;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774];CHEMBL1201862;Non-molecular target assigned;N;488745;7;CHEMBL364;;
CLD0;confirmatory;HEK-293T;CHEMBL1738494;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489041];CHEMBL1201862;Default value - Target has yet to be curated;U;489026;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614045;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774];CHEMBL1201862;Non-molecular target assigned;N;488752;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1738552;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465];CHEMBL1201862;Default value - Target has yet to be curated;U;489033;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738588;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125];CHEMBL1201862;Direct protein target assigned;D;504467;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1613933;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375];CHEMBL1201862;Direct protein target assigned;D;1477;7;CHEMBL2093862;;
CLD0;confirmatory;;CHEMBL1738675;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493125, AID504467];CHEMBL1201862;Direct protein target assigned;D;493107;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1613922;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;488816;7;CHEMBL5027;;
CLD0;confirmatory;;CHEMBL1737868;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493143, AID504466];CHEMBL1201862;Direct protein target assigned;D;493106;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1737902;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355];CHEMBL1201862;Default value - Target has yet to be curated;U;493014;7;CHEMBL612545;;
CLD0;confirmatory;HEK-293T;CHEMBL1737912;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489026];CHEMBL1201862;Default value - Target has yet to be curated;U;489041;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL1737978;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431];CHEMBL1201862;Non-molecular target assigned;N;504726;7;CHEMBL399;;
CLD0;confirmatory;;CHEMBL1737980;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493163, AID504444, AID504648];CHEMBL1201862;Direct protein target assigned;D;493153;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL1737991;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402];CHEMBL1201862;Direct protein target assigned;D;504339;7;CHEMBL5896;;
CLD0;confirmatory;;CHEMBL1737994;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444];CHEMBL1201862;Default value - Target has yet to be curated;U;504648;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738096;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Initial hit validation from the primary screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2675, AID2700];CHEMBL1201862;Direct protein target assigned;D;493199;7;CHEMBL1293317;;
CLD0;confirmatory;;CHEMBL1738184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648];CHEMBL1201862;Direct protein target assigned;D;504444;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL1738186;[];Salmonidae;[];;;8015.0;;;B;Binding;BAO_0000217;biochemical format;;Target assigned is molecular non-protein target;3;PUBCHEM_BIOASSAY: C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431];CHEMBL1201862;Molecular target other than protein assigned;M;504727;7;CHEMBL612408;;
CLD0;confirmatory;;CHEMBL1738317;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143];CHEMBL1201862;Direct protein target assigned;D;504466;7;CHEMBL1741209;;
CLD0;confirmatory;;CHEMBL1738433;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Cytotoxicity screening for potential Inhibitors of Bacterial Capsule Biogenesis. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488970];CHEMBL1201862;Default value - Target has yet to be curated;U;493020;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1614194;[];Bacillus subtilis;[];;;1423.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485296];CHEMBL1201862;Homologous protein target assigned;H;485295;7;CHEMBL3897;;
CLD0;screening;;CHEMBL1738439;[];;[];;;;;;U;Unassigned;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: Nitrocefin-based VIM2 Inhibition Assay;CHEMBL1201862;Homologous protein target assigned;H;2317_2;7;CHEMBL1293246;;
CLD0;screening;;CHEMBL1738440;[];;[];;;;;;U;Unassigned;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: Nitrocefin-based IMP1 Inhibition Counterscreen;CHEMBL1201862;Homologous protein target assigned;H;2317_3;7;CHEMBL1293246;;
CLD0;screening;;CHEMBL1738441;[];;[];;;;;;U;Unassigned;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: VIM-2 Ki Assay;CHEMBL1201862;Homologous protein target assigned;H;2317_1;7;CHEMBL1293246;;
CLD0;confirmatory;;CHEMBL1738442;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404];CHEMBL1201862;Direct protein target assigned;D;504332;7;CHEMBL6032;;
CLD0;confirmatory;;CHEMBL1738498;[];Influenza A virus (A/California/07/2009(H1N1));[];;;641809.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Discovery of Small Molecule Probes for H1N1 Influenza NS1A. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504399];CHEMBL1201862;Homologous protein target assigned;H;504329;7;CHEMBL1293303;;
CLD0;confirmatory;;CHEMBL1738509;[];Trypanosoma brucei TREU927;[];;;185431.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504632];CHEMBL1201862;Homologous protein target assigned;H;504547;7;CHEMBL1741167;;
CLD0;confirmatory;;CHEMBL1738570;[];Leishmania major strain Friedlin;[];;;347515.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504639];CHEMBL1201862;Homologous protein target assigned;H;504548;7;CHEMBL1741202;;
CLD0;confirmatory;;CHEMBL1738606;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398];CHEMBL1201862;Direct protein target assigned;D;504327;7;CHEMBL5501;;
CLD0;confirmatory;;CHEMBL1614279;[];Trypanosoma brucei;[];;;185431.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961];CHEMBL1201862;Homologous protein target assigned;H;485368;7;CHEMBL5686;;
CLD0;confirmatory;;CHEMBL1738610;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962];CHEMBL1201862;Direct protein target assigned;D;488953;7;CHEMBL1741193;;
CLD0;confirmatory;;CHEMBL1738622;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Initial hit validation in AlphaScreen assay for MBNL1-(CUG)12 binding. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2675, AID2700];CHEMBL1201862;Direct protein target assigned;D;493205;7;CHEMBL1293317;;
CLD0;confirmatory;;CHEMBL1738402;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;488949;7;CHEMBL1741210;;
CLD0;other;;CHEMBL1741321;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_2;7;CHEMBL289;;
CLD0;other;;CHEMBL1741322;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_4;7;CHEMBL3356;;
CLD0;other;;CHEMBL1741323;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_1;7;CHEMBL3622;;
CLD0;other;;CHEMBL1741324;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_3;7;CHEMBL340;;
CLD0;other;;CHEMBL1741325;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active;CHEMBL1201862;Homologous protein target assigned;H;1851_5;7;CHEMBL3397;;
CLD0;;;CHEMBL1743158;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Substrates of transporters of clinical importance in the absorption and disposition of drugs, BCRP;CHEMBL1743141;Direct protein target assigned;D;14;1;CHEMBL5393;;
CLD0;;;CHEMBL1743160;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Substrates of transporters of clinical importance in the absorption and disposition of drugs, MRP2;CHEMBL1743141;Direct protein target assigned;D;16;1;CHEMBL5748;;
CLD0;;A549;CHEMBL1763107;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells after 72 hrs;CHEMBL1759843;Non-molecular target assigned;N;361041;1;CHEMBL392;;
CLD0;;HL-60;CHEMBL1763108;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 72 hrs;CHEMBL1759843;Non-molecular target assigned;N;361042;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL1764595;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells;CHEMBL1759981;Non-molecular target assigned;N;365305;1;CHEMBL383;;
CLD0;;HL60/MX2;CHEMBL1764596;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Cytotoxicity against human HL60/MX2 cells;CHEMBL1759981;Non-molecular target assigned;N;365306;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL1764597;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Resistance index, ratio IC50 for human HL60/MX2 cells to IC50 for human HL60 cells;CHEMBL1759981;Non-molecular target assigned;N;365307;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL1769827;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells by MTT assay;CHEMBL1765038;Non-molecular target assigned;N;358297;1;CHEMBL383;;
CLD0;;A549;CHEMBL1769828;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells by MTT assay;CHEMBL1765038;Non-molecular target assigned;N;358298;1;CHEMBL392;;
CLD0;;HCT-116;CHEMBL1769829;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells by MTT assay;CHEMBL1765038;Non-molecular target assigned;N;358299;1;CHEMBL394;;
CLD0;;MCF7;CHEMBL1769830;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells by MTT assay;CHEMBL1765038;Non-molecular target assigned;N;358300;1;CHEMBL387;;
CLD0;;KB ;CHEMBL1772155;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB/HeLa cells after 48 hrs by XTT assay;CHEMBL1770061;Non-molecular target assigned;N;370011;1;CHEMBL3879801;;
CLD0;;SK-OV-3;CHEMBL1772156;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Antiproliferative activity against human SKOV3 cells after 48 hrs by XTT assay;CHEMBL1770061;Non-molecular target assigned;N;370012;1;CHEMBL614925;;
CLD0;;SF-268;CHEMBL1772157;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Antiproliferative activity against human SF268 cells after 48 hrs by XTT assay;CHEMBL1770061;Non-molecular target assigned;N;370013;1;CHEMBL613977;;
CLD0;;NCI-H460;CHEMBL1772158;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Antiproliferative activity against human NCI-H460 cells after 48 hrs by XTT assay;CHEMBL1770061;Non-molecular target assigned;N;370014;1;CHEMBL396;;
CLD0;;RKOp27;CHEMBL1772159;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human RKOp27 cells after 48 hrs by XTT assay;CHEMBL1770061;Non-molecular target assigned;N;370015;1;CHEMBL3879801;;
CLD0;;;CHEMBL1772160;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human RKOp27IND cells after 48 hrs by XTT assay;CHEMBL1770061;Non-molecular target assigned;N;370016;1;CHEMBL3879801;;
CLD0;;HCT-116;CHEMBL1772488;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay;CHEMBL1770094;Non-molecular target assigned;N;369986;1;CHEMBL394;;
CLD0;;MES-SA ;CHEMBL1772489;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;Cytotoxicity against human MES-SA cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay;CHEMBL1770094;Non-molecular target assigned;N;369987;1;CHEMBL3879801;;
CLD0;;MES-SA/Dx5;CHEMBL1772490;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;Cytotoxicity against human MES-SA/Dx5 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay;CHEMBL1770094;Non-molecular target assigned;N;369988;1;CHEMBL3879801;;
CLD0;;MES-SA ;CHEMBL1772491;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Default value - Target unknown or has yet to be assigned;0;Resistant factor, ratio of IC50 for doxorubicin-resistant human MES-SA/Dx5 cells to IC50 for doxorubicin-sensitive human MES-SA cells;CHEMBL1770094;Default value - Target has yet to be curated;U;369989;1;CHEMBL612545;;
CLD0;;A549;CHEMBL1786566;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells after 24 hrs by MTT assay;CHEMBL1781940;Non-molecular target assigned;N;369503;1;CHEMBL392;;
CLD0;;HCT-116;CHEMBL1786567;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Cytotoxicity against human HCT116 cells after 24 hrs by MTT assay;CHEMBL1781940;Non-molecular target assigned;N;369504;1;CHEMBL394;;
CLD0;;HL-60;CHEMBL1786568;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 24 hrs by MTT assay;CHEMBL1781940;Non-molecular target assigned;N;369505;1;CHEMBL383;;
CLD0;confirmatory;;CHEMBL1794352;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411];CHEMBL1201862;Homologous protein target assigned;H;588342;7;CHEMBL5567;;
CLD0;confirmatory;;CHEMBL1794367;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588349, AID588380];CHEMBL1201862;Homologous protein target assigned;H;588378;7;CHEMBL1795085;;
CLD0;confirmatory;HEK293;CHEMBL1794308;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249];CHEMBL1201862;Non-molecular target assigned;N;540256;7;CHEMBL614818;;
CLD0;confirmatory;;CHEMBL1794311;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855];CHEMBL1201862;Homologous protein target assigned;H;504847;7;CHEMBL1977;;
CLD0;confirmatory;;CHEMBL1794375;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278];CHEMBL1201862;Default value - Target has yet to be curated;U;540276;7;CHEMBL612545;;
CLD0;confirmatory;SH-SY5Y;CHEMBL1794380;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307740;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588378, AID588380];CHEMBL1201862;Non-molecular target assigned;N;588349;7;CHEMBL614910;;
CLD0;confirmatory;;CHEMBL1794345;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504834;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794401;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962];CHEMBL1201862;Homologous protein target assigned;H;540317;7;CHEMBL1741193;;
CLD0;confirmatory;;CHEMBL1794423;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504849];CHEMBL1201862;Homologous protein target assigned;H;504836;7;CHEMBL1781865;;
CLD0;confirmatory;;CHEMBL1794461;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous protein complex subunits assigned;6;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262];CHEMBL1201862;Homologous protein target assigned;H;540253;7;CHEMBL3885569;;
CLD0;confirmatory;;CHEMBL1794467;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878];CHEMBL1201862;Homologous protein target assigned;H;504865;7;CHEMBL1795087;;
CLD0;confirmatory;;CHEMBL1794483;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623];CHEMBL1201862;Homologous protein target assigned;H;588590;7;CHEMBL5391;;
CLD0;confirmatory;;CHEMBL1794486;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813];CHEMBL1201862;Homologous protein target assigned;H;588795;7;CHEMBL5027;;
CLD0;confirmatory;;CHEMBL1794499;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856];CHEMBL1201862;Homologous protein target assigned;H;504845;7;CHEMBL1795091;;
CLD0;confirmatory;;CHEMBL1794521;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Confirmation dose response of additional hit compounds from high-throughput yeast screen for caloric restriction mimetics that inhibit age-related superoxide. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2714];CHEMBL1201862;Default value - Target has yet to be curated;U;504927;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1794536;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638];CHEMBL1201862;Homologous protein target assigned;H;588579;7;CHEMBL5365;;
CLD0;confirmatory;HepG2;CHEMBL1794553;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860];CHEMBL1201862;Non-molecular target assigned;N;588856;7;CHEMBL395;;
CLD0;confirmatory;;CHEMBL1794557;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000217;biochemical format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442];CHEMBL1201862;Homologous protein target assigned;H;588345;7;CHEMBL5508;;
CLD0;confirmatory;;CHEMBL1794569;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636];CHEMBL1201862;Homologous protein target assigned;H;588591;7;CHEMBL5542;;
CLD0;confirmatory;;CHEMBL1794580;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504832;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794584;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860];CHEMBL1201862;Homologous protein target assigned;H;588855;7;CHEMBL1293258;;
CLD0;confirmatory;;CHEMBL1794585;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;504891;7;CHEMBL2288;;
CLD0;;HL-60;CHEMBL1820600;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL1817624;Non-molecular target assigned;N;394355;1;CHEMBL383;;
CLD0;;K562;CHEMBL1820601;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for homoharringtonine300-resistant human K562 cells to IC50 for human K562 cells;CHEMBL1817624;Non-molecular target assigned;N;394356;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL1820602;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for vinblastine100-resistant human CCRF-CEM cells to IC50 for human CCRF-CEM cells;CHEMBL1817624;Non-molecular target assigned;N;394357;1;CHEMBL382;;
CLD0;;;CHEMBL1908080;[];Homo sapiens;[];;;9606.0;In vitro;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Specific activity of expressed human recombinant UGT1A1;CHEMBL1907987;Direct protein target assigned;D;1;1;CHEMBL1287617;;
CLD0;;;CHEMBL1908083;[];Homo sapiens;[];;;9606.0;In vitro;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Specific activity of expressed human recombinant UGT1A6;CHEMBL1907987;Direct protein target assigned;D;4;1;CHEMBL1743316;;
CLD0;;;CHEMBL1908086;[];Homo sapiens;[];;;9606.0;In vitro;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Specific activity of expressed human recombinant UGT1A9;CHEMBL1907987;Direct protein target assigned;D;7;1;CHEMBL1743319;;
CLD0;;MDR1-MDCKII;CHEMBL1908285;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;1;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908286;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;2;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908289;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;A;ADME;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;5;1;CHEMBL4302;;
CLD0;;Sf9;CHEMBL1908291;[];Spodoptera frugiperda;[];(null);Membrane;7108.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM;CHEMBL1908284;Homologous protein target assigned;H;7;1;CHEMBL4302;;
CLD0;;MDR1-MDCKII;CHEMBL1908292;[];Canis lupus familiaris;[];(null);;9615.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay;CHEMBL1908284;Homologous protein target assigned;H;8;1;CHEMBL4302;;
CLD0;;;CHEMBL1909163;[];Cavia porcellus;[];;;10141.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4);CHEMBL1909046;Direct protein target assigned;D;67;15;CHEMBL1909043;CHEMBL3638235;
CLD0;;CHO-K1;CHEMBL1909164;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4);CHEMBL1909046;Homologous protein target assigned;H;68;15;CHEMBL1798;;
CLD0;;Reticulocytes;CHEMBL1909165;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid);CHEMBL1909046;Direct protein target assigned;D;69;15;CHEMBL4358;;
CLD0;;HEK293;CHEMBL1909166;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;70;15;CHEMBL4644;;
CLD0;;HEK293;CHEMBL1909167;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;71;15;CHEMBL259;;
CLD0;;HEK293;CHEMBL1909168;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;72;15;CHEMBL4608;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909169;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine);CHEMBL1909046;Homologous protein target assigned;H;73;15;CHEMBL1951;;
CLD0;;CHO-K1;CHEMBL1909170;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;74;15;CHEMBL216;;
CLD0;;CHO-K1;CHEMBL1909171;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;75;15;CHEMBL211;;
CLD0;;CHO-K1;CHEMBL1909172;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;76;15;CHEMBL245;;
CLD0;;CHO-K1;CHEMBL1909173;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;77;15;CHEMBL1821;;
CLD0;;CHO-K1;CHEMBL1909174;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;78;15;CHEMBL2035;;
CLD0;;SK-N-MC;CHEMBL1909175;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307551;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;79;15;CHEMBL4777;;
CLD0;;KAN-TS;CHEMBL1909176;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;80;15;CHEMBL4018;;
CLD0;;IMR-32;CHEMBL1909177;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307656;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine);CHEMBL1909046;Default value - Target has yet to be curated;U;81;15;CHEMBL612545;;
CLD0;;;CHEMBL1909178;[];Rattus norvegicus;[];;;10116.0;In vitro;Cerebellum;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine);CHEMBL1909046;Direct protein target assigned;D;82;15;CHEMBL3048;CHEMBL3638233;
CLD0;;;CHEMBL1909179;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine);CHEMBL1909046;Homologous protein target assigned;H;83;15;CHEMBL3464;;
CLD0;;HEK293;CHEMBL1909180;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole);CHEMBL1909046;Homologous protein target assigned;H;84;15;CHEMBL236;;
CLD0;;HEK293;CHEMBL1909181;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;85;15;CHEMBL237;;
CLD0;;CHO-K1;CHEMBL1909182;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;86;15;CHEMBL233;;
CLD0;;;CHEMBL1909183;[];Mus musculus;[];ICR;Membrane;10090.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu);CHEMBL1909046;Default value - Target has yet to be curated;U;87;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Platelet;CHEMBL1909184;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;88;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909185;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;89;15;CHEMBL612545;;
CLD0;;Platelet;CHEMBL1909186;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP);CHEMBL1909046;Direct protein target assigned;D;90;15;CHEMBL1827;;
CLD0;;Platelet;CHEMBL1909187;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF);CHEMBL1909046;Direct protein target assigned;D;91;15;CHEMBL250;;
CLD0;;NIH3T3;CHEMBL1909188;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF);CHEMBL1909046;Default value - Target has yet to be curated;U;92;15;CHEMBL612545;;
CLD0;;HIT-T15;CHEMBL1909189;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide);CHEMBL1909046;Default value - Target has yet to be curated;U;93;15;CHEMBL612545;;
CLD0;;HEK293;CHEMBL1909190;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);CHEMBL1909046;Homologous protein target assigned;H;94;15;CHEMBL240;;
CLD0;;;CHEMBL1909191;[];Bos taurus;[];;;9913.0;In vitro;Uterus;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020);CHEMBL1909046;Direct protein target assigned;D;95;15;CHEMBL1909044;CHEMBL3638197;
CLD0;;;CHEMBL1909192;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG);CHEMBL1909046;Direct protein target assigned;D;96;15;CHEMBL4074;CHEMBL3638235;
CLD0;;;CHEMBL1909193;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC);CHEMBL1909046;Homologous protein target assigned;H;97;15;CHEMBL4801;;
CLD0;;Neutrophil;CHEMBL1909194;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC);CHEMBL1909046;Direct protein target assigned;D;98;15;CHEMBL4071;;
CLD0;;Neutrophil;CHEMBL1909195;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA);CHEMBL1909046;Direct protein target assigned;D;99;15;CHEMBL248;;
CLD0;;;CHEMBL1909196;[];Homo sapiens;[];;;9606.0;In vitro;Rheumatoid synovial fibroblasts;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Direct protein target assigned;D;100;15;CHEMBL332;;
CLD0;;;CHEMBL1909197;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Homologous protein target assigned;H;101;15;CHEMBL321;;
CLD0;;Sf9;CHEMBL1909198;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone);CHEMBL1909046;Homologous protein target assigned;H;102;15;CHEMBL299;;
CLD0;;;CHEMBL1909199;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;103;15;CHEMBL3385;;
CLD0;;;CHEMBL1909200;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;104;15;CHEMBL4040;;
CLD0;;;CHEMBL1909201;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;105;15;CHEMBL260;;
CLD0;;;CHEMBL1909202;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;106;15;CHEMBL4445;;
CLD0;;Insect cells;CHEMBL1909203;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;107;15;CHEMBL203;;
CLD0;;Insect cells;CHEMBL1909204;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;108;15;CHEMBL1841;;
CLD0;;Insect cells;CHEMBL1909205;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;109;15;CHEMBL1824;;
CLD0;;Insect cells;CHEMBL1909206;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;110;15;CHEMBL258;;
CLD0;;;CHEMBL1909207;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;111;15;CHEMBL3243;;
CLD0;;;CHEMBL1909208;[];Oryctolagus cuniculus;[];New Zealand albino;Membrane;9986.0;In vitro;Urinary bladder;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;112;15;CHEMBL612545;CHEMBL3638205;
CLD0;;CHO-K1;CHEMBL1909209;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT);CHEMBL1909046;Homologous protein target assigned;H;113;15;CHEMBL273;;
CLD0;;;CHEMBL1909210;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Direct protein target assigned;D;114;15;CHEMBL3459;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909211;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin);CHEMBL1909046;Homologous protein target assigned;H;115;15;CHEMBL224;;
CLD0;;HEK293;CHEMBL1909212;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine);CHEMBL1909046;Homologous protein target assigned;H;1;15;CHEMBL220;;
CLD0;;CHO;CHEMBL1909213;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX);CHEMBL1909046;Homologous protein target assigned;H;2;15;CHEMBL226;;
CLD0;;HEK293;CHEMBL1909214;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;3;15;CHEMBL251;;
CLD0;;CHO-K1;CHEMBL1909215;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;4;15;CHEMBL256;;
CLD0;;;CHEMBL1909084;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine);CHEMBL1909046;Default value - Target has yet to be curated;U;5;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909085;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Submaxillary gland;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;6;15;CHEMBL319;CHEMBL3987361;
CLD0;;;CHEMBL1909086;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;7;15;CHEMBL315;CHEMBL3559723;
CLD0;;HEK293;CHEMBL1909087;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Homologous protein target assigned;H;8;15;CHEMBL223;;
CLD0;;Sf9;CHEMBL1909088;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912);CHEMBL1909046;Homologous protein target assigned;H;9;15;CHEMBL1867;;
CLD0;;CHO-K1;CHEMBL1909089;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine);CHEMBL1909046;Homologous protein target assigned;H;10;15;CHEMBL1942;;
CLD0;;Sf9;CHEMBL1909090;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912);CHEMBL1909046;Homologous protein target assigned;H;11;15;CHEMBL1916;;
CLD0;;CHO-K1;CHEMBL1909091;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;12;15;CHEMBL213;;
CLD0;;CHO;CHEMBL1909092;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177);CHEMBL1909046;Homologous protein target assigned;H;13;15;CHEMBL210;;
CLD0;;HEK293;CHEMBL1909093;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;14;15;CHEMBL246;;
CLD0;;MDCK;CHEMBL1909094;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308370;Homologous single protein target assigned;8;DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;15;15;CHEMBL222;;
CLD0;;;CHEMBL1909095;[];Rattus norvegicus;[];;;10116.0;In vitro;Lens of camera-type eye;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde);CHEMBL1909046;Direct protein target assigned;D;16;15;CHEMBL2622;CHEMBL3638191;
CLD0;;CHO-K1;CHEMBL1909096;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A);CHEMBL1909046;Homologous protein target assigned;H;17;15;CHEMBL4607;;
CLD0;;;CHEMBL1909097;[];Sus scrofa;[];;;9823.0;In vitro;Heart;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;18;15;CHEMBL612545;CHEMBL3638187;
CLD0;;;CHEMBL1909098;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Adrenal gland;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat));CHEMBL1909046;Default value - Target has yet to be curated;U;19;15;CHEMBL612545;CHEMBL3638251;
CLD0;;;CHEMBL1909099;[];Bacillus cereus;[];;;1396.0;In vitro;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin);CHEMBL1909046;Default value - Target has yet to be curated;U;20;15;CHEMBL612545;;
CLD0;;Chem-1;CHEMBL1909100;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin);CHEMBL1909046;Homologous protein target assigned;H;21;15;CHEMBL3157;;
CLD0;;T47D;CHEMBL1909101;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307606;Homologous single protein target assigned;8;DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon));CHEMBL1909046;Homologous protein target assigned;H;22;15;CHEMBL1832;;
CLD0;;;CHEMBL1909102;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem);CHEMBL1909046;Default value - Target has yet to be curated;U;23;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909103;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine);CHEMBL1909046;Default value - Target has yet to be curated;U;24;15;CHEMBL612545;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909104;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;116;15;CHEMBL1833;;
CLD0;;CHO-K1;CHEMBL1909105;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine);CHEMBL1909046;Homologous protein target assigned;H;117;15;CHEMBL225;;
CLD0;;HEK293;CHEMBL1909106;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630);CHEMBL1909046;Default value - Target has yet to be curated;U;118;15;CHEMBL612545;;
CLD0;;;CHEMBL1909107;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Striatum;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808);CHEMBL1909046;Direct protein target assigned;D;119;15;CHEMBL5017;CHEMBL3638255;
CLD0;;HeLa;CHEMBL1909108;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;120;15;CHEMBL3371;;
CLD0;;HEK293;CHEMBL1909109;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine);CHEMBL1909046;Homologous protein target assigned;H;121;15;CHEMBL228;;
CLD0;;Jurkat;CHEMBL1909110;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307526;Homologous single protein target assigned;8;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CHEMBL1909046;Homologous protein target assigned;H;122;15;CHEMBL287;;
CLD0;;;CHEMBL1909111;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil);CHEMBL1909046;Default value - Target has yet to be curated;U;123;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909112;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin);CHEMBL1909046;Default value - Target has yet to be curated;U;124;15;CHEMBL612545;CHEMBL3638188;
CLD0;;CHO;CHEMBL1909113;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P);CHEMBL1909046;Homologous protein target assigned;H;125;15;CHEMBL249;;
CLD0;;CHO;CHEMBL1909114;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968);CHEMBL1909046;Homologous protein target assigned;H;126;15;CHEMBL2327;;
CLD0;;;CHEMBL1909115;[];Escherichia coli;[];;Membrane;562.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone);CHEMBL1909046;Homologous protein target assigned;H;127;15;CHEMBL3072;;
CLD0;;Platelet;CHEMBL1909116;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2);CHEMBL1909046;Direct protein target assigned;D;128;15;CHEMBL1835;;
CLD0;;U-937;CHEMBL1909117;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha);CHEMBL1909046;Default value - Target has yet to be curated;U;129;15;CHEMBL612545;;
CLD0;;HUVEC;CHEMBL1909118;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307501;Homologous single protein target assigned;8;DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF);CHEMBL1909046;Homologous protein target assigned;H;130;15;CHEMBL1868;;
CLD0;;HT-29;CHEMBL1909119;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307768;Homologous single protein target assigned;8;DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP);CHEMBL1909046;Homologous protein target assigned;H;131;15;CHEMBL5144;;
CLD0;;HEK293;CHEMBL1909120;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr);CHEMBL1909046;Homologous protein target assigned;H;132;15;CHEMBL1889;;
CLD0;;;CHEMBL1909121;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888));CHEMBL1909046;Default value - Target has yet to be curated;U;25;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Chem-1;CHEMBL1909122;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A);CHEMBL1909046;Homologous protein target assigned;H;26;15;CHEMBL218;;
CLD0;;Erythrocyte;CHEMBL1909123;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833281;Direct single protein target assigned;9;DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA));CHEMBL1909046;Direct protein target assigned;D;27;15;CHEMBL205;;
CLD0;;CHO-K1;CHEMBL1909124;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1);CHEMBL1909046;Homologous protein target assigned;H;28;15;CHEMBL4015;;
CLD0;;Chem-1;CHEMBL1909125;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC);CHEMBL1909046;Homologous protein target assigned;H;29;15;CHEMBL2414;;
CLD0;;HEK293;CHEMBL1909126;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha);CHEMBL1909046;Homologous protein target assigned;H;30;15;CHEMBL274;;
CLD0;;;CHEMBL1909127;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR1 (IL-8A);CHEMBL1909046;Homologous protein target assigned;H;31;15;CHEMBL4029;;
CLD0;;CHO-K1;CHEMBL1909128;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8);CHEMBL1909046;Homologous protein target assigned;H;32;15;CHEMBL2434;;
CLD0;;1321-N1;CHEMBL1909129;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718);CHEMBL1909046;Homologous protein target assigned;H;33;15;CHEMBL1901;;
CLD0;;Platelet;CHEMBL1909130;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Direct protein target assigned;D;34;15;CHEMBL221;;
CLD0;;Sf21;CHEMBL1909131;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL4106362;Homologous single protein target assigned;8;DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Homologous protein target assigned;H;35;15;CHEMBL230;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909132;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;36;15;CHEMBL3356;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909133;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;37;15;CHEMBL5282;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909134;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;38;15;CHEMBL3622;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909135;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;39;15;CHEMBL3397;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909136;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;40;15;CHEMBL289;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909137;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;41;15;CHEMBL5281;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909138;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin);CHEMBL1909046;Homologous protein target assigned;H;42;15;CHEMBL340;;
CLD0;;CHO;CHEMBL1909139;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390);CHEMBL1909046;Homologous protein target assigned;H;43;15;CHEMBL2056;;
CLD0;;CHO;CHEMBL1909140;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;44;15;CHEMBL217;;
CLD0;;CHO;CHEMBL1909141;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;45;15;CHEMBL234;;
CLD0;;CHO-K1;CHEMBL1909142;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;46;15;CHEMBL219;;
CLD0;;CHO-K1;CHEMBL1909143;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;47;15;CHEMBL238;;
CLD0;;CHO-K1;CHEMBL1909144;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1);CHEMBL1909046;Homologous protein target assigned;H;48;15;CHEMBL252;;
CLD0;;Sf9;CHEMBL1909145;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;49;15;CHEMBL206;;
CLD0;;Sf9;CHEMBL1909146;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;50;15;CHEMBL242;;
CLD0;;;CHEMBL1909147;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol);CHEMBL1909046;Default value - Target has yet to be curated;U;51;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909148;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam);CHEMBL1909046;Default value - Target has yet to be curated;U;52;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909149;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB);CHEMBL1909046;Default value - Target has yet to be curated;U;53;15;CHEMBL612545;CHEMBL3559724;
CLD0;;HeLa S3;CHEMBL1909150;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Homologous single protein target assigned;8;DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone);CHEMBL1909046;Homologous protein target assigned;H;54;15;CHEMBL2034;;
CLD0;;;CHEMBL1909151;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA);CHEMBL1909046;Default value - Target has yet to be curated;U;55;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909152;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid);CHEMBL1909046;Default value - Target has yet to be curated;U;56;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909153;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653);CHEMBL1909046;Default value - Target has yet to be curated;U;57;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909154;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP);CHEMBL1909046;Default value - Target has yet to be curated;U;58;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909155;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Spinal cord;B;Binding;BAO_0000249;cell membrane format;;Multiple direct protein targets may be assigned;5;DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine);CHEMBL1909046;Direct protein target assigned;D;59;15;CHEMBL3392921;CHEMBL3638246;
CLD0;;CHO-K1;CHEMBL1909156;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine);CHEMBL1909046;Homologous protein target assigned;H;60;15;CHEMBL231;;
CLD0;;CHO-K1;CHEMBL1909157;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine);CHEMBL1909046;Homologous protein target assigned;H;61;15;CHEMBL1941;;
CLD0;;;CHEMBL1909158;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA);CHEMBL1909046;Homologous protein target assigned;H;62;15;CHEMBL402;;
CLD0;;;CHEMBL1909159;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan);CHEMBL1909046;Default value - Target has yet to be curated;U;63;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909160;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin);CHEMBL1909046;Direct protein target assigned;D;64;15;CHEMBL5486;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL1909161;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta);CHEMBL1909046;Default value - Target has yet to be curated;U;65;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909162;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4);CHEMBL1909046;Default value - Target has yet to be curated;U;66;15;CHEMBL612545;;
CLD0;;;CHEMBL1909307;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";CHEMBL1909294;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909308;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";CHEMBL1909294;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909309;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";CHEMBL1909294;Non-molecular target assigned;N;3;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909310;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";CHEMBL1909294;Non-molecular target assigned;N;4;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909311;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";CHEMBL1909294;Non-molecular target assigned;N;5;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909312;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";CHEMBL1909294;Non-molecular target assigned;N;6;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909313;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";CHEMBL1909294;Non-molecular target assigned;N;7;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909314;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";CHEMBL1909294;Non-molecular target assigned;N;8;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909315;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";CHEMBL1909294;Non-molecular target assigned;N;9;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909316;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";CHEMBL1909294;Non-molecular target assigned;N;10;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909317;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";CHEMBL1909294;Non-molecular target assigned;N;11;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909318;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";CHEMBL1909294;Non-molecular target assigned;N;12;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909319;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";CHEMBL1909294;Non-molecular target assigned;N;13;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909320;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";CHEMBL1909294;Non-molecular target assigned;N;14;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1920323;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Inhibition of ATP-dependent ABCG2 pump assessed as ratio of compound IC50 for HEK/ABCG2-482-R2 cells to IC50 for HEK293/pcDNA3.1 cells after 72 hrs by MTT assay;CHEMBL1914443;Homologous protein target assigned;H;411479;1;CHEMBL5393;;
CLD0;;;CHEMBL1925788;[];;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Displacement of ethidium bromide from DNA by fluorometric analysis;CHEMBL1921783;Molecular target other than protein assigned;M;416716;1;CHEMBL345;;
CLD0;;LoVo;CHEMBL1925790;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Cytotoxicity against human LoVo cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay;CHEMBL1921783;Non-molecular target assigned;N;416718;1;CHEMBL614721;;
CLD0;;LoVo;CHEMBL1925791;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Cytotoxicity against human LoVo cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay;CHEMBL1921783;Non-molecular target assigned;N;416719;1;CHEMBL614721;;
CLD0;;MCF7;CHEMBL1925792;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against doxorubicin-sensitive human MCF7 cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay;CHEMBL1921783;Non-molecular target assigned;N;416720;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL1925793;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against doxorubicin-sensitive human MCF7 cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay;CHEMBL1921783;Non-molecular target assigned;N;416721;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL1925794;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against doxorubicin-resistant human MCF7 cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay;CHEMBL1921783;Non-molecular target assigned;N;416722;1;CHEMBL387;;
CLD0;;MCF7;CHEMBL1925795;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against doxorubicin-resistant human MCF7 cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay;CHEMBL1921783;Non-molecular target assigned;N;416723;1;CHEMBL387;;
CLD0;;PC-3;CHEMBL1929959;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Cytotoxicity against human PC3 cells after 48 hrs by SRB assay;CHEMBL1926565;Non-molecular target assigned;N;420558;1;CHEMBL390;;
CLD0;;NCI-H1299;CHEMBL1955300;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is molecular non-protein target;3;Inhibition of human TERT expression in H1299 cells at 1 uM after 24 hrs by secreted alkaline phosphatase reporter gene assay relative to control;CHEMBL1949585;Molecular target other than protein assigned;M;434095;1;CHEMBL612546;;
CLD0;;NCI-H1299;CHEMBL1955301;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is molecular non-protein target;3;Inhibition of human TERT expression in H1299 cells at 10 uM after 24 hrs by secreted alkaline phosphatase reporter gene assay relative to control;CHEMBL1949585;Molecular target other than protein assigned;M;434096;1;CHEMBL612546;;
CLD0;;NCI-H1299;CHEMBL1955302;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is molecular non-protein target;3;Inhibition of human TERT expression in H1299 cells at 100 uM after 24 hrs by secreted alkaline phosphatase reporter gene assay relative to control;CHEMBL1949585;Molecular target other than protein assigned;M;434097;1;CHEMBL612546;;
CLD0;;NCI-H1299;CHEMBL1955303;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;Cytotoxicity against human H1299 cells assessed as cell growth at 1 uM after 48 hrs by MTT assay;CHEMBL1949585;Non-molecular target assigned;N;434098;1;CHEMBL3879801;;
CLD0;;NCI-H1299;CHEMBL1955304;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;Cytotoxicity against human H1299 cells assessed as cell growth at 10 uM after 48 hrs by MTT assay;CHEMBL1949585;Non-molecular target assigned;N;434099;1;CHEMBL3879801;;
CLD0;;NCI-H1299;CHEMBL1955305;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;Cytotoxicity against human H1299 cells assessed as cell growth at 100 uM after 48 hrs by MTT assay;CHEMBL1949585;Non-molecular target assigned;N;434100;1;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL1963972;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624134;7;CHEMBL612545;;
CLD0;confirmatory;MDA-N;CHEMBL1963976;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307532;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;87;7;CHEMBL614078;;
CLD0;confirmatory;SN12C;CHEMBL1963981;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307518;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;145;7;CHEMBL614054;;
CLD0;confirmatory;NCI-H23;CHEMBL1963985;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1;7;CHEMBL614997;;
CLD0;confirmatory;ACHN;CHEMBL1963989;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;139;7;CHEMBL614519;;
CLD0;confirmatory;UO-31;CHEMBL1963990;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;143;7;CHEMBL614388;;
CLD0;confirmatory;HOP-92;CHEMBL1963991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308091;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;13;7;CHEMBL613889;;
CLD0;confirmatory;HL-60;CHEMBL1963994;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;125;7;CHEMBL383;;
CLD0;confirmatory;DU-145;CHEMBL1964017;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;43;7;CHEMBL613508;;
CLD0;confirmatory;SF-539;CHEMBL1964018;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307721;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;49;7;CHEMBL614860;;
CLD0;confirmatory;SK-MEL-5;CHEMBL1964021;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307744;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;37;7;CHEMBL614922;;
CLD0;confirmatory;Malme-3M;CHEMBL1964025;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307507;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;29;7;CHEMBL614021;;
CLD0;confirmatory;K562;CHEMBL1964030;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;121;7;CHEMBL385;;
CLD0;confirmatory;A498;CHEMBL1964034;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;129;7;CHEMBL614516;;
CLD0;confirmatory;OVCAR-3;CHEMBL1964037;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;99;7;CHEMBL614213;;
CLD0;confirmatory;MOLT-4;CHEMBL1964040;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;123;7;CHEMBL614177;;
CLD0;confirmatory;HOP-62;CHEMBL1964043;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307671;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;9;7;CHEMBL614643;;
CLD0;confirmatory;NCI/ADR-RES;CHEMBL1964045;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;93;7;CHEMBL613829;;
CLD0;confirmatory;U-251;CHEMBL1964047;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;59;7;CHEMBL615022;;
CLD0;confirmatory;OVCAR-8;CHEMBL1964048;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307975;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;109;7;CHEMBL612555;;
CLD0;confirmatory;OVCAR-5;CHEMBL1964049;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307565;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;107;7;CHEMBL614214;;
CLD0;confirmatory;Schwann;CHEMBL1964055;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624044;7;CHEMBL2007624;;
CLD0;confirmatory;SNB-19;CHEMBL1964059;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307552;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;53;7;CHEMBL614164;;
CLD0;confirmatory;DMS-273;CHEMBL1964062;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308487;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;61;7;CHEMBL614034;;
CLD0;confirmatory;MDA-MB-231;CHEMBL1964063;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;95;7;CHEMBL400;;
CLD0;confirmatory;SR;CHEMBL1964065;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307586;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;115;7;CHEMBL614300;;
CLD0;confirmatory;TK-10;CHEMBL1964066;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308453;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;141;7;CHEMBL614056;;
CLD0;confirmatory;SW-620;CHEMBL1964072;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;81;7;CHEMBL612262;;
CLD0;confirmatory;M19-MEL;CHEMBL1964074;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307506;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;27;7;CHEMBL614019;;
CLD0;confirmatory;NCI-H522;CHEMBL1964075;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308392;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;15;7;CHEMBL614387;;
CLD0;confirmatory;KM12;CHEMBL1964077;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307689;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;73;7;CHEMBL614709;;
CLD0;confirmatory;Schwann;CHEMBL1964081;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624032;7;CHEMBL2007624;;
CLD0;confirmatory;M14;CHEMBL1964085;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307591;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;25;7;CHEMBL614317;;
CLD0;confirmatory;XF498;CHEMBL1964086;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308037;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;51;7;CHEMBL613533;;
CLD0;confirmatory;NCI-H322M;CHEMBL1964087;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307710;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;5;7;CHEMBL614803;;
CLD0;confirmatory;RPMI-8226;CHEMBL1964088;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;113;7;CHEMBL614882;;
CLD0;confirmatory;OVCAR-4;CHEMBL1964091;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307517;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;105;7;CHEMBL614051;;
CLD0;confirmatory;LOX IMVI ;CHEMBL1964092;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307535;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;23;7;CHEMBL614096;;
CLD0;confirmatory;P388;CHEMBL1964095;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;111;7;CHEMBL389;;
CLD0;confirmatory;BT-549;CHEMBL1964099;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308490;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;89;7;CHEMBL614072;;
CLD0;confirmatory;SK-MEL-2;CHEMBL1963844;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307743;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;35;7;CHEMBL614917;;
CLD0;confirmatory;KM-20L2;CHEMBL1963848;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307782;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;75;7;CHEMBL614791;;
CLD0;confirmatory;A549;CHEMBL1963854;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;19;7;CHEMBL392;;
CLD0;confirmatory;HCC 2998;CHEMBL1963860;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308074;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;77;7;CHEMBL613855;;
CLD0;confirmatory;;CHEMBL1963865;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;602199;7;CHEMBL1977;;
CLD0;confirmatory;SNB-75;CHEMBL1963866;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307616;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;55;7;CHEMBL614451;;
CLD0;confirmatory;HCT-15;CHEMBL1963868;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;71;7;CHEMBL612263;;
CLD0;confirmatory;HCT-116;CHEMBL1963874;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;79;7;CHEMBL394;;
CLD0;confirmatory;SF-268;CHEMBL1963876;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;45;7;CHEMBL613977;;
CLD0;confirmatory;EKVX ;CHEMBL1963880;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307626;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;21;7;CHEMBL614487;;
CLD0;confirmatory;;CHEMBL1963881;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;602204;7;CHEMBL612545;;
CLD0;confirmatory;MCF7;CHEMBL1963882;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;83;7;CHEMBL387;;
CLD0;confirmatory;PC-3;CHEMBL1963885;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;41;7;CHEMBL390;;
CLD0;confirmatory;DMS-114;CHEMBL1963887;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307670;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;63;7;CHEMBL614642;;
CLD0;confirmatory;;CHEMBL1963893;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;602332;7;CHEMBL1781865;;
CLD0;confirmatory;SK-OV-3;CHEMBL1963895;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;103;7;CHEMBL614925;;
CLD0;confirmatory;T47D;CHEMBL1963900;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;91;7;CHEMBL614361;;
CLD0;confirmatory;NCI-H460;CHEMBL1963901;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;7;7;CHEMBL396;;
CLD0;confirmatory;UACC-62;CHEMBL1963903;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307660;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;31;7;CHEMBL614610;;
CLD0;confirmatory;CAKI-1;CHEMBL1963911;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;131;7;CHEMBL614067;;
CLD0;confirmatory;;CHEMBL1963913;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624132;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1963915;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;602202;7;CHEMBL1977;;
CLD0;confirmatory;P388/ADR;CHEMBL1963918;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;117;7;CHEMBL614218;;
CLD0;confirmatory;MDA-MB-435;CHEMBL1963921;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;85;7;CHEMBL614697;;
CLD0;confirmatory;SF-295;CHEMBL1963922;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307738;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;47;7;CHEMBL614908;;
CLD0;confirmatory;IGROV-1;CHEMBL1963929;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;101;7;CHEMBL613984;;
CLD0;confirmatory;;CHEMBL1963934;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;602201;7;CHEMBL1977;;
CLD0;confirmatory;Hs-578T;CHEMBL1963945;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307672;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;97;7;CHEMBL614645;;
CLD0;confirmatory;786-0;CHEMBL1963953;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;137;7;CHEMBL613102;;
CLD0;confirmatory;SNB-78;CHEMBL1963954;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307969;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;57;7;CHEMBL612543;;
CLD0;confirmatory;UACC-257;CHEMBL1963960;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308008;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;33;7;CHEMBL612796;;
CLD0;confirmatory;CCRF-CEM;CHEMBL1963961;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;119;7;CHEMBL382;;
CLD0;confirmatory;DLD-1;CHEMBL1963963;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307580;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;69;7;CHEMBL614285;;
CLD0;confirmatory;Shn3RL;CHEMBL1963999;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624133;7;CHEMBL612545;;
CLD0;confirmatory;NCI-H226;CHEMBL1964004;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307697;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;3;7;CHEMBL614740;;
CLD0;confirmatory;HT-29;CHEMBL1964006;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;65;7;CHEMBL384;;
CLD0;confirmatory;SK-MEL-28;CHEMBL1964007;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;39;7;CHEMBL614919;;
CLD0;confirmatory;RXF 393;CHEMBL1964009;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307734;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;133;7;CHEMBL614886;;
CLD0;confirmatory;COLO 205;CHEMBL1964012;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;67;7;CHEMBL614561;;
CLD0;confirmatory;HOP-18;CHEMBL1964014;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307783;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;11;7;CHEMBL614809;;
CLD0;confirmatory;SN12K1;CHEMBL1964015;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307784;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;127;7;CHEMBL1909241;;
CLD0;;Sf9;CHEMBL2077081;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;TP_TRANSPORTER: ATP hydrolysis in membrane vesicle from BCRP-expressing Sf9 cells;CHEMBL2074508;Homologous protein target assigned;H;214;18;CHEMBL5393;;
CLD0;;Oocyte;CHEMBL2077538;[];Xenopus laevis;[];;;8355.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308859;Homologous single protein target assigned;8;TP_TRANSPORTER: uptake in BCRP-expressing oocyte cells;CHEMBL2074207;Homologous protein target assigned;H;266;18;CHEMBL5393;;
CLD0;;PA317;CHEMBL2077540;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in BCRP-expressing PA317 cells;CHEMBL2074406;Homologous protein target assigned;H;268;18;CHEMBL5393;;
CLD0;;MDCK-II;CHEMBL2076278;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing MDCKII cells;CHEMBL2073990;Homologous protein target assigned;H;328;18;CHEMBL4302;;
CLD0;;LLC-PK1;CHEMBL2076475;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307655;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in BCRP-expressing LLC-PK1 cells;CHEMBL2074466;Homologous protein target assigned;H;377;18;CHEMBL5393;;
CLD0;;K562;CHEMBL2076476;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in BCRP-expressing K562 cells;CHEMBL2074130;Homologous protein target assigned;H;378;18;CHEMBL5393;;
CLD0;;"S1;S1-M1-80";CHEMBL2075593;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: intracellular accumulation in S1 and S1-M1-80 cells;CHEMBL2073744;Homologous protein target assigned;H;958;18;CHEMBL5393;;
CLD0;;"MCF-7; MCF-7 AdVp3000";CHEMBL2075594;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: intracellular accumulation in MCF-7 and MCF-7 AdVp3000 cells;CHEMBL2073744;Homologous protein target assigned;H;959;18;CHEMBL5393;;
CLD0;;MCF7;CHEMBL2075600;[];;[];;Membrane vesicle;;In vitro;;F;Functional;BAO_0000249;cell membrane format;CHEMBL3308403;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of MTX update by Mitoxantrone at a concentration of 50uM in membrane vesicles from BCRP-expressing MCF7 cells;CHEMBL2073962;Homologous protein target assigned;H;965;18;CHEMBL5393;;
CLD0;;Hepatocyte;CHEMBL2075711;[];Rattus norvegicus;[];;;10116.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308027;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot from primary hepatocytes;CHEMBL2074079;Direct protein target assigned;D;2201;18;CHEMBL1075229;;
CLD0;;;CHEMBL2075712;[];Rattus norvegicus;[];Wistar;;10116.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot in vivo Wistar rat;CHEMBL2074079;Direct protein target assigned;D;2202;18;CHEMBL1075229;;
CLD0;;MCF7;CHEMBL2075734;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Homologous single protein target assigned;8;TP_TRANSPORTER: transport in etoposide-selected MCF7 cells;CHEMBL2074176;Homologous protein target assigned;H;2224;18;CHEMBL3004;;
CLD0;;MDCK-II;CHEMBL2076208;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;9;18;CHEMBL4302;;
CLD0;;MDCK-II;CHEMBL2076217;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308862;Homologous single protein target assigned;8;TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing MDCKII cells;CHEMBL1908284;Homologous protein target assigned;H;18;18;CHEMBL4302;;
CLD0;;Sf9;CHEMBL2076219;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells;CHEMBL1908284;Homologous protein target assigned;H;20;18;CHEMBL4302;;
CLD0;;"MEF3.8;M32;T6400";CHEMBL2078262;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: cell accumulation in MEF3.8, M32 and T6400 cells;CHEMBL2074571;Homologous protein target assigned;H;1475;18;CHEMBL2073705;;
CLD0;;"KOT52;D320";CHEMBL2078263;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: cell accumulation in KOT52 and D320 cells;CHEMBL2074571;Homologous protein target assigned;H;1476;18;CHEMBL2073705;;
CLD0;;;CHEMBL2078364;[];Rattus norvegicus;[];Wistar;;10116.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot in vivo Wistar rat;CHEMBL2074079;Direct protein target assigned;D;1523;18;CHEMBL1075135;;
CLD0;;MCF;CHEMBL2078378;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: efflux in MCF7/VP and MCF cells;CHEMBL2074577;Homologous protein target assigned;H;2314;18;CHEMBL3004;;
CLD0;;MCF7/MRP1-M6;CHEMBL2078384;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: cell accumulation in MCF7/MRP1-M6 cells;CHEMBL2074176;Homologous protein target assigned;H;2320;18;CHEMBL3004;;
CLD0;;MCF7/MRP1-M24;CHEMBL2078385;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: cell accumulation in MCF7/MRP1-M24 cells;CHEMBL2074176;Homologous protein target assigned;H;2321;18;CHEMBL3004;;
CLD0;;MCF7/MRP1-10;CHEMBL2078386;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: cell accumulation in MCF7/MRP1-10 cells;CHEMBL2074176;Homologous protein target assigned;H;2322;18;CHEMBL3004;;
CLD0;;MCF7/MRP1-10;CHEMBL2078443;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: ATP- and GSH-dependent transport in MCF7/MRP1-10 cells;CHEMBL2074176;Homologous protein target assigned;H;2328;18;CHEMBL3004;;
CLD0;;"MT-4/; MT-4/DOX500";CHEMBL2078484;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: Cytotoxicity in MT-4 and MT-4/DOX500 cells;CHEMBL2074221;Homologous protein target assigned;H;132;18;CHEMBL5393;;
CLD0;;MEF3.8;CHEMBL2078493;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;TP_TRANSPORTER: drug resistance in BCRP-expressing MEF3.8 cells;CHEMBL2074346;Homologous protein target assigned;H;141;18;CHEMBL2073705;;
CLD0;;;CHEMBL2077937;[];Mus musculus;[];NMRI;;10090.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Direct single protein target assigned;9;TP_TRANSPORTER: Northern blot in vivo NMRI mouse;CHEMBL2074079;Direct protein target assigned;D;3035;18;CHEMBL3467;;
CLD0;;LoVo;CHEMBL2091083;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307691;Target assigned is non-molecular;1;Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay;CHEMBL2086290;Non-molecular target assigned;N;470855;1;CHEMBL614721;;
CLD0;;LoVo/DX;CHEMBL2091084;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human LoVo/DX cells after 72 hrs by SRB assay;CHEMBL2086290;Non-molecular target assigned;N;470856;1;CHEMBL3879801;;
CLD0;;MES-SA ;CHEMBL2091086;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;Antiproliferative activity against human MESSA cells after 72 hrs by SRB assay;CHEMBL2086290;Non-molecular target assigned;N;470858;1;CHEMBL3879801;;
CLD0;;MES-SA/Dx5;CHEMBL2091131;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;Antiproliferative activity against human MESSA/DX5 cells after 72 hrs by SRB assay;CHEMBL2086290;Non-molecular target assigned;N;470859;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL2091133;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay;CHEMBL2086290;Non-molecular target assigned;N;470861;1;CHEMBL383;;
CLD0;;HL60/MX2;CHEMBL2091134;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Antiproliferative activity against human HL60/MX2 cells after 72 hrs by SRB assay;CHEMBL2086290;Non-molecular target assigned;N;470862;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL2091135;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Resistance index, ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells;CHEMBL2086290;Non-molecular target assigned;N;470863;1;CHEMBL383;;
CLD0;confirmatory;;CHEMBL2114847;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Fluorescein FP. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624160;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114861;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624418;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114863;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in WT MEF Cells: Hit Validation. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651789;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL2114881;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624330;7;CHEMBL2146306;;
CLD0;confirmatory;;CHEMBL2114715;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: HTRF Assay. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624162;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114736;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624351;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114738;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624170;7;CHEMBL2146302;;
CLD0;confirmatory;;CHEMBL2114744;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624455;7;CHEMBL2056;;
CLD0;confirmatory;;CHEMBL2114775;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651820;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651635;7;CHEMBL1795085;;
CLD0;confirmatory;;CHEMBL2114788;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624417;7;CHEMBL1784;;
CLD0;confirmatory;;CHEMBL2114796;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651768;7;CHEMBL2146312;;
CLD0;confirmatory;;CHEMBL2114811;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Hit Validation. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651784;7;CHEMBL2842;;
CLD0;confirmatory;;CHEMBL2114817;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624288;7;CHEMBL4377;;
CLD0;confirmatory;;CHEMBL2114832;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - HeLa Cytotoxicity. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;624300;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL2114836;[];Human immunodeficiency virus 1;[];;;11676.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651644;7;CHEMBL2146310;;
CLD0;confirmatory;;CHEMBL2114913;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624291;7;CHEMBL2146305;;
CLD0;confirmatory;;CHEMBL2114914;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Texas Red FP. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;624161;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114916;[];Trypanosoma brucei;[];;;5691.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624173;7;CHEMBL2146316;;
CLD0;confirmatory;;CHEMBL2114931;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624172;7;CHEMBL1784;;
CLD0;;HL-60;CHEMBL2150100;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;473954;1;CHEMBL383;;
CLD0;;K562;CHEMBL2150101;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;474020;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL2150102;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay;CHEMBL2146381;Non-molecular target assigned;N;474023;1;CHEMBL382;;
CLD0;;HL-60;CHEMBL2150103;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474028;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150104;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for human HL60/ADR cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474029;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150105;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474030;1;CHEMBL383;;
CLD0;;HL-60;CHEMBL2150106;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for doxorubicin-resistant human HL60 cells to IC50 for human HL60 cells;CHEMBL2146381;Non-molecular target assigned;N;474031;1;CHEMBL383;;
CLD0;;K562;CHEMBL2150107;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for doxorubicin-resistant human K562 cells to IC50 for human K562 cells;CHEMBL2146381;Non-molecular target assigned;N;474032;1;CHEMBL385;;
CLD0;;K562;CHEMBL2150108;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Ratio of IC50 for human K562/HHT300 cells to IC50 for human K562 cells;CHEMBL2146381;Non-molecular target assigned;N;474033;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL2150109;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/C2 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474034;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL2150110;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/VM-1-5 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474035;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL2150111;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Ratio of IC50 for human CCRF-CEM/VLB100 cells IC50 for human CCRF-CEM cells;CHEMBL2146381;Non-molecular target assigned;N;474036;1;CHEMBL382;;
CLD0;;HEK293;CHEMBL2169429;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466159;1;CHEMBL1697668;;
CLD0;;HEK293;CHEMBL2169430;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466160;1;CHEMBL1743121;;
CLD0;;HEK293;CHEMBL2169431;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting;CHEMBL2163248;Direct protein target assigned;D;466161;1;CHEMBL1743124;;
CLD0;;C6;CHEMBL3073186;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Inhibition of nuclear DNA synthesis in Rattus norvegicus (rat) C6 cells assessed as decrease in bromodeoxyuridine incorpoRattus norvegicus (rat)ion measured during S phase at IC50 after 24 hr by ELISA;CHEMBL3046656;Non-molecular target assigned;N;545650;1;CHEMBL614657;;
CLD0;;A549;CHEMBL3073188;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Inhibition of nuclear DNA synthesis in Homo sapiens (human) A549 cells assessed as decrease in bromodeoxyuridine incorporation measured during S phase at IC50 after 24 hr by ELISA;CHEMBL3046656;Non-molecular target assigned;N;545648;1;CHEMBL392;;
CLD0;;C6;CHEMBL3072278;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Inhibition of nuclear DNA synthesis in Rattus norvegicus (rat) C6 cells assessed as decrease in bromodeoxyuridine incorpoRattus norvegicus (rat)ion measured during S phase after 24 hr by ELISA;CHEMBL3046656;Non-molecular target assigned;N;545432;1;CHEMBL614657;;
CLD0;;A549;CHEMBL3072279;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Inhibition of nuclear DNA synthesis in Homo sapiens (human) A549 cells assessed as decrease in bromodeoxyuridine incorporation measured during S phase after 24 hr by ELISA;CHEMBL3046656;Non-molecular target assigned;N;545416;1;CHEMBL392;;
CLD0;;NIH3T3;CHEMBL3072282;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307716;Target assigned is non-molecular;1;Cytotoxicity against Mus musculus (mouse) NIH/3T3 cells after 24 hr by MTT assay;CHEMBL3046656;Non-molecular target assigned;N;545411;1;CHEMBL614822;;
CLD0;;C6;CHEMBL3072283;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Cytotoxicity against Rattus norvegicus (rat) C6 cells after 24 hr by MTT assay;CHEMBL3046656;Non-molecular target assigned;N;545410;1;CHEMBL614657;;
CLD0;;A549;CHEMBL3072284;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against Homo sapiens (human) A549 cells after 24 hr by MTT assay;CHEMBL3046656;Non-molecular target assigned;N;545408;1;CHEMBL392;;
CLD0;;MDCK-II;CHEMBL2320294;[];;[];;;;In vitro;;U;Unassigned;BAO_0000219;cell-based format;CHEMBL3308862;Default value - Target unknown or has yet to be assigned;0;Ratio of Cmax unbound to IC50 for human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells;CHEMBL2311273;Default value - Target has yet to be curated;U;518705;1;CHEMBL612545;;
CLD0;;HEK293;CHEMBL2320295;[];;[];;;;;;U;Unassigned;BAO_0000219;cell-based format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;Ratio of Cmax unbound to IC50 for human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells;CHEMBL2311273;Default value - Target has yet to be curated;U;518704;1;CHEMBL612545;;
CLD0;;HEK293;CHEMBL2320297;[];;[];;;;;;U;Unassigned;BAO_0000219;cell-based format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;Ratio of Cmax unbound to IC50 for human MATE1-mediated ASP+ uptake expressed in HEK293 cells;CHEMBL2311273;Default value - Target has yet to be curated;U;518703;1;CHEMBL612545;;
CLD0;;MDCK-II;CHEMBL2320298;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308862;Direct single protein target assigned;9;Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis;CHEMBL2311273;Direct protein target assigned;D;518522;1;CHEMBL1743126;;
CLD0;;HEK293;CHEMBL2320299;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis;CHEMBL2311273;Direct protein target assigned;D;518516;1;CHEMBL1743126;;
CLD0;;HEK293;CHEMBL2320300;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay;CHEMBL2311273;Direct protein target assigned;D;518504;1;CHEMBL1743127;;
CLD0;;HEK293;CHEMBL2320301;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay;CHEMBL2311273;Direct protein target assigned;D;518503;1;CHEMBL2073673;;
CLD0;;HEK293;CHEMBL2320302;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay;CHEMBL2311273;Direct protein target assigned;D;518502;1;CHEMBL5685;;
CLD0;;HEK293;CHEMBL2320303;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay;CHEMBL2311273;Direct protein target assigned;D;518500;1;CHEMBL1743122;;
CLD0;;HEK293;CHEMBL2320304;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay;CHEMBL2311273;Direct protein target assigned;D;518499;1;CHEMBL1743127;;
CLD0;;HEK293;CHEMBL2320306;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay;CHEMBL2311273;Direct protein target assigned;D;518494;1;CHEMBL1743126;;
CLD0;;MV4-11;CHEMBL2330098;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308063;Target assigned is non-molecular;1;Effect on total PIM1 level in human MV411 cells at 10 to 100 nM after 12 hrs by Western blotting analysis;CHEMBL2321759;Non-molecular target assigned;N;550417;1;CHEMBL613835;;
CLD0;;K562;CHEMBL2330099;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308378;Direct single protein target assigned;9;Inhibition of PIM1-mediated BAD phosphorylation in human K562 cells at 0.1 to 30 uM after 12 hrs by Western blotting analysis;CHEMBL2321759;Direct protein target assigned;D;535900;1;CHEMBL2147;;
CLD0;;MV4-11;CHEMBL2330100;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308063;Target assigned is non-molecular;1;Effect on total BAD level in human MV411 cells at 10 to 100 nM after 12 hrs by Western blotting analysis;CHEMBL2321759;Non-molecular target assigned;N;535895;1;CHEMBL613835;;
CLD0;;MV4-11;CHEMBL2330101;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308063;Direct single protein target assigned;9;Inhibition of PIM1-mediated BAD phosphorylation in human MV411 cells at 100 nM after 12 hrs by Western blotting analysis;CHEMBL2321759;Direct protein target assigned;D;535894;1;CHEMBL2147;;
CLD0;;MV4-11;CHEMBL2330102;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308063;Direct single protein target assigned;9;Inhibition of PIM1-mediated BAD phosphorylation in human MV411 cells after 12 hrs by Western blotting analysis;CHEMBL2321759;Direct protein target assigned;D;535892;1;CHEMBL2147;;
CLD0;;K562;CHEMBL2330103;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308378;Direct single protein target assigned;9;Inhibition of PIM1-mediated BAD phosphorylation in human K562 cells after 12 hrs by Western blotting analysis;CHEMBL2321759;Direct protein target assigned;D;535891;1;CHEMBL2147;;
CLD0;;;CHEMBL2330104;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000224;protein format;;Multiple direct protein targets may be assigned;5;Inhibition of human recombinant casein kinase 2 using [gamma-32P] ATP;CHEMBL2321759;Direct protein target assigned;D;535885;1;CHEMBL3832943;;
CLD0;;;CHEMBL2330105;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of BTK (unknown origin);CHEMBL2321759;Direct protein target assigned;D;535879;1;CHEMBL5251;;
CLD0;;;CHEMBL2330106;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of recombinant PIM1 (unknown origin) expressed in Escherichia coli BL21(DE3) after 1 hr by HTRF assay;CHEMBL2321759;Direct protein target assigned;D;535852;1;CHEMBL2147;;
CLD0;;;CHEMBL2330107;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of BTK (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay;CHEMBL2321759;Direct protein target assigned;D;535811;1;CHEMBL5251;;
CLD0;;;CHEMBL2330108;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of AKT1 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay;CHEMBL2321759;Direct protein target assigned;D;535812;1;CHEMBL4282;;
CLD0;;;CHEMBL2330109;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of CHK2 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay;CHEMBL2321759;Direct protein target assigned;D;535810;1;CHEMBL2527;;
CLD0;;;CHEMBL2330173;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of PIM1 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assayATP;CHEMBL2321759;Direct protein target assigned;D;535808;1;CHEMBL2147;;
CLD0;;;CHEMBL2330174;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of CK2alpha2 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay;CHEMBL2321759;Direct protein target assigned;D;535803;1;CHEMBL4070;;
CLD0;;;CHEMBL2330175;[];Mycobacterium tuberculosis;[];;;1773.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Mycobacterium tuberculosis protein kinase B;CHEMBL2321759;Default value - Target has yet to be curated;U;535799;1;CHEMBL612545;;
CLD0;;;CHEMBL2346391;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus DNA up to 5 mM;CHEMBL2331492;Molecular target other than protein assigned;M;561989;1;CHEMBL3140325;;
CLD0;;;CHEMBL2346394;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human RKOp27IND cells after 48 hrs;CHEMBL2331492;Non-molecular target assigned;N;561972;1;CHEMBL3879801;;
CLD0;;RKOp27;CHEMBL2346395;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human RKOp27 cells after 48 hrs;CHEMBL2331492;Non-molecular target assigned;N;561970;1;CHEMBL3879801;;
CLD0;;NCI-H460;CHEMBL2346399;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Antiproliferative activity against human NCI-H460 cells after 48 hrs;CHEMBL2331492;Non-molecular target assigned;N;561967;1;CHEMBL396;;
CLD0;;SF-268;CHEMBL2346401;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Antiproliferative activity against human SF268 cells after 48 hrs;CHEMBL2331492;Non-molecular target assigned;N;561965;1;CHEMBL613977;;
CLD0;;SK-OV-3;CHEMBL2346402;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Antiproliferative activity against human SKOV3 cells after 48 hrs;CHEMBL2331492;Non-molecular target assigned;N;561963;1;CHEMBL614925;;
CLD0;;KB ;CHEMBL2339115;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Antiproliferative activity against human KB/HeLa cells after 48 hrs;CHEMBL2331492;Non-molecular target assigned;N;561961;1;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL2354205;[];;[];;;;;;F;Functional;BAO_0000217;biochemical format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. RAD52: DNA binders Measured in Biochemical System Using Plate Reader - 7018-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;652128;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354211;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;686971;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354221;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686978;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354254;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686979;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354282;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;652106;7;CHEMBL6152;;
CLD0;confirmatory;;CHEMBL2354285;[];;[];;;;;;F;Functional;BAO_0000217;biochemical format;;Homologous single protein target assigned;8;PubChem BioAssay. FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;652116;7;CHEMBL2362978;;
CLD0;confirmatory;RMG-I;CHEMBL2354301;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308778;Homologous single protein target assigned;8;PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;687027;7;CHEMBL2362980;;
CLD0;confirmatory;;CHEMBL2354311;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686970;7;CHEMBL2007625;;
CLD0;;NCI-H460;CHEMBL2428415;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H460 cells after 48 hrs by resazurin dye assay;CHEMBL2424651;Non-molecular target assigned;N;594562;1;CHEMBL396;;
CLD0;;SK-OV-3;CHEMBL2428416;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Cytotoxicity against human SKOV3 cells after 48 hrs by resazurin dye assay;CHEMBL2424651;Non-molecular target assigned;N;594561;1;CHEMBL614925;;
CLD0;;KB ;CHEMBL2428417;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307959;Target assigned is non-molecular;1;Cytotoxicity against human KB/HeLa cells after 48 hrs by resazurin dye assay;CHEMBL2424651;Non-molecular target assigned;N;594560;1;CHEMBL3879801;;
CLD0;;QSG7701;CHEMBL2433627;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Growth inhibition of human QSG7701 cells at 10 uM after 48 hrs by MTT assay relative to control;CHEMBL2429715;Default value - Target has yet to be curated;U;599397;1;CHEMBL612558;;
CLD0;;HepG2;CHEMBL2433629;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Growth inhibition of human HepG2 cells at 10 uM after 48 hrs by MTT assay relative to control;CHEMBL2429715;Non-molecular target assigned;N;599395;1;CHEMBL395;;
CLD0;;HCT-116;CHEMBL2433630;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Growth inhibition of human HCT116 cells at 10 uM after 48 hrs by MTT assay relative to control;CHEMBL2429715;Non-molecular target assigned;N;599396;1;CHEMBL394;;
CLD0;;K562;CHEMBL2433631;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Growth inhibition of human K562 cells at 10 uM after 48 hrs by MTT assay relative to control;CHEMBL2429715;Non-molecular target assigned;N;599394;1;CHEMBL385;;
CLD0;;;CHEMBL2439156;[];Trypanosoma brucei brucei;[];427;;5702.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antitrypanosomal activity against bloodstream form of Trypanosoma brucei brucei 427 after 3 days by Alamar Blue assay;CHEMBL2434842;Non-molecular target assigned;N;599478;1;CHEMBL612851;;
CLD0;;;CHEMBL2439157;[];Trypanosoma brucei brucei;[];;;5702.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Trypanocidal activity against Trypanosoma brucei brucei by Alamar Blue assay;CHEMBL2434842;Non-molecular target assigned;N;599477;1;CHEMBL612851;;
CLD0;;CHO-K1;CHEMBL3090301;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Antagonist activity at human recombinant dopamine D2 long receptor expressed in CHOK1 cells coexpressing mitochondrial apoaequorin assessed as inhibition of agonist-induced effect at 50 uM after 15 mins by luminometric analysis relative to haloperidol;CHEMBL3085742;Direct protein target assigned;D;606532;1;CHEMBL217;;
CLD0;;CHO-K1;CHEMBL3088732;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Agonist activity at human recombinant dopamine D2 long receptor expressed in CHOK1 cells coexpressing mitochondrial apoaequorin at 100 uM by luminometric analysis relative to quinpirol;CHEMBL3085742;Direct protein target assigned;D;606530;1;CHEMBL217;;
CLD0;;CHO-K1;CHEMBL3088734;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Antagonist activity at human recombinant dopamine D1 receptor expressed in CHOK1 cells assessed as inhibition of agonist-induced cAMP accumulation at 100 uM preincubated for 10 mins prior to agonist addition measured after 30 mins by HTRF assay relative to SCH23390;CHEMBL3085742;Direct protein target assigned;D;606527;1;CHEMBL2056;;
CLD0;;CHO-K1;CHEMBL3088736;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Agonist activity at human recombinant dopamine D1 receptor expressed in CHOK1 cells assessed as stimulation of cAMP accumulation at 100 uM after 30 mins by HTRF assay relative to SKF81297;CHEMBL3085742;Direct protein target assigned;D;606518;1;CHEMBL2056;;
CLD0;;;CHEMBL3123711;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human tert transcriptional activity assessed as SEAP activity at 100 uM after 24 hrs by SEAP reporter assay;CHEMBL3120102;Direct protein target assigned;D;626417;1;CHEMBL2916;;
CLD0;;;CHEMBL3123712;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human tert transcriptional activity assessed as SEAP activity at 10 uM after 24 hrs by SEAP reporter assay;CHEMBL3120102;Direct protein target assigned;D;626416;1;CHEMBL2916;;
CLD0;;;CHEMBL3123713;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human tert transcriptional activity assessed as SEAP activity at 1 uM after 24 hrs by SEAP reporter assay;CHEMBL3120102;Direct protein target assigned;D;626415;1;CHEMBL2916;;
CLD0;;NCI-H1299;CHEMBL3123714;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;Cytotoxicity against human H1299 cells assessed as cell viability at 100 uM after 48 hrs by MTT assay;CHEMBL3120102;Non-molecular target assigned;N;626414;1;CHEMBL3879801;;
CLD0;;NCI-H1299;CHEMBL3123715;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;Cytotoxicity against human H1299 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay;CHEMBL3120102;Non-molecular target assigned;N;626413;1;CHEMBL3879801;;
CLD0;;NCI-H1299;CHEMBL3123716;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308501;Target assigned is non-molecular;1;Cytotoxicity against human H1299 cells assessed as cell viability at 1 uM after 48 hrs by MTT assay;CHEMBL3120102;Non-molecular target assigned;N;626412;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137722;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;1;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137723;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;2;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137724;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;3;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137725;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source];CHEMBL3137667;Non-molecular target assigned;N;4;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137726;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;5;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137727;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;6;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137728;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;7;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137729;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;8;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137730;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;9;1;CHEMBL612545;;
CLD0;;;CHEMBL3137731;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source];CHEMBL3137667;Non-molecular target assigned;N;10;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137732;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;11;1;CHEMBL612545;;
CLD0;;;CHEMBL3137733;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;12;1;CHEMBL612545;;
CLD0;;;CHEMBL3137734;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;13;1;CHEMBL612545;;
CLD0;;;CHEMBL3137735;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source];CHEMBL3137667;Non-molecular target assigned;N;14;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137736;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Animal toxicity known. [column 'TOXIC' in source];CHEMBL3137667;Non-molecular target assigned;N;15;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137737;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Presence of at least one case with successful reintroduction. [column 'REINT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;16;1;CHEMBL612545;;
CLD0;;;CHEMBL3137738;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Comments (NB not yet translated). [column 'COMMENTAIRES' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;17;1;CHEMBL612545;;
CLD0;;;CHEMBL3137739;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source];CHEMBL3137667;Non-molecular target assigned;N;18;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137740;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Proposed mechanism(s) of liver damage. [column 'MEC' in source];CHEMBL3137667;Non-molecular target assigned;N;19;1;CHEMBL3879801;CHEMBL3559723;
CLD0;confirmatory;;CHEMBL3214944;[];;[];;;;;;B;Binding;BAO_0000217;biochemical format;;Homologous single protein target assigned;8;PubChem BioAssay. Development of Small Molecule Probes of the Histone Methyltransferase, NSD2 Measured in Biochemical System Using Plate Reader - 7053-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;1053173;7;CHEMBL3108645;;
CLD0;confirmatory;;CHEMBL3214946;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: Confirmatory Assay for Cherry-picked Compounds..   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720497;7;CHEMBL2146312;;
CLD0;confirmatory;;CHEMBL3214953;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;743255;7;CHEMBL1795087;;
CLD0;confirmatory;;CHEMBL3215013;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686947;7;CHEMBL2073;;
CLD0;confirmatory;;CHEMBL3215015;[];;[];;;;;;B;Binding;BAO_0000217;biochemical format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Alphascreen Interference Assay Measured in Biochemical System Using Plate Reader - 2160-02_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720494;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215017;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720579;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215034;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: Thiazole Orange DNA Binding Counterscreen.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720499;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215035;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of Polymerase Kappa: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720501;7;CHEMBL5365;;
CLD0;confirmatory;;CHEMBL3215069;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Counterscreen for inhibitors of the HGIII-SPLA2: QFRET-based biochemical high throughput dose response assay to identify inhibitors that optically interfere with 535nm fluorescence.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743455;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215072;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. QFRET-based biochemical high throughput dose response assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2).   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743457;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215096;[];;[];;;;;;B;Binding;BAO_0000217;biochemical format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. C. difficile toxins: Counterscreen in absence of substrate UDPG Measured in Biochemical System Using Plate Reader - 7074-02_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720650;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215105;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720502;7;CHEMBL5542;;
CLD0;confirmatory;;CHEMBL3215106;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;743266;7;CHEMBL1793;;
CLD0;confirmatory;;CHEMBL3215169;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720533;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215181;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;"PubChem BioAssay. qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen.   (Class of assay: confirmatory) ";CHEMBL1201862;Default value - Target has yet to be curated;U;720542;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215185;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720538;7;CHEMBL2193;;
CLD0;confirmatory;;CHEMBL3215234;[];;[];;;;;;B;Binding;BAO_0000217;biochemical format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. ALPHAscreen artifact counterscreen Measured in Biochemical System Using Plate Reader - 7053-03_Inhibitor_Dose_CherryPick_Activity. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1053174;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215270;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720580;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215284;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720559;7;CHEMBL2487;;
CLD0;confirmatory;;CHEMBL3214809;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: BLM Helicase Counterscreen for WRN Inhibitors.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720503;7;CHEMBL1293237;;
CLD0;confirmatory;;CHEMBL3214817;[];;[];;;;;;B;Binding;BAO_0000217;biochemical format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720495;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214850;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter).   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720573;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214875;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for the Inhibitors of FEN1: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720498;7;CHEMBL5027;;
CLD0;confirmatory;;CHEMBL3214913;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720532;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214963;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;720496;7;CHEMBL5391;;
CLD0;confirmatory;;CHEMBL3214965;[];;[];;;;;;B;Binding;BAO_0000217;biochemical format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720512;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214970;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743244;7;CHEMBL612545;;
CLD0;;HEK293;CHEMBL3241169;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Unbound fraction in HEK293 cell homogenate at 0.1 uM by equilibrium dialysis based UPLC-MS/MS analysis;CHEMBL3232907;Non-molecular target assigned;N;659300;1;CHEMBL3879801;;
CLD0;;HEK293;CHEMBL3240728;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity against HEK293 cells overexpressing ABCG2 after 72 hrs by MTT assay;CHEMBL3232774;Non-molecular target assigned;N;660875;1;CHEMBL614818;;
CLD0;;HEK293;CHEMBL3240731;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity against HEK293 cells after 72 hrs by MTT assay;CHEMBL3232774;Non-molecular target assigned;N;660889;1;CHEMBL614818;;
CLD0;;P388;CHEMBL3252298;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 2 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667372;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252299;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 1 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667373;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252300;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 0.5 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667374;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252301;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 0.25 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667375;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252302;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.12'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 0.12 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667376;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252303;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.06', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.06'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 0.06 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667378;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252743;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 2 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667398;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252744;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 0.5 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667399;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252745;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 0.25 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667400;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252746;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.12'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 0.12 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667401;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252747;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.06', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.06'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 0.06 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667402;1;CHEMBL389;;
CLD0;;P388;CHEMBL3252762;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];BDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 2 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667417;1;CHEMBL375;;
CLD0;;P388;CHEMBL3252763;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];BDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 1 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667418;1;CHEMBL375;;
CLD0;;P388;CHEMBL3252764;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];BDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 0.5 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667419;1;CHEMBL375;;
CLD0;;P388;CHEMBL3252765;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}];BDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 0.25 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667420;1;CHEMBL375;;
CLD0;;P388;CHEMBL3252766;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.12'}];BDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 0.12 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667421;1;CHEMBL375;;
CLD0;;P388;CHEMBL3252767;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.06', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.06'}];BDF1;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 0.06 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667422;1;CHEMBL375;;
CLD0;;B16;CHEMBL3252370;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse assessed as survival at 2 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657050;1;CHEMBL381;;
CLD0;;B16;CHEMBL3252371;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse at 2 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657051;1;CHEMBL381;;
CLD0;;B16;CHEMBL3252372;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse assessed as survival at 1 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657052;1;CHEMBL381;;
CLD0;;B16;CHEMBL3252373;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse at 1 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657053;1;CHEMBL381;;
CLD0;;B16;CHEMBL3252374;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse assessed as survival at 0.5 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657054;1;CHEMBL381;;
CLD0;;B16;CHEMBL3252375;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse at 0.5 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657055;1;CHEMBL381;;
CLD0;;B16;CHEMBL3252376;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse assessed as survival at 0.25 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657056;1;CHEMBL381;;
CLD0;;B16;CHEMBL3252377;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse at 0.25 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657057;1;CHEMBL381;;
CLD0;;Colon 26;CHEMBL3252378;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.08', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.08'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307623;Target assigned is non-molecular;1;Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse assessed as survival at 1.08 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657059;1;CHEMBL614466;;
CLD0;;Colon 26;CHEMBL3252379;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.08', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.08'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307623;Target assigned is non-molecular;1;Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse at 1.08 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657060;1;CHEMBL614466;;
CLD0;;Colon 26;CHEMBL3252380;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.69', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.69'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307623;Target assigned is non-molecular;1;Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse assessed as survival at 0.69 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657062;1;CHEMBL614466;;
CLD0;;Colon 26;CHEMBL3252381;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.69', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.69'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307623;Target assigned is non-molecular;1;Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse at 0.69 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657063;1;CHEMBL614466;;
CLD0;;Colon 26;CHEMBL3252382;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.39', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.39'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307623;Target assigned is non-molecular;1;Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse assessed as survival at 0.39 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657064;1;CHEMBL614466;;
CLD0;;Colon 26;CHEMBL3252383;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.39', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.39'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307623;Target assigned is non-molecular;1;Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse at 0.39 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657065;1;CHEMBL614466;;
CLD0;;L1210;CHEMBL3252384;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '18.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '18.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 18 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657066;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3252385;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '18.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '18.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 18 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657069;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3252386;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.8', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.8'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 10.8 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657070;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3252387;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '10.8', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.8'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 10.8 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657071;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3252388;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 4 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657072;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256952;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '4.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '4.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 4 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657073;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256953;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 2 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657074;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256954;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 2 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657075;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256955;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 1 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657076;1;CHEMBL386;;
CLD0;;L1210;CHEMBL3256956;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 1 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657077;1;CHEMBL386;;
CLD0;;P388;CHEMBL3256957;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 2 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657080;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256958;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '2.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '2.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 2 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657081;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256959;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 1 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657083;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256960;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 1 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657084;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256961;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 0.5 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657085;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256962;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 0.5 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657086;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256963;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 0.25 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657087;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256964;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.25', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.25'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 0.25 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657088;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256965;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.12'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 0.12 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657091;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256966;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.12', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.12'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 0.12 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657092;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256967;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.06', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.06'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 0.06 mg/kg qd for 9 days;CHEMBL3244053;Non-molecular target assigned;N;657095;1;CHEMBL389;;
CLD0;;P388;CHEMBL3256968;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.06', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.06'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 0.06 mg/kg qd for 9 days relative to control;CHEMBL3244053;Non-molecular target assigned;N;657097;1;CHEMBL389;;
CLD0;;B16;CHEMBL3257129;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as increase in survival time at 1 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667429;1;CHEMBL381;;
CLD0;;B16;CHEMBL3257130;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.5'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as increase in survival time at 0.5 mg/kg administered 24 hrs post challenge relative to control;CHEMBL3244338;Non-molecular target assigned;N;667430;1;CHEMBL381;;
CLD0;;P388;CHEMBL3252590;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as minimum effective dose administered as single dose;CHEMBL3244336;Non-molecular target assigned;N;667312;1;CHEMBL389;;
CLD0;;B16;CHEMBL3252606;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '0.8', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '0.8'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as increase of median life span at 0.8 mg/kg, ip on day 1 to 9 measured up to 80 days relative to control;CHEMBL3244336;Non-molecular target assigned;N;667281;1;CHEMBL381;;
CLD0;;P388;CHEMBL3253029;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '6.2', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '6.2'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase of median life span at 6.2 mg/kg, ip on day 1, 5 and 9 measured up to 60 days relative to control;CHEMBL3244336;Non-molecular target assigned;N;667296;1;CHEMBL389;;
CLD0;;P388;CHEMBL3253031;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '1.6', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '1.6'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in mouse assessed as increase of median life span at 1.6 mg/kg, ip on day 1, 5 and 9 measured up to 60 days relative to control;CHEMBL3244336;Non-molecular target assigned;N;667298;1;CHEMBL389;;
CLD0;;B16;CHEMBL3253035;[{'assay_class_id': 114, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Spontaneous Autoimmune Diseases In Animals', 'source': 'Vogel_2008'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '3.1', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '3.1'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Intraperitoneal', 'standard_type': 'ROUTE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Intraperitoneal', 'type': 'ROUTE', 'units': None, 'value': None}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308454;Target assigned is non-molecular;1;Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as increase of median life span at 3.1 mg/kg, ip on day 1 to 9 measured up to 80 days relative to control;CHEMBL3244336;Non-molecular target assigned;N;667304;1;CHEMBL381;;
CLD0;;P388;CHEMBL3253039;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as minimum effective dose administered as once each 4 days for 3 total injection;CHEMBL3244336;Non-molecular target assigned;N;667313;1;CHEMBL389;;
CLD0;;P388;CHEMBL3253040;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted ip dosed mouse assessed as maximum tolerated dose administered as single dose;CHEMBL3244336;Non-molecular target assigned;N;667314;1;CHEMBL375;;
CLD0;;P388;CHEMBL3253041;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Toxicity in mouse P388 cells allografted ip dosed mouse assessed as maximum tolerated dose administered as once each 4 days for 3 total injection;CHEMBL3244336;Non-molecular target assigned;N;667315;1;CHEMBL375;;
CLD0;;P388;CHEMBL3253042;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose providing 40% increase in life span administered as single dose;CHEMBL3244336;Non-molecular target assigned;N;667317;1;CHEMBL389;;
CLD0;;P388;CHEMBL3253043;[{'assay_class_id': 89, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Leukemia Oncology Models', 'l3': 'P388 Experimental Leukemia', 'source': 'phenotype'}, {'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose providing 40% increase in life span administered as once each 4 days for 3 total injection;CHEMBL3244336;Non-molecular target assigned;N;667318;1;CHEMBL389;;
CLD0;;P388;CHEMBL3253044;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000218;organism-based format;CHEMBL3308401;Default value - Target unknown or has yet to be assigned;0;Therapeutic index, ratio of MTD for mouse P388 cells allografted ip dosed mouse to MED for mouse P388 cells allografted in ip dosed mouse administered as single dose;CHEMBL3244336;Default value - Target has yet to be curated;U;667321;1;CHEMBL612558;;
CLD0;;P388;CHEMBL3253045;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000218;organism-based format;CHEMBL3308401;Default value - Target unknown or has yet to be assigned;0;Therapeutic index, ratio of MTD for mouse P388 cells allografted ip dosed mouse to MED for mouse P388 cells allografted in ip dosed mouse administered as once each 4 days for 3 total injection;CHEMBL3244336;Default value - Target has yet to be curated;U;667322;1;CHEMBL612558;;
CLD0;;Lewis lung carcinoma cell line;CHEMBL3253046;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307859;Target assigned is non-molecular;1;Antitumor activity against mouse LLC cells subcutaneously implanted in mouse;CHEMBL3244336;Non-molecular target assigned;N;667330;1;CHEMBL614088;;
CLD0;;Lewis lung carcinoma cell line;CHEMBL3253047;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307859;Target assigned is non-molecular;1;Antitumor activity against mouse LLC cells intravenously implanted in mouse;CHEMBL3244336;Non-molecular target assigned;N;667331;1;CHEMBL614088;;
CLD0;;L5178Y;CHEMBL3253048;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307690;Target assigned is non-molecular;1;Ratio of adriamycin to compound for inhibition of RNA synthesis in mouse L5178Y cells;CHEMBL3244336;Non-molecular target assigned;N;667335;1;CHEMBL614720;;
CLD0;;L5178Y;CHEMBL3253049;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307690;Target assigned is non-molecular;1;Ratio of adriamycin to compound for inhibition of DNA synthesis in mouse L5178Y cells;CHEMBL3244336;Non-molecular target assigned;N;667337;1;CHEMBL614720;;
CLD0;;HepG2;CHEMBL3294562;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay;CHEMBL3286236;Non-molecular target assigned;N;687076;1;CHEMBL395;;
CLD0;;HEK293;CHEMBL3381157;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Intrinsic cytotoxicity against HEK293 cells assessed as reduction in cell viability after 72 hrs by MTT assay;CHEMBL3352248;Non-molecular target assigned;N;723192;1;CHEMBL614818;;
CLD0;;;CHEMBL3398686;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human purified MPG pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates by gel-based excision activity assay;CHEMBL3397015;Direct protein target assigned;D;727216;1;CHEMBL3396943;;
CLD0;;;CHEMBL3398687;[];Not specified;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Binding affinity to ethenoadenine containing 5'-TCGAGGATCCTGAGCTCGAGTCGACGXTCGCGAATTCTGCGGATCCAAGC-3' duplex oligonucleotide DNA (unknown origin) at 15 uM by SPR assay;CHEMBL3397015;Default value - Target has yet to be curated;U;727217;1;CHEMBL612545;;
CLD0;;;CHEMBL3411290;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human OATP1B1-mediated [3H]estrone 3-sulfate at 100 uM after 5 mins relative to control;CHEMBL3407465;Direct protein target assigned;D;732530;1;CHEMBL1697668;;
CLD0;;;CHEMBL3411292;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human OATP1B3-mediated [3H]CCK-8 at 100 uM after 5 mins relative to control;CHEMBL3407465;Direct protein target assigned;D;732532;1;CHEMBL1743121;;
CLD0;;;CHEMBL3411294;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human OATP1B3-mediated [3H]CCK-8 after 5 mins by Dixon plot method;CHEMBL3407465;Direct protein target assigned;D;732534;1;CHEMBL1743121;;
CLD0;;CHO;CHEMBL3436184;[];Cricetulus griseus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'CA_SOL_CONC', 'standard_type_fixed': 0, 'standard_units': 'mM', 'standard_value': '1.8', 'text_value': None, 'type': 'CA_SOL_CONC', 'units': 'mM', 'value': '1.8'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'QPatch automated patch clamp', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'QPatch automated patch clamp', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '-40', 'standard_type': 'HOLDING_POTENTIAL', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '-40', 'type': 'HOLDING_POTENTIAL', 'units': 'mV', 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'MEAS_VOLT', 'standard_type_fixed': 0, 'standard_units': 'mV', 'standard_value': '0.0', 'text_value': None, 'type': 'MEAS_VOLT', 'units': 'mV', 'value': '0.0'}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'T1_PULSE', 'standard_type_fixed': 0, 'standard_units': 'ms', 'standard_value': '150.0', 'text_value': None, 'type': 'T1_PULSE', 'units': 'ms', 'value': '150.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Ambient', 'standard_type': 'TEMP', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Ambient', 'type': 'TEMP', 'units': None, 'value': None}];;;10029.0;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Multiple homologous protein targets may be assigned;4;Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits;CHEMBL3436045;Homologous protein target assigned;H;150;1;CHEMBL2095229;;
CLD0;;;CHEMBL3537288;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Brain;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Fraction unbound in Sprague-Dawley rat brain homogenates at 5 uM by equilibrium dialysis analysis;CHEMBL3525927;Non-molecular target assigned;N;651117;1;CHEMBL613617;CHEMBL3638188;
CLD0;;;CHEMBL3537289;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Brain;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Unbound volume of distribution in Sprague-Dawley rat brain slices at 100 nM after 5 hrs;CHEMBL3525927;Non-molecular target assigned;N;651120;1;CHEMBL613617;CHEMBL3638188;
CLD0;;;CHEMBL3537290;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Plasma;A;ADME;BAO_0000366;cell-free format;;Target assigned is non-molecular;1;Unbound drug partitioning coefficient, Kp of the compound assessed as ratio of unbound concentration in Sprague-Dawley rat brain to unbound concentration in plasma;CHEMBL3525927;Non-molecular target assigned;N;651155;1;CHEMBL613617;CHEMBL3559721;
CLD0;;;CHEMBL3537296;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Brain;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Drug uptake in Sprague-Dawley rat brain slices at 100 nM after 5 hrs in presence of 10 uM of fumitremorgin-C;CHEMBL3525927;Non-molecular target assigned;N;651357;1;CHEMBL613617;CHEMBL3638188;
CLD0;;;CHEMBL3537297;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Brain;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Drug uptake in Sprague-Dawley rat brain slices at 100 nM after 5 hrs in presence of 20 uM of MK-571;CHEMBL3525927;Non-molecular target assigned;N;651359;1;CHEMBL613617;CHEMBL3638188;
CLD0;;;CHEMBL3537298;[];Rattus norvegicus;[];Sprague-Dawley;;10116.0;;Brain;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Drug uptake in Sprague-Dawley rat brain slices at 100 nM after 5 hrs in presence of 10 uM of fumitremorgin-C and 20 uM of MK-571;CHEMBL3525927;Non-molecular target assigned;N;651361;1;CHEMBL613617;CHEMBL3638188;
CLD0;;;CHEMBL3537618;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Dissociation constant, pKa of the basic compound by capillary electrophoresis-mass spectrometry analysis;CHEMBL3525927;Default value - Target has yet to be curated;U;651795;1;CHEMBL2362975;;
CLD0;;;CHEMBL3532944;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Dissociation constant, pKa of the acidic compound by capillary electrophoresis-mass spectrometry analysis;CHEMBL3525927;Default value - Target has yet to be curated;U;651113;1;CHEMBL2362975;;
CLD0;;Caco-2;CHEMBL3529272;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651650;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529273;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651651;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529274;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis;CHEMBL3526001;Default value - Target has yet to be curated;U;651652;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529276;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651654;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529277;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651655;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529278;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651656;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529279;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651657;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529280;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651658;1;CHEMBL612558;;
CLD0;;Caco-2;CHEMBL3529281;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Default value - Target unknown or has yet to be assigned;0;Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979;CHEMBL3526001;Default value - Target has yet to be curated;U;651659;1;CHEMBL612558;;
CLD0;;;CHEMBL3527758;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Fraction absorbed in human;CHEMBL3526001;Non-molecular target assigned;N;651649;1;CHEMBL372;;
CLD0;confirmatory;;CHEMBL3561973;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117303;7;CHEMBL612545;;
CLD0;confirmatory;C2C12;CHEMBL3561978;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308003;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117325;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561981;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117309;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561990;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117310;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3561991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117349;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561996;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. SW480 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117338;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562021;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. RKO viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117322;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562024;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117324;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562026;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117347;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562027;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117332;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562033;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117308;7;CHEMBL612545;;
CLD0;confirmatory;SNU-C1;CHEMBL3562038;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308249;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. SNU-C1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117323;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562043;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117337;7;CHEMBL612545;;
CLD0;confirmatory;THP-1;CHEMBL3562054;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;PubChem BioAssay. A cell based assay for assessing THP-1 cell cytotoxicity of Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G.   (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1117359;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL3562064;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117314;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562069;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Colo320 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117334;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562077;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. High Throughput Screening for Foot and Mouth Disease Virus Antivirals.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1159524;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562078;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. A TR-FRET Counter Screen assay to evaluate Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G.   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;1117362;7;CHEMBL4105850;;
CLD0;confirmatory;;CHEMBL3562085;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117318;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562088;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117315;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562112;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117311;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562115;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells in S-phase-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117348;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562119;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117298;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562120;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117351;7;CHEMBL612545;;
CLD0;confirmatory;C2C12;CHEMBL3562121;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308003;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117327;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562123;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. HT-29 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117330;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562124;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. DLD-1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117352;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562130;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117339;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562133;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117302;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562135;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117301;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562136;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117304;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562137;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117319;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562139;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117350;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562144;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117316;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562146;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117305;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562152;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117312;7;CHEMBL612545;;
CLD0;;HCT-116;CHEMBL3592575;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay;CHEMBL3588860;Non-molecular target assigned;N;753246;1;CHEMBL394;;
CLD0;;HeLa;CHEMBL3592576;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay;CHEMBL3588860;Non-molecular target assigned;N;753247;1;CHEMBL399;;
CLD0;;FM3;CHEMBL3592577;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Antiproliferative activity against human FM3 cells after 72 hrs by MTT assay;CHEMBL3588860;Non-molecular target assigned;N;753248;1;CHEMBL3879801;;
CLD0;;Ishikawa;CHEMBL3592578;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307675;Target assigned is non-molecular;1;Antiproliferative activity against human Ishikawa cells after 72 hrs by MTT assay;CHEMBL3588860;Non-molecular target assigned;N;753249;1;CHEMBL614649;;
CLD0;;Daudi;CHEMBL3592579;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307579;Target assigned is non-molecular;1;Antiproliferative activity against human Daudi cells after 72 hrs by MTT assay;CHEMBL3588860;Non-molecular target assigned;N;753250;1;CHEMBL614281;;
CLD0;;MES-SA ;CHEMBL3592580;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Target assigned is non-molecular;1;Antiproliferative activity against human MES-SA cells after 72 hrs by MTT assay;CHEMBL3588860;Non-molecular target assigned;N;753251;1;CHEMBL3879801;;
CLD0;;MES-SA/Dx5;CHEMBL3592581;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308373;Target assigned is non-molecular;1;Antiproliferative activity against human MES-SA/Dx5 cells after 72 hrs by MTT assay;CHEMBL3588860;Non-molecular target assigned;N;753252;1;CHEMBL3879801;;
CLD0;;MES-SA ;CHEMBL3592582;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307599;Default value - Target unknown or has yet to be assigned;0;Ratio of IC50 for human MES-SA/Dx5 cells to IC50 for human MES-SA cells;CHEMBL3588860;Default value - Target has yet to be curated;U;753253;1;CHEMBL612545;;
CLD0;;MCF7;CHEMBL3599765;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells;CHEMBL3596161;Non-molecular target assigned;N;755920;1;CHEMBL387;;
CLD0;;MCF-7 FLV1000;CHEMBL3599769;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human MCF-7 FLV1000 cells expressing ABCB2;CHEMBL3596161;Non-molecular target assigned;N;755924;1;CHEMBL3879801;;
CLD0;;;CHEMBL3706545;[];Homo sapiens;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSED_COMPOUND_ID', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': '2582827.0', 'text_value': None, 'type': 'DOSED_COMPOUND_ID', 'units': None, 'value': '2582827.0'}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Mitoxantrone', 'standard_type': 'DOSED_COMPOUND_NAME', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Mitoxantrone', 'type': 'DOSED_COMPOUND_NAME', 'units': None, 'value': None}];;;9606.0;In vivo;Urine;A;ADME;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Percentage of administered dose recovered as unchanged drug in urine within 48 h of drug administration;CHEMBL3706496;Default value - Target has yet to be curated;U;1;31;CHEMBL612558;CHEMBL3638201;
CLD0;;HEK293;CHEMBL3734567;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Direct single protein target assigned;9;Inhibition of Tet-induced Flag-tagged mouse TRPM7 expressed in HEK293 cells assessed as inhibition of channel-mediated cell death in presence of Mg2+ incubated for 24 to 48 hrs by propidium iodide uptake assay;CHEMBL3727350;Direct protein target assigned;D;811347;38;CHEMBL3714706;;
CLD0;;HEK293;CHEMBL3734568;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Effect on Tet-induced Flag-tagged mouse TRPM7 expression in HEK293 cells;CHEMBL3727350;Non-molecular target assigned;N;811350;38;CHEMBL614818;;
CLD0;;;CHEMBL3749672;[];Bos taurus;[];;;9913.0;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Binding affinity to calf thymus double stranded DNA by spectrophotometric titration method;CHEMBL3745659;Molecular target other than protein assigned;M;791646;1;CHEMBL612514;;
CLD0;;A549;CHEMBL3755739;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells after 24 hrs by MTT assay;CHEMBL3751820;Non-molecular target assigned;N;792388;1;CHEMBL392;;
CLD0;;C6;CHEMBL3755740;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308345;Target assigned is non-molecular;1;Cytotoxicity against rat C6 cells after 24 hrs by MTT assay;CHEMBL3751820;Non-molecular target assigned;N;792398;1;CHEMBL614657;;
CLD0;;5RP7;CHEMBL3755741;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against rat 5RP7 cells after 24 hrs by MTT assay;CHEMBL3751820;Non-molecular target assigned;N;792399;1;CHEMBL3879801;;
CLD0;;NIH3T3;CHEMBL3755742;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay;CHEMBL3751820;Default value - Target has yet to be curated;U;792400;1;CHEMBL612558;;
CLD0;;HaCaT;CHEMBL3788872;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308509;Target assigned is non-molecular;1;Cytotoxicity against human HaCaT cells by Cell titre-blue assay;CHEMBL3785064;Non-molecular target assigned;N;817672;1;CHEMBL614392;;
881056;;HL-60;CHEMBL3881620;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human mitoxantrone-sensitive HL60 cells;CHEMBL3881525;Non-molecular target assigned;N;;38;CHEMBL3879801;;
881057;;HL-60;CHEMBL3881621;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human mitoxantrone-resistant HL60/MX2 cells;CHEMBL3881525;Non-molecular target assigned;N;;38;CHEMBL3879801;;
881058;;HL-60;CHEMBL3881622;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of IC50 for human mitoxantrone-sensitive HL60 cells to IC50 for human mitoxantrone-resistant HL60/MX2 cells;CHEMBL3881525;Non-molecular target assigned;N;;38;CHEMBL383;;
881174;;Jurkat;CHEMBL3881634;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;Induction of apoptosis in human Jurkat cells assessed as caspase3 activation;CHEMBL3881525;Non-molecular target assigned;N;;38;CHEMBL397;;
881175;;Jurkat;CHEMBL3881635;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;Cytotoxicity against human Jurkat cells;CHEMBL3881525;Non-molecular target assigned;N;;38;CHEMBL3879801;;
881178;;Jurkat;CHEMBL3881636;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;Cytotoxicity against human Jurkat cells assessed as cell death;CHEMBL3881525;Non-molecular target assigned;N;;38;CHEMBL3879801;;
881210;;HL-60;CHEMBL3881650;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Ratio of EC50 for human mitoxantrone-sensitive HL60 cells to EC50 for human mitoxantrone-resistant HL60/MX2 cells;CHEMBL3881525;Non-molecular target assigned;N;;38;CHEMBL383;;
1;;;CHEMBL3885882;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daily Repeat', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daily Repeat', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 50 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
901416;;;CHEMBL3997694;[];Mus musculus;[];;Nucleus;10090.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug uptake in mouse 4T1.2 cell nucleus at 5 uM after 4 hrs by laser scanning confocal microscopic method;CHEMBL3994676;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
901417;;;CHEMBL3997695;[];Mus musculus;[];;Nucleus;10090.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug uptake in mouse 4T1.2 cell nucleus at 5 uM encapsulated within cucurbit[8]uril after 4 hrs by laser scanning confocal microscopic method;CHEMBL3994676;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
901418;;;CHEMBL3997696;[];Mus musculus;[];;Lysosome;10090.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Drug uptake in mouse 4T1.2 cell lysosomes at 5 uM encapsulated within cucurbit[8]uril after 20 mins by LysoTracker Green staining based laser scanning confocal microscopic method;CHEMBL3994676;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
901419;;4T1.2;CHEMBL3997697;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4483001;Target assigned is non-molecular;1;Growth inhibition of mouse 4T1.2 cells up to 20000 nM after 48 hrs by MTT assay;CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL4483221;;
901420;;4T1.2;CHEMBL3997698;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4483001;Target assigned is non-molecular;1;Growth inhibition of mouse 4T1.2 cells up to 20000 nM encapsulated within cucurbit[8]uril after 48 hrs by MTT assay;CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL4483221;;
901421;;;CHEMBL3997699;[];Mus musculus;[];Balb/c;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Balb/c mouse assessed as body weight loss at 2 mg/kg, iv administered twice weekly for 2 weeks relative to control;CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL375;;
901422;;;CHEMBL3997700;[];Mus musculus;[];Balb/c;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Balb/c mouse assessed as body weight loss at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks;CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL375;;
901423;;;CHEMBL3997701;[];Mus musculus;[];Balb/c;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Toxicity in Balb/c mouse implanted with mouse 4T1.2 cells assessed as body weight loss at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks;CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL375;;
901424;;4T1.2;CHEMBL3997702;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL4483001;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as tumor growth inhibition at 2 mg/kg, iv administered twice weekly for 2 weeks;CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL4483221;;
901425;;4T1.2;CHEMBL3997703;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL4483001;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as tumor growth inhibition at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks;CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL4483221;;
901426;;4T1.2;CHEMBL3997704;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL4483001;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as mouse survival time at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks measured up to 33 days;CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL4483221;;
901427;;4T1.2;CHEMBL3997705;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL4483001;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as mouse survival rate at 2 mg/kg, iv administered twice weekly for 2 weeks measured up to 33 days (rvb = 30%);CHEMBL3994676;Non-molecular target assigned;N;;1;CHEMBL4483221;;
905987;;L1210;CHEMBL4006907;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity against mouse L1210 cells assessed as reduction in cell viability after 24 hrs by MTT assay;CHEMBL4004858;Non-molecular target assigned;N;;1;CHEMBL386;;
905988;;NIH3T3;CHEMBL4006908;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307716;Target assigned is non-molecular;1;Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell viability after 24 hrs by MTT assay;CHEMBL4004858;Non-molecular target assigned;N;;1;CHEMBL614822;;
905989;;;CHEMBL4006909;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Selectivity index, ratio of IC50 for mouse NIH/3T3 cells to IC50 for mouse L1210 cells;CHEMBL4004858;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
911630;;;CHEMBL4029349;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
911633;;;CHEMBL4029350;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
931981;;HL-60;CHEMBL4029720;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 72 hrs by sulforhodamine B assay;CHEMBL4028815;Non-molecular target assigned;N;;1;CHEMBL383;;
931982;;HL60/MX2;CHEMBL4029721;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Cytotoxicity against human HL60/MX2 cells after 72 hrs by sulforhodamine B assay;CHEMBL4028815;Non-molecular target assigned;N;;1;CHEMBL4296431;;
931985;;;CHEMBL4029723;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance index, ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells;CHEMBL4028815;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
911983;;HL-60;CHEMBL4050875;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay;CHEMBL4049418;Non-molecular target assigned;N;;1;CHEMBL383;;
912060;;HL60/MX2;CHEMBL4050952;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Antiproliferative activity against human HL60/MX2 cells after 72 hrs by MTT assay;CHEMBL4049418;Non-molecular target assigned;N;;1;CHEMBL4296431;;
912061;;;CHEMBL4050953;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance factor, ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells;CHEMBL4049418;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
996856;;;CHEMBL4138020;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Growth inhibition of human umbilical cord cells;CHEMBL4130641;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
996858;;Bone marrow cell;CHEMBL4138021;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL4295341;Target assigned is non-molecular;1;Growth inhibition of human bone marrow cells;CHEMBL4130641;Non-molecular target assigned;N;;1;CHEMBL4296515;;
1003890;;;CHEMBL4138765;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of ROS1 (unknown origin) using poly (Glu,Tyr)4:1 substrate and ATP incubated for 60 mins by ELISA;CHEMBL4138072;Direct protein target assigned;D;;1;CHEMBL5568;;
1003891;;HCC78;CHEMBL4138766;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Cytotoxicity in human HCC78 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003892;;CCD 19Lu;CHEMBL4138767;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308347;Target assigned is non-molecular;1;Cytotoxicity in human CCD-19Lu cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay;CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL614538;;
1003893;;HCC78;CHEMBL4138768;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry;CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003898;;HCC78;CHEMBL4138773;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as viable cells level at 5 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 80.8%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003899;;HCC78;CHEMBL4138774;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as early apoptotic cells level at 5 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 6.33%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003900;;HCC78;CHEMBL4138775;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as late apoptotic cells level at 5 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 13.8%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003901;;HCC78;CHEMBL4138776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as necrotic cells level at 5 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 0.06%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003902;;HCC78;CHEMBL4138777;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as viable cells level at 10 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 80.8%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003903;;HCC78;CHEMBL4138778;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as early apoptotic cells level at 10 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 6.33%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003904;;HCC78;CHEMBL4138779;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as late apoptotic cells level at 10 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 13.8%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003905;;HCC78;CHEMBL4138780;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as necrotic cells level at 10 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 0.06%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003906;;HCC78;CHEMBL4138781;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as viable cells level at 20 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 80.8%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003907;;HCC78;CHEMBL4138782;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as early apoptotic cells level at 20 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 6.33%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003908;;HCC78;CHEMBL4138783;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as late apoptotic cells level at 20 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 13.8%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003909;;HCC78;CHEMBL4138784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295389;Target assigned is non-molecular;1;Induction of apoptosis in human HCC78 cells assessed as necrotic cells level at 20 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 0.06%);CHEMBL4138072;Non-molecular target assigned;N;;1;CHEMBL4296421;;
1003914;;HCC78;CHEMBL4138789;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of ROS1 phosphorylation in human HCC78 cells incubated for 48 hrs by Western blot method;CHEMBL4138072;Direct protein target assigned;D;;1;CHEMBL5568;;
1003915;;HCC78;CHEMBL4138790;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of ROS1 in human HCC78 cells assessed as reduction in STAT3 phosphorylation incubated for 48 hrs by Western blot method;CHEMBL4138072;Direct protein target assigned;D;;1;CHEMBL5568;;
1003916;;HCC78;CHEMBL4138791;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of ROS1 in human HCC78 cells assessed as reduction in AKT phosphorylation incubated for 48 hrs by Western blot method;CHEMBL4138072;Direct protein target assigned;D;;1;CHEMBL5568;;
1003917;;HCC78;CHEMBL4138792;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of ROS1 in human HCC78 cells assessed as reduction in ERK phosphorylation incubated for 48 hrs by Western blot method;CHEMBL4138072;Direct protein target assigned;D;;1;CHEMBL5568;;
1002531;;;CHEMBL4143718;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE-mediated Ubcl2-NEDD8 conjugation in human Caco2 cells at 10 uM after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002536;;;CHEMBL4143719;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE-mediated Ubcl2-NEDD8 conjugation in human Caco2 cells after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002538;;;CHEMBL4143720;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Direct protein complex subunits assigned;7;Inhibition of NAE (unknown origin) assessed as decrease in NAE-mediated Ubc12-NEDD8 conjugation levels preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002558;;;CHEMBL4143721;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Direct protein complex subunits assigned;7;Inhibition of SAE (unknown origin) assessed as decrease in SAE-mediated Ubc9-SUMO conjugation levels up to 10 uM preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL2095174;;
1002573;;;CHEMBL4143722;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of UAE1 (unknown origin) assessed as decrease in UAE1-mediated Ubc10-ubiquitin conjugation levels up to 10 uM preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL5924;;
1002594;;;CHEMBL4143723;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Direct protein complex subunits assigned;7;Competitive inhibition of NAE (unknown origin) assessed as decrease in NAE-mediated Ubc12-NEDD8 conjugation levels at 10 uM preincubated for 10 mins followed by Mg2+ and various concentrations of ATP addition measured after 60 mins by Lineweaver-Burk plot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002599;;;CHEMBL4143724;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000223;protein complex format;;Direct protein complex subunits assigned;7;Inhibition of NAE (unknown origin) assessed as decrease in NAE-mediated Ubc12-NEDD8 conjugation levels at 10 uM treated for 10 mins post ATP and Mg2+ addition measured after 60 mins by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002609;;;CHEMBL4143725;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as increase in p53 protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002610;;Caco-2;CHEMBL4143726;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Upregulation of p53 protein levels in NAE knockdown human Caco2 cells at 10 uM after 16 hrs by Western blot analysis;CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002612;;;CHEMBL4143727;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as increase in p53 protein levels at 1 to 10 uM after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002623;;;CHEMBL4143728;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as increase in p53 protein levels by measuring p53 degradation at 10 uM preincubated for 16 hrs followed by cycloheximide addition measured up to 60 mins by Western blot analysis relative to control;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002624;;;CHEMBL4143729;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells harboring p53-luc plasmid assessed as increase in p53 transcriptional activity after 16 hrs by luciferase reporter gene assay;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002626;;;CHEMBL4143730;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as increase in beta-catenin protein levels after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002627;;;CHEMBL4143731;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as increase in c-myc protein levels after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002629;;;CHEMBL4143732;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as increase in p27 protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002630;;;CHEMBL4143733;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as decrease in cyclin D1 protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002631;;;CHEMBL4143734;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as decrease in Bcl2 protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002632;;;CHEMBL4143735;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of NAE in human Caco2 cells assessed as increase in phosphorylated NF-kappaB protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL3831283;;
1002640;;Caco-2;CHEMBL4143736;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as viable cells at 1 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 98.4%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002641;;Caco-2;CHEMBL4143737;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as early apoptotic cells at 1 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 1.40%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002642;;Caco-2;CHEMBL4143738;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as late apoptotic cells at 1 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.072%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002643;;Caco-2;CHEMBL4143739;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as necrotic cells at 1 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.12%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002644;;Caco-2;CHEMBL4143740;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as viable cells at 5 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 98.4%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002645;;Caco-2;CHEMBL4143741;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as early apoptotic cells at 5 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 1.40%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002646;;Caco-2;CHEMBL4143742;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as late apoptotic cells at 5 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.072%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002647;;Caco-2;CHEMBL4143743;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as necrotic cells at 5 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.12%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002648;;Caco-2;CHEMBL4143744;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as viable cells at 10 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 98.4%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002649;;Caco-2;CHEMBL4143745;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as early apoptotic cells at 10 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 1.40%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002650;;Caco-2;CHEMBL4143746;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as late apoptotic cells at 10 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.072%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002651;;Caco-2;CHEMBL4143747;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Induction of apoptosis in human Caco2 cells assessed as necrotic cells at 10 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.12%);CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002656;;Caco-2;CHEMBL4143748;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay;CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002658;;Caco-2;CHEMBL4143749;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Cytotoxicity against NAE-knockdown human Caco2 cells after 72 hrs by MTT assay;CHEMBL4138244;Non-molecular target assigned;N;;1;CHEMBL614058;;
1002832;;;CHEMBL4143750;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct protein complex subunits assigned;7;Inhibition of SAE-mediated Ubc9-SUMO conjugation in human Caco2 cells up to 10 uM preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL2095174;;
1002833;;;CHEMBL4143751;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of UAE1-mediated Ubc10-ubiquitin conjugation in human Caco2 cells up to 10 uM preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis;CHEMBL4138244;Direct protein target assigned;D;;1;CHEMBL5924;;
969928;;;CHEMBL4185153;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay;CHEMBL4184129;Direct protein target assigned;D;;1;CHEMBL5619;;
1016978;;HCT-116;CHEMBL4196661;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay;CHEMBL4196011;Non-molecular target assigned;N;;1;CHEMBL394;;
1016979;;HT-29;CHEMBL4196662;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay;CHEMBL4196011;Non-molecular target assigned;N;;1;CHEMBL384;;
1016980;;HeLa;CHEMBL4196663;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay;CHEMBL4196011;Non-molecular target assigned;N;;1;CHEMBL399;;
1016981;;K562;CHEMBL4196664;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells after 48 hrs by MTT assay;CHEMBL4196011;Non-molecular target assigned;N;;1;CHEMBL385;;
1016982;;HepG2;CHEMBL4196665;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay;CHEMBL4196011;Non-molecular target assigned;N;;1;CHEMBL395;;
1027570;;;CHEMBL4233267;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Resistance index, ratio of IC50 for antiproliferative activity against human HL60/MX2 cells to IC50 for antiproliferative activity against human HL60 cells;CHEMBL4229419;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1027569;;HL60/MX2;CHEMBL4233274;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Antiproliferative activity against human HL60/MX2 cells after 72 hrs by SRB assay;CHEMBL4229419;Non-molecular target assigned;N;;1;CHEMBL4296431;;
1027567;;HL-60;CHEMBL4233275;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay;CHEMBL4229419;Non-molecular target assigned;N;;1;CHEMBL383;;
1007273;;Jurkat;CHEMBL4253055;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;Induction of apoptosis in human Jurkat T cells assessed as downregulation of Bcl2 expression at 10 uM after 48 hrs by Western blot analysis;CHEMBL4251586;Non-molecular target assigned;N;;1;CHEMBL397;;
GP_020;;;CHEMBL4296184;[];Staphylococcus aureus subsp. aureus;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 43300;;46170.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL2366800;;
GN_001;;;CHEMBL4296185;[];Escherichia coli;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 25922;;562.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL354;;
GN_003;;;CHEMBL4296186;[];Klebsiella pneumoniae;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 700603;;573.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL350;;
GN_042;;;CHEMBL4296187;[];Pseudomonas aeruginosa;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 27853;;287.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL348;;
GN_034;;;CHEMBL4296188;[];Acinetobacter baumannii;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Bacterial Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Bacterial Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD600)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD600)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 19606;;470.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL614425;;
FG_001;;;CHEMBL4296189;[];Candida albicans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Absorption (OD530)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Absorption (OD530)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 90028;;5476.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL366;;
FG_002R;;;CHEMBL4296190;[];Cryptococcus neoformans;"[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Inhibition of Fungal Growth', 'standard_type': 'ASSAY_TEST', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Inhibition of Fungal Growth', 'type': 'ASSAY_TEST', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Resazurin; Absorption (OD600-OD570)', 'standard_type': 'DETECTION_METHOD', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Resazurin; Absorption (OD600-OD570)', 'type': 'DETECTION_METHOD', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'CAMHB', 'standard_type': 'MEDIA', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'CAMHB', 'type': 'MEDIA', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '384well; NBS; CORNING #3640 ', 'standard_type': 'PLATE_TYPE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '384well; NBS; CORNING #3640 ', 'type': 'PLATE_TYPE', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_type_fixed': 0, 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '18.0'}]";ATCC 208821;;5207.0;In vitro;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)";CHEMBL4296181;Non-molecular target assigned;N;;40;CHEMBL365;;
1_ELL;;Caco-2;CHEMBL4303805;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307519;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging;CHEMBL4303101;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_HEI;;HRCE;CHEMBL4303810;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4303839;Target assigned is non-molecular;1;Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits);CHEMBL4303122;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_TOU;;Vero C1008;CHEMBL4303819;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs;CHEMBL4303097;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1160019;;A549;CHEMBL4316387;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Multiple direct protein targets may be assigned;5;Inhibition of Nedd8-cullin1 adduct formation in human A549 cells assessed as decrease in cullin1 neddylation at 75 uM measured after 6 hrs by Western blot analysis;CHEMBL4312031;Direct protein target assigned;D;;1;CHEMBL4523655;;
1160020;;A549;CHEMBL4316388;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307651;Multiple direct protein targets may be assigned;5;Inhibition of Nedd8-cullin1 adduct formation in human A549 cells assessed as decrease in cullin1 neddylation at 50 uM measured after 6 hrs by Western blot analysis;CHEMBL4312031;Direct protein target assigned;D;;1;CHEMBL4523655;;
1088442;;A549;CHEMBL4316822;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells after 48 hrs by MTT assay;CHEMBL4316584;Non-molecular target assigned;N;;1;CHEMBL392;;
1175427;;;CHEMBL4322536;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of BCRP in human HEK293/R2 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay;CHEMBL4321806;Direct protein target assigned;D;;1;CHEMBL5393;;
1175428;;;CHEMBL4322537;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of MRP1 in human 2008/MRP1 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay;CHEMBL4321806;Direct protein target assigned;D;;1;CHEMBL3004;;
1175429;;;CHEMBL4322538;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Inhibition of MDR in human LCC6MDR cells assessed as reduction in cell viability after 5 days by MTS/PMS assay;CHEMBL4321806;Direct protein target assigned;D;;1;CHEMBL4302;;
1175430;;HEK293;CHEMBL4322539;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307715;Target assigned is non-molecular;1;Cytotoxicity against human HEK293 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay;CHEMBL4321806;Non-molecular target assigned;N;;1;CHEMBL614818;;
1175431;;2008;CHEMBL4322540;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308015;Target assigned is non-molecular;1;Antiproliferative activity against human 2008 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay;CHEMBL4321806;Non-molecular target assigned;N;;1;CHEMBL612818;;
1175432;;;CHEMBL4322541;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Antiproliferative activity against human LCC6 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay;CHEMBL4321806;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1175433;;;CHEMBL4322542;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance factor, ratio of IC50 for human HEK293/R2 cells overexpressing BCRP to IC50 for human HEK293 cells;CHEMBL4321806;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1175434;;;CHEMBL4322543;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance factor, ratio of IC50 for human 2008/MRP1 cells overexpressing MRP1 to IC50 for human 2008 cells;CHEMBL4321806;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1175435;;;CHEMBL4322544;[];Homo sapiens;[];;;9606.0;;;U;Unassigned;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Resistance factor, ratio of IC50 for human LCC6MDR cells overexpressing P-gp to IC50 for human LCC6 cells;CHEMBL4321806;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1196370;;U2OS;CHEMBL4345279;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307757;Direct single protein target assigned;9;Inhibition of MTH1 in human U2OS cells assessed as activation of p53 at 2.25 uM incubated for 4 and 24 hrs by Peggy sue Western blot assay;CHEMBL4342490;Direct protein target assigned;D;;1;CHEMBL3708265;;
1115331;;Bel-7402;CHEMBL4348375;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307770;Target assigned is non-molecular;1;Cytotoxicity against human Bel7402 cells assessed as reduction in cell viability preincubated for 5 hrs followed by compound washout and measured after 48 hrs by CCK8 assay;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614279;;
1115333;;MCF7;CHEMBL4348377;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Cytotoxicity against human MCF7 cells assessed as reduction in cell viability preincubated for 5 hrs followed by compound washout and measured after 48 hrs by CCK8 assay;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL387;;
1115335;;A-375;CHEMBL4348379;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308077;Target assigned is non-molecular;1;Cytotoxicity against human A375 cells assessed as reduction in cell viability preincubated for 5 hrs followed by compound washout and measured after 48 hrs by CCK8 assay;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL613859;;
1115337;;H22;CHEMBL4348381;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Dark toxicity against mouse H22 cells assessed as reduction in cell viability preincubated for 5 hrs followed by compound washout and measured after 48 hrs by CCK8 assay;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1115345;;H22;CHEMBL4348389;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Induction of immunogenic cell death in mouse H22 cells assessed as increase in extracellular ATP level at 2 uM measured after 5 hrs by chemiluminescence-based assay;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1115346;;H22;CHEMBL4348390;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Induction of immunogenic cell death in mouse H22 cells assessed as extracellular ATP level at 2 uM measured after 24 hrs by chemiluminescence-based assay;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1115426;;H22;CHEMBL4348393;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Induction of immunogenic cell death in mouse H22 cells assessed as increase in extracellular HMGB1 level at 2 uM incubated for 5 hrs by ELISA;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1115350;;H22;CHEMBL4348395;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Induction of immunogenic cell death in mouse H22 cells assessed as increase in calreticulin level in cell surface at 2 uM incubated for 5 hrs by Hoechst staining based fluorescence microscopic analysis;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1115354;;H22;CHEMBL4348399;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antitumor activity against mouse H22 cells allografted in immunocompetent Balb/c mouse assessed as inhibition of tumour formation at 2 uM incubated with cells for 5 hrs prior to 20 mins 2 mW/cm2 UVA irradiation post compound washout followed by vaccination and measured within 5 days;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1115355;;H22;CHEMBL4348400;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antitumor activity against mouse H22 cells allografted in immunocompetent Balb/c mouse assessed as decrease in lump formation at challenge site at 2 uM incubated with cells for 5 hrs followed by compound washout prior to vaccination and subsequent H22 cells addition 10 days post vaccination and measured over 30 days;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1117434;;H22;CHEMBL4348406;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antitumor activity against mouse H22 cells allografted in immunocompetent Balb/c mouse assessed as decrease in lump formation in vaccination site at 2 uM incubated with cells for 5 hrs prior to 20 mins 2 mW/cm2 UVA irradiation post compound washout followed by vaccination and measured over 30 days;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1118978;;H22;CHEMBL4348409;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307751;Target assigned is non-molecular;1;Induction of immunogenic cell death in mouse H22 cells assessed as increase in intracellular calreticulin level at 2 uM measured after 5 hrs by flow cytometric analysis;CHEMBL4346685;Non-molecular target assigned;N;;1;CHEMBL614998;;
1128186;;NCI-H460;CHEMBL4354738;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Cytotoxicity against human NCI-H460 cells assessed as inhibition of cell viability incubated for 2 hrs by MTT assay;CHEMBL4351028;Non-molecular target assigned;N;;1;CHEMBL396;;
1128187;;;CHEMBL4354739;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human NCI-H460/MX20 cells assessed as inhibition of cell viability incubated for 2 hrs by MTT assay;CHEMBL4351028;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1144250;;;CHEMBL4360119;[];Mycobacterium smegmatis;[];atR10;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis atR10 assessed as decrease in drug resistance development at 10 nmol/disc after 2 to 3 days by paper disc method;CHEMBL4359813;Non-molecular target assigned;N;;1;CHEMBL613088;;
1144251;;;CHEMBL4360120;[];Mycobacterium smegmatis;[];atR17;;1772.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antimycobacterial activity against Mycobacterium smegmatis atR17 assessed as decrease in drug resistance at 10 nmol/disc after 2 to 3 days by paper disc method;CHEMBL4359813;Non-molecular target assigned;N;;1;CHEMBL613088;;
1064386;;HL-60;CHEMBL4384569;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Antiproliferative activity against human HL60 cells after 72 hrs by CCK8 assay;CHEMBL4382251;Non-molecular target assigned;N;;1;CHEMBL383;;
1064387;;A549;CHEMBL4384570;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay;CHEMBL4382251;Non-molecular target assigned;N;;1;CHEMBL392;;
1064388;;SGC-7901;CHEMBL4384571;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307739;Target assigned is non-molecular;1;Antiproliferative activity against human SGC7901 cells after 72 hrs by sulforhodamine B assay;CHEMBL4382251;Non-molecular target assigned;N;;1;CHEMBL614909;;
1_KUZ;;;CHEMBL4495582;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate;CHEMBL4495564;Direct protein target assigned;D;;52;CHEMBL4523582;;
1_LEY;;Vero C1008;CHEMBL4513082;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4495565;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1208882;;;CHEMBL4617047;[];Not specified;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Stabilization of [32P]-labelled dsDNA (unknown origin) assessed as drug-DNA adduct formation by measuring adduct half life incubated for 12 hrs in presence of formaldehyde by phosphorimaging analysis;CHEMBL4616593;Molecular target other than protein assigned;M;;1;CHEMBL4649922;;
1208875;;;CHEMBL4617048;[];Not specified;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Stabilization of [32P]-labelled dsDNA (unknown origin) assessed as drug-DNA adduct formation at 5 uM in presence of formaldehyde incubated for 12 hrs by phosphorimaging analysis relative to control;CHEMBL4616593;Molecular target other than protein assigned;M;;1;CHEMBL4649922;;
1208907;;;CHEMBL4617059;[];Not specified;[];;;;;;B;Binding;BAO_0000225;nucleic acid format;;Target assigned is molecular non-protein target;3;Stabilization of dsBE12 oligonucleotide (unknown origin) assessed as drug-DNA adduct formation at 5 to 50 uM incubated for 4 hrs in presence of formaldehyde using [gamma-32P]ATP by phosphorimaging analysis relative to control;CHEMBL4616593;Molecular target other than protein assigned;M;;1;CHEMBL4649922;;
1212431;;;CHEMBL4627527;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of TDP-43 (unknown origin) binding to RNA;CHEMBL4627248;Direct protein target assigned;D;;1;CHEMBL2362981;;
CARE_1_ELL;;Vero C1008;CHEMBL4651403;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4651402;Non-molecular target assigned;N;;57;CHEMBL4303835;;
1249412;;HepG2;CHEMBL4677485;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay;CHEMBL4673288;Non-molecular target assigned;N;;1;CHEMBL395;;
1249409;;K562;CHEMBL4677486;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay;CHEMBL4673288;Non-molecular target assigned;N;;1;CHEMBL385;;
1256650;;SMMC-7721;CHEMBL4717323;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Antiproliferative activity against human SMMC-7221 cells assessed as inhibition of cell proliferation at 1 uM measured after 48 hrs by MTT assay relative to control;CHEMBL4715719;Non-molecular target assigned;N;;1;CHEMBL613831;;
1256651;;SMMC-7721;CHEMBL4717324;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308059;Target assigned is non-molecular;1;Antiproliferative activity against human SMMC-7221 cells assessed as inhibition of cell proliferation at 5 uM measured after 48 hrs by MTT assay relative to control;CHEMBL4715719;Non-molecular target assigned;N;;1;CHEMBL613831;;
1256654;;HepG2;CHEMBL4717327;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation at 1 uM measured after 48 hrs by MTT assay relative to control;CHEMBL4715719;Non-molecular target assigned;N;;1;CHEMBL395;;
1256655;;HepG2;CHEMBL4717328;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation at 5 uM measured after 48 hrs by MTT assay relative to control;CHEMBL4715719;Non-molecular target assigned;N;;1;CHEMBL395;;
1256658;;QSG7701;CHEMBL4717331;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human QSG7701 cells assessed as inhibition of cell proliferation at 1 uM measured after 48 hrs by MTT assay relative to control;CHEMBL4715719;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1256659;;QSG7701;CHEMBL4717332;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity against human QSG7701 cells assessed as inhibition of cell proliferation at 5 uM measured after 48 hrs by MTT assay relative to control;CHEMBL4715719;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1256876;;H22;CHEMBL4717355;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antitumor activity against mouse H22 cells implanted in Kunming mouse assessed as reduction in tumor weight at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days (Rvb = 2.15 +/- 0.51 g);CHEMBL4715719;Non-molecular target assigned;N;;1;CHEMBL614998;;
1256881;;H22;CHEMBL4717360;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antitumor activity against mouse H22 cells implanted in Kunming mouse assessed as tumor growth inhibition at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days relative to control;CHEMBL4715719;Non-molecular target assigned;N;;1;CHEMBL614998;;
1256886;;;CHEMBL4717365;[];Mus musculus;[];Kunming;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in Kunming mouse implanted with mouse H22 cells assessed as change in mouse body weight at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days (Rvb = 21 %);CHEMBL4715719;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1256888;;;CHEMBL4717366;[];Mus musculus;[];Kunming;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in iv dosed Kunming mouse assessed as maximum tolerated dose;CHEMBL4715719;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1256893;;H22;CHEMBL4717371;[{'assay_class_id': 93, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Metastatic Oncology Models', 'l3': 'Metastatic Activity', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antimetastatic activity against mouse H22 cells implanted in Kunming mouse assessed as number of metastatic focus at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days (Rvb = 5.73 +/- 14.6 No_unit);CHEMBL4715719;Non-molecular target assigned;N;;1;CHEMBL614998;;
1256898;;H22;CHEMBL4717376;[{'assay_class_id': 93, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Metastatic Oncology Models', 'l3': 'Metastatic Activity', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307751;Target assigned is non-molecular;1;Antimetastatic activity against mouse H22 cells implanted in Kunming mouse assessed as inhibition of metastasis at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days relative to control;CHEMBL4715719;Non-molecular target assigned;N;;1;CHEMBL614998;;
1256903;;;CHEMBL4717381;[];Mus musculus;[];Kunming;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in Kunming mouse implanted with mouse H22 cells assessed as change in body weight at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days (Rvb = 5.2 %);CHEMBL4715719;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1257880;;;CHEMBL4717397;[];Mus musculus;[];;;10090.0;;;T;Toxicity;BAO_0000218;organism-based format;;Default value - Target unknown or has yet to be assigned;0;Toxicity in Kunming mouse implanted with mouse H22 cells assessed as mouse mortality at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days;CHEMBL4715719;Default value - Target has yet to be curated;U;;1;CHEMBL612558;;
1429344;;K562;CHEMBL5106141;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells assessed as inhibition of cell growth;CHEMBL5104159;Non-molecular target assigned;N;;1;CHEMBL385;;
1429346;;A549;CHEMBL5106143;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Antiproliferative activity against human A549 cells assessed as inhibition of cell growth;CHEMBL5104159;Non-molecular target assigned;N;;1;CHEMBL392;;
1429347;;HeLa;CHEMBL5106144;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Target assigned is non-molecular;1;Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth;CHEMBL5104159;Non-molecular target assigned;N;;1;CHEMBL399;;
1410428;;4T1;CHEMBL5138850;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307995;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as apoptotic rate of dissected tumor cell at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by flow cytometric analysis (Rvb = 64.83%);CHEMBL5137015;Non-molecular target assigned;N;;1;CHEMBL612589;;
1410303;;4T1;CHEMBL5138891;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307995;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as tumor growth inhibition by measuring T/C ratio at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate;CHEMBL5137015;Non-molecular target assigned;N;;1;CHEMBL612589;;
1410380;;4T1;CHEMBL5138893;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];Balb/c;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307995;Target assigned is non-molecular;1;Protection of Balb/c mouse spleen implanted with mouse 4T1 cells at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate;CHEMBL5137015;Non-molecular target assigned;N;;1;CHEMBL375;;
1410388;;4T1;CHEMBL5138894;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307995;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as tumor growth inhibition at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate relative to control;CHEMBL5137015;Non-molecular target assigned;N;;1;CHEMBL612589;;
1410417;;4T1;CHEMBL5138895;[];Mus musculus;[];Balb/c;;10090.0;;Heart;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307995;Default value - Target unknown or has yet to be assigned;0;Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as heart lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis;CHEMBL5137015;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3638187;
1410421;;4T1;CHEMBL5138896;[];Mus musculus;[];Balb/c;;10090.0;;Liver;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307995;Default value - Target unknown or has yet to be assigned;0;Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as liver lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis;CHEMBL5137015;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559723;
1410423;;4T1;CHEMBL5138897;[];Mus musculus;[];Balb/c;;10090.0;;Spleen;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307995;Default value - Target unknown or has yet to be assigned;0;Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as spleen lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis;CHEMBL5137015;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3559722;
1410424;;4T1;CHEMBL5138898;[];Mus musculus;[];Balb/c;;10090.0;;Lung;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307995;Default value - Target unknown or has yet to be assigned;0;Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as lung lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis;CHEMBL5137015;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3638235;
1410425;;4T1;CHEMBL5138899;[];Mus musculus;[];Balb/c;;10090.0;;Kidney;T;Toxicity;BAO_0000218;organism-based format;CHEMBL3307995;Default value - Target unknown or has yet to be assigned;0;Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as kidney lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis;CHEMBL5137015;Default value - Target has yet to be curated;U;;1;CHEMBL612558;CHEMBL3638241;
1410427;;4T1;CHEMBL5138900;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307995;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as nuclei disappearance at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate;CHEMBL5137015;Non-molecular target assigned;N;;1;CHEMBL612589;;
1410432;;4T1;CHEMBL5138901;[{'assay_class_id': 115, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Neoplasm Oncology Models', 'l3': 'Neoplasms', 'source': 'phenotype'}];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307995;Target assigned is non-molecular;1;Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as TUNEL positive cells at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by TUNEL staining analysis;CHEMBL5137015;Non-molecular target assigned;N;;1;CHEMBL612589;;
1376720;;U2OS;CHEMBL5160425;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;Antitumor immunity against human U2OS cells assessed as inhibition of RNA synthesis at 3 uM pretreated for 2.5 hrs by bright field microscopic analysis;CHEMBL5154772;Non-molecular target assigned;N;;1;CHEMBL615023;;
1376772;;U2OS;CHEMBL5160428;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;Antitumor immunity against human U2OS cells assessed as decrease in ATP by measuring reduction in quinacrine green fluorescence intensity at 3 uM pretreated for 24 hrs by live fluorescence microscopic analysis;CHEMBL5154772;Non-molecular target assigned;N;;1;CHEMBL615023;;
1376784;;U2OS;CHEMBL5160430;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;Antitumor immunity against human U2OS cells expressing CALR-GFP fusion protein assessed as accumulation CALR-GFP fusion protein at 3 uM measured upto 24 hrs by live cell microscopic analysis;CHEMBL5154772;Non-molecular target assigned;N;;1;CHEMBL615023;;
1376788;;U2OS;CHEMBL5160432;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307757;Target assigned is non-molecular;1;Antitumor immunity against human U2OS cells expressing HMGBI-GFP fusion protein assessed as accumulation HMGBI-GFP fusion protein at 3 uM measured upto 24 hrs by live cell microscopic analysis;CHEMBL5154772;Non-molecular target assigned;N;;1;CHEMBL615023;;
